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SUMMARY
Heart failure is characterised by abnormalities of m yocardial systolic and 
diastolic function. While there are changes in the structure of the heart 
which could account, in part, for these abnorm alities, there is strong 
evidence to suggest that the regulation of calcium within the failing cardiac 
myocyte is abnormal. A diminished ability to release and sequester calcium 
could give rise to such contractile abnormalities and so the sarcoplasmic 
reticulum (SR), as the main site for calcium uptake and release, is the major 
focus of study in this thesis.
Two rabbit m odels of heart failure were studied: adriam ycin-induced 
cardiom yopathy and coronary artery ligation. The adriam ycin-treated  
animals were studied 2 weeks after stopping 8 weeks of chronic intravenous 
administration. The coronary ligation animals were studied in two groups : 8 
weeks after ligation and 15 weeks after ligation. The effects of down- 
regulation of adrenoreceptors on SR function was studied in a rabbit model 
following 7 days continuous administration of isoprenaline by mini-osmotic 
pum p. Lastly, hum an ventricular trabeculae were studied  from  patients 
undergoing cardiac transplantation and are presented as a separate chapter. 
The severity of heart failure was assessed in each rabbit by echocardiography 
and by invasive m easurem ent of cardiac ou tpu t and left ventricular 
pressures.
The preparation chosen to study the SR was the saponin-treated cardiac 
ventricular trabecula. This preparation has a number of advantages in that it 
leaves the SR anatomically undisrupted, the SR can load and leak calcium in 
a physiological way, the permeabilised sarcolemma allows free access to 
d rugs and chemicals and the m yofilam ents m ay be assessed both in 
association w ith the SR and independently following treatm ent w ith the 
detergent Triton-XlOO. Furthermore, in our hands, this technique is very
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reliable and reproducible which is extremely im portant since very few 
animals which started the protocol, for any of the models, failed to produce 
results from the saponin-treated fibres. This has im portant implications for 
animal suffering.
Sarcoplasmic reticulum  function was assessed in the rabbit m odel of 
ad riam y c in -in d u ced  card io m y o p a th y . The m eth o d  for in d u c in g  
cardiom yopathy is described in chapter 2 (methods 1) and the results are 
described in chapter 3. U nfortunately few anim als w ith significant left 
ventricular dysfunction were produced but those with ejection fractions of 
less than 45% dem onstrated enhanced SR Calcium loading com pared with 
saline-treated controls and w ith adriam ycin treated anim als w ith higher 
ejection fractions. The ability of the m yofilaments to produce force was 
unaffected by chronic treatm ent w ith  adriam ycin  and  the calcium  
responsiveness of the myofilam ents was also unaffected by adriam ycin 
treatm ent.
8 weeks after coronary ligation, rabbits w ith significant left ventricular 
dysfunction dem onstrated enhanced SR calcium uptake com pared w ith 
controls. A group of ligation anim als w ith less severe left ventricular 
dysfunction, assessed by a scoring system, also dem onstrated enhanced SR 
calcium loading but the difference between this group and sham -operated 
controls was less marked. Additionally , this enhanced SR calcium loading 
was correlated with a num ber of indices of heart failure including ejection 
fraction, left ventricular end-diastolic pressure and resting cardiac output. 
E nhanced  SR calcium  loading  w as associated  w ith  an increased  
p red isposition  to calcium overload, revealed as spontaneous tension 
oscillations. These oscillations were observed more frequently in the ligated 
anim als and at lower loading calcium concentrations than in the control 
anim als. This pattern of SR loading was observed in both left and right 
ventricular preparations although the greatest increase in SR loading was
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observed in the left ventricle. The ability of the myofilaments to produce 
force was not altered in the left ventricle but there was a fall in the 
m axim um  force produced by trabeculae from the right ventricle in the 
ligated group. The calcium responsiveness of the m yofilam ents was not 
different between groups.
Chapter 4 examines SR calcium loading 15 weeks after coronary ligation. In 
these animals there was no significant difference in SR calcium loading 
ability  betw een ligation and control trabeculae. The ligated  anim als 
dem onstrated significant left ventricular dysfunction but this was not more 
severe than that observed in 8 week animals. Myofilament force production 
was unaltered as was calcium responsiveness of the myofilaments.
Chapter 6 examines possible changes in the SR calcium release mechanism. 
There was no difference in the sensitivity of the m echanism  of caffeine- 
induced  calcium release in ligation anim als com pared w ith  controls. 
Trabeculae from ligation animals appeared more sensitive to the calcium 
channel blocking agent, ryanodine, w hen app lied  d u rin g  susta ined  
oscillations. In a separate set of experiments SR calcium leak was assessed. 
There was a tendency for ligation trabeculae to dem onstrate less SR calcium 
leak compared with controls.
C hapter 7 examines sarcoplasmic reticulum  calcium loading in rabbits 
infused w ith isoprenaline for a period of 7 days. There was evidence of 
p-receptor down-regulation in isoprenaline treated animals assessed in-vivo 
by invasive measurements of cardiac output, left ventricular pressures and 
heart rate response to isoprenaline. In isolated saponin-treated ventricular 
trabeculae, there was no significant difference in SR calcium loading ability 
betw een isoprenaline and saline infused anim als. M yofilam ent force 
production was unaltered and calcium responsiveness was also unaffected. 
H um an right ventricular trabeculae were obtained from hearts of patients 
undergoing transplantation. Following saponin-treatm ent, SR function was
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found to be inversely correlated with the severity of heart failure as assessed 
by a range of haemodynamic variables and by radio nuclide left ventricular 
ejection fraction. Patien ts w ith  m oderate ly  im paired  LV function  
dem onstrated greater SR calcium loading ability than patients with severely 
im paired  LV function. Patients w ith idiopathic dilated cardiom yopathy 
dem onstrated  reduced SR calcium loading com pared w ith  patients with 
m oderate ly  im paired LV function. M yofilam ent force p roduction  and 
calcium responsiveness was not correlated with severity of heart failure. 
Chapter 9 compares the response of SR calcium loading to cAMP in ligation 
rabbits, isoprenaline-infused rabbits and failing hum an trabeculae. Of all the 
preparations studied, hum an trabeculae demonstrated the greatest response 
to cAMP while isoprenaline-infused rabbits dem onstrated a significantly 
greater response than their respective saline-treated controls. Ligation rabbits 
dem onstrated a slightly greater response than the sham -operated controls but 
this was less marked than the isoprenaline-infused rabbits and the hum an 
trabeculae.
In the concluding chapter these results are considered together. The 
adriam ycin-induced cardiom yopathy may represent a m ore com plicated 
m odel of left ventricular dysfunction since this drug has specific effects on 
the SR in addition to possible secondary changes resulting from  heart failure. 
The enhanced calcium loading ability in ligation animals at 8 weeks may 
represent a compensatory phase, in the rabbit, resulting from  ventricular 
overload  following m yocardial infarction. This phenom enon m ay have 
implications for arrhythmogenesis early in the developm ent of heart failure. 
W ith time, SR calcium loading ability reduces such that at 15 weeks there is 
no significant difference from controls, p-receptor dow n-regulation appears 
to play no direct role in the SR calcium pum p changes observed in the rabbit. 
In the hum an, SR calcium loading ability dim inishes w ith  increasing 
severity of heart failure. The level of phosphorylation of the SR calcium
XVI
pum p may play a major part in the observed SR calcium loading ability in 
saponin-treated cardiac trabeculae in this study.
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CHAPTER 1 
General Introduction
1
INTRODUCTION
Heart failure: a definition
There are a number of definitions of heart failure which take account of the 
force of contraction of the heart, oxygen delivery to the tissues and the 
response of this system to increased demands of the body. The simplest, by 
far, is that of Wood (1950): "A state in which the heart fails to maintain an 
adequate circulation for the needs of the body despite a satisfactory filling  
pressure ". However, this definition takes no account of w ider and more 
generalised changes resulting from chronic heart failure. A more holistic and 
progressive definition of heart failure was proposed by Poole-Wilson :
" A  clinical syndrome caused by an abnormality of the heart and recognised 
by a characteristic pattern of haemodynamic, renal, neural and hormonal 
responses
A brief historical account of heart failure
The earliest recorded diagnosis and attempted treatment of heart failure was 
that of the fatal illness of Alexius I, ruler of the Byzantine Empire from 1081- 
1118. His daughter noted that the attending physicians “felt his pulse and
found all kinds of irregularities  he was unable to lie on either side  for
never for one moment could he breath freely. He was forced to sit upright to
breath at all but when his stomach was visibly enlarged and his feet also
swelled up, some of the doctors with scant regard for the fever had recourse 
to cauterisation" (Lutz, 1988).
Theophile Bonet (1620-1689) published detailed accounts of the clinico- 
pathology of patients w ith valvular heart disease and heart failure and 
linked the increase in size of the cardiac chambers to the sym ptom s of 
dyspnoea and oedema. Francesco Albertini (1662-1738) described pulm onary 
oedema and associated this with dyspnoea. Jean Baptiste de Senac (1693-1770) 
also drew  attention to the association of dyspnoea, orthopnoea and oedema
as a m anifestations of heart failure (East, 1958). Perhaps the m ost famous 
therapeutic advance of that era was made by William W ithering (1741-1791) 
w hen he discovered the benefits of the extract of the Foxglove (Willius & 
Keys, 1941).
The nineteenth century saw a num ber of advances in the understanding of 
heart failure. Pierre Potain (1825-1901) described the origin of gallop rhythm 
while Ludwig Traube (1818-1876) described pulsus alternans in severe heart 
failure. The underlying cause of heart failure rem ained obscure although 
valvular heart disease was the major contribution. Peter M alunsten (1811- 
1883) prov ided  evidence that coronary occlusion was associated w ith 
m yocardial infarction and Charles Fagge (1838-1883) described areas of focal 
fibrosis in a series of patients dying from heart failure.
T herapeutic options in heart failure were extrem ely lim ited un til the 
tw entieth century. Venesection, starvation, and purgation were commonly 
prescribed remedies. Reginald Southey (1835-1899) advocated the use of his 
eponym ous tubes for the relief of peripheral oedema introduced through the 
skin and allowing fluid to drain directly from the tissues. The discovery of 
m ercurial com pounds as diuretics in the early tw entieth century w as the 
m ost significant pharmacological advance in the treatm ent of heart failure 
since W ithering had discovered digitalis (Baldry, 1971). Following this, a 
series of less toxic compounds with potent diuretic effects were m anufactured 
over the next fifty years. Ernest Starling (1866-1927), in 1914, provided  an 
understand ing  of the physiological m echanism by which the concept of 
altering the load on the heart, using vasodilators, was based. In the last 
tw enty years the use of drugs which produce changes in pre-load and after­
load have improved the symptoms of heart failure but have failed to reduce 
m ortality which has remained as high as 50% for one year. Only in recent 
years have we been able to see a true im provem ent in the survival from
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heart failure brought about by the use of angiotensin converting enzyme 
inhibitors.
Heart failure in the 1990's
"During the last decade heart failure has evolved into the most important 
public health problem in cardiovascular medicine " (Garg, Packer, P itt & 
Yusuf, 1993). In the United Kingdom it is estimated that the cost of treating 
people with heart failure is now in excess of £300 million per year which 
represents 1.2% of the NHS budget (McMurray & Hart, 1993). In the United 
States heart failure is estimated to affect 1.5% of the population at an annual 
cost to the nation of $8 billion. The problem has arisen as a result of a 
num ber of factors but mainly due to increasing longevity. The Framingham 
study clearly indicated that the incidence of heart failure rises dramatically 
w ith age, with a tenfold increase between 59 and 80 years (Ho, Anderson, 
Kannel, Grossman & Levy, 1993). Increased life expectancy, as a result of 
improvements in health care and general living conditions, has largely been 
responsible for this epidemic (Pitt, 1993).
A num ber of studies, using large numbers of patients in carefully designed 
protocols, have yielded im portant clinical information both of the clinical 
course of the disease and of the appalling prognosis even when treated with 
conventional drug therapy. In the Framingham study a diagnosis of heart 
failure, based on clinical criteria, was associated with a m edian survival time 
of 1.7 years in men and 3.2 years in women, with a five year survival of 25% 
and 38% for men and women respectively (Ho et al, 1993). D isappointingly, 
the age adjusted incidence of heart failure has reduced by only 11% per 
calendar decade in men and by 17% per calendar decade in women in the last 
40 years despite the advances in treatm ent of ischaemic heart disease and 
hypertension which were the major underlying causes of heart failure in the 
Fram ingham  population. In the SOLVD registry (6273 patients w ith radio 
nuclide ejection fractions of less than 45%) the most common cause of heart
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failure was ischaemic heart disease (70%) with hypertension contributing in 
32% of blacks and 4% of white cases. The 1 year total mortality rate was 18% 
w ith  19% having at least one hospital admission with a diagnosis of heart 
failure during  the first year of follow-up. The m ost significant factor 
influencing endpoints of death and hospital admission w ith heart failure 
w as age. The event rate was low under the age of 55 and increased 
progressively thereafter.
Several large studies have now addressed the question of whether drugs can 
alter outcome in heart failure. The combination of vasodilators, hydralazine 
and isosorbide dinitrate, was found to significantly reduce m ortality (Cohn, 
Johnson, Ziesche et al, 1986) with further benefit obtained by the use of 
enalapril (Cohn, Johnson, Ziesche et al, 1991). There are now  a num ber of 
studies which indicate that ACE inhibitors can significantly reduce mortality 
in patients w ith severe heart failure (CONSENSUS), patients w ith reduced 
ejection fraction and mild to moderate heart failure (SOLVD trial, 1991, Cohn 
et al, 1991) and patients w ith asym ptom atic left ventricular dysfunction 
(SAVE, 1992, SOLVD, 1992). These trials are often associated with only small 
reductions in mortality but because mortality is so high in heart failure, even 
a small reduction results in a significant number of lives saved.
D espite the therapeutic benefits conveyed by ACE inhibition, the overall 
effect on m ortality is m odest and mortality from heart failure remains high 
even w ith treatm ent - possibly around 20% in 1 year. There is, therefore, a 
need  for im proved understanding of the pathophysiological processes 
invo lved  in heart failure to allow the developm ent of new  clinical 
therapeutic strategies.
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The pathophysiology of heart failure
In patients with heart failure cardiac ou tpu t is often norm al at rest but 
typically fails to increase with exercise or stress so that vasoconstriction must 
occur to m aintain blood pressure. This is brought about by activation of a 
num ber of physiological mechanisms which act to m aintain or increase 
blood pressure including the renin/angiotensin system and the sympathetic 
nervous system. The physiological effects of this are w idespread and affect 
the peripheral, renal and pulm onary circulations. V irtually every major 
organ of the body, with the exception of the brain, is affected in heart failure 
w ith changes occurring in the kidney, lung, skeletal muscle and, of course, 
the heart.
Anatomical and structural changes in the failing heart
Gross structural changes occur in the heart as a result of heart failure which 
have profound effects on function. A reduction in cardiac muscle mass as a 
result of myocardial infarction is the most common clinical cause of myocyte 
loss although apoptosis secondary to viral infection or toxic damage may play 
a role in the muscle loss observed in dilated cardiomyopathy.
Ventricular wall tension is described by the law of Laplace :
T o c r . P
w here P is the transm ural pressure, r is the radius of the chamber and T is 
wall tension. It is clear from this relationship that an increase in end-diastolic 
volum e and end-diastolic pressure, such as occur in heart failure, will have 
p ro found  effects on the tension within the wall of the ventricle. This 
increase in wall stress is thought to initiate the process of cellular 
hypertrophy  (Pfeffer & Braunwauld, 1990). Nuclear im aging has allowed 
repeated assessments of ventricular function in patients w ith heart failure 
over a period of 1-2 years (Pouleur, Konstam, Udelson & Rouseau, 1993). 
This study indicated that, with time, systolic ejection fraction decreases and
the ventricle dilates producing an increases in wall tension. As the ventricle 
dilates, there follows a period of compensation afforded by the Starling 
m echanism  and compensatory cellular hypertrophy. This m aintains the 
ejection fraction at a relatively stable level despite fu rther d ilatation. 
However, if the ability of the heart to compensate is overcome by progressive 
dilatation then ejection fraction falls further and clinical heart failure will 
follow. Throughout this period of remodelling inco-ordinate contraction 
resu lting  from  infarction or abnorm al electrical activation  m ay also 
contribute to LV dysfunction.
There are additional abnormalities of cellular architecture in the failing heart 
w hich m ay give rise to contractile dysfunction. The m yocard ium  is 
composed of a number of different cell types. The largest tissue component, 
by far, is that of the cardiac myocyte which makes-up approximately 75% of 
the total mass but represents only one third of the total num ber of cells (Zak, 
1973). The remaining two thirds include fibroblasts, vascular smooth muscle 
cells and  endothelial cells. Changes in these, such as occur d u ring  
rem odelling, will dramatically alter the structure and function of the heart. 
The relative proportions of type III to type I collagen are a ltered  in 
hypertrophied  rat heart (Doering, Jalil, Janicki et al, 1983) and a similar 
alteration in the production of collagen can be reproduced in cultured cardiac 
fibroblasts exposed to mechanical stretch (Carver, Nagpal & Nachtigal et al,
1991). These changes in collagen production to less elastic forms tends to 
reduce the compliance of the ventricle. The stiffness of the m yocardium  is 
also affected by m edial thickening of intra-m yocardial coronary arteries 
a lthough  the overall contribution of this is probably relatively  small 
com pared to that of collagen (O'Brien & Moore, 1966). While these factors 
will clearly influence relaxation they may have additional influences on the 
ability of the heart to develop force. A stiffer extracellular m atrix  may 
dim inish the ability of the myocyte to generate force as a result of being
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"encased in concrete". Myocardial cell slippage may cause abnormal cellular 
alignm ent which will affect the ability of the syncytium to develop tension 
and m ay also affect the mechanism and co-ordination of cellular activation 
(Schaper & Schaper, 1983, Weber & Brilla, 1991).
In addition to biophysical factors which may alter the structure of the failing 
heart, there are a num ber of neurohormonal factors which may also play a 
role. Angiotensin II is known to have powerful direct effects on myocardial 
cell g row th  and function (L indpainter & G anten, 1991). Local tissue 
production of angiotensin II may be im portant and some of the benefits of 
ACE inhibitors in heart failure may be m ediated by a reduction in tissue 
levels of the ACE (Lindpainter et al, 1991). A lthough angiotensin II is 
though t to have inotropic effects on the heart, the effects of the renin- 
angiotensin system on fibroblast activity, mediated by aldosterone (Weber & 
Brilla, 1991), may be more important.
8
Cellular aspects of failing myocardium
The intrinsic ability of isolated cardiac myofilam ents to produce force is 
unaltered in heart failure (Newman, 1983) and although significant shifts in 
m yosin isoenzymes have been described in anim al m odels (Greenen, 
Malhotra & Scheuer, 1989) such changes may be less im portant in the failing 
hum an myocardium (Solaro, Powers, Gao & Gwathmey, 1993). Mechanisms 
underlying contractile dysfunction have, therefore, been a ttribu ted  to a 
num ber of cellular processes such as shifts in adrenoreceptor populations 
(Bristow & Grunsburg, 1982), reduced levels of high energy phosphates 
(Conway, Allis, H ardy et al, 1991) and abnorm alities of Ca2+ regulation 
(Morgan, 1992).
M yofilament changes in heart failure
A num ber of changes have been described in the structure and function of 
the cardiac myofilaments during the developm ent of heart failure. One 
consistent biochemical finding, for both small m am m al and hum an heart 
failure, is a depression of Ca2+-dependent MgATPase activity (Pagani, Alousi, 
Grant et al, 1988, Geenen, Malhotra & Scheuer, 1989). In small mammals this 
has been attributed to a change in the ventricular myosin heavy chain (MHC) 
w ith a shift from faster forms (VI) to slower more efficient (V3) forms 
(Mercadier et al, 1981). However, there have been no reported changes in the 
expression of MHC in hum an heart failure and so an alternative mechanism 
to explain the observed depression of Mg2+-ATPase activity has been sought. 
Familial cardiomyopathy has been shown to be associated w ith a m utation 
on the myosin molecule which could alter the ATPase rate (Feldman, Ray, 
Silanef al, 1991). The ATPase rate may also be affected by loss of myosin light 
chain-2 (MLC-2) in human heart failure (Margossian, White, Caulfield et al, 
1992).
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There is growing evidence that the expression of thin filament proteins may 
change in heart failure (Anderson, Malouf, Pagani & Allen, 1991, Hunkeler, 
Kullman & M urphy, 1991). There are a number of phosphorylation sites on 
the thin filaments which can alter Mg2+-ATPase activity of myosin (England, 
1976) and can also alter Ca2+ responsiveness (Herzig, Kohler, Pfitzer, Ruegg, 
Wolffe, 1981). Solaro et al (1993) have proposed an additional mechanism by 
which an alteration in co-operativity between weakly and strongly bound 
cross-bridges may influence myosin ATPase rate and play a role in the 
changes observed in the failing hum an heart.
These molecular changes have been supported in some studies by evidence 
indicating a functional difference in myofilaments in heart failure. Increased 
C a 2+ sensitivity, which fails to increase further w ith stretch, has been 
reported  in ventricular strips isolated from patients w ith  heart failure 
(Schwinger, Bohm, Koch et al, 1994). These authors proposed that this lack of 
response to stretch represents an inability of the failing heart to use the 
Frank-Starling mechanism. However, since they failed to m easure sarcomere 
length directly in these preparations it is not clear w hether this was a 
consequence of reduced compliance or a true loss of the mechanism of length 
sensitivity of the myofilaments. In another study from the same group no 
difference was found in the Ca2+ sensitivity of failing hum an ventricular 
fibres (Wankerl, Bohm, Morano et al, 1990). A num ber of other studies have 
also failed to demonstrate a difference in steady state Ca2+ sensitivity of the 
m yofilam ents (D 'Agnolo, Luciano, Mazucco, Gallucci & Salviati, 1992, 
G w athm ey & Hajjar, 1990). There is, therefore, no consistent change in 
myofibrillar responsiveness to Ca2+ in heart failure. However, one consistent 
finding  is that the maximal response of the m yofilam ents to Ca2+ is 
unchanged in heart failure in the hum an (Hajjar, Grossm an & Gwathmey,
1992) and  in a num ber of animal models (see review by Gw athm ey & 
Davidoff, 1993).
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Adrenoreceptor changes in heart failure
H eart failure induces widespread activation of the neurohorm onal system 
w hich results in high circulating levels of adrenaline and noradrenaline. 
Spill-over of noradrenaline from the failing heart, which is not taken up  by 
m yocardial nerve endings, accounts for 30-50% of the circulating pool 
(Hasking, Esler, Jennings et al, 1986). This chronic stim ulation results in 
dow n-regulation of pi-receptors (reduction in receptor density) w ith no 
significant down regulation of p2-receptors but with a m odest uncoupling of 
the p2-response (Bristow, H ershberger, Port, R asm ussen, 1989). This 
uncoupling of response occurs between the p-receptor and adenylate-cyclase 
by increased activity of a G-inhibitory (Gi) peptide with no significant change 
in the G-stim ulatory (Gs) peptide (Feldman, Gates, Veazey et al, 1988). This 
results in dim inished production of cyclic adenosine m onophosphate which 
attenuates the activation of protein kinase C. Interestingly, this dim inished 
response to P-receptor stim ulation occurs predom inantly  in the failing 
ventricle and does not appear in the non-failing ventricle (e.g. LV in primary 
pulm onary  hypertension) despite high circulating levels of catecholamines 
(Bristow, Minobe, Rasmussen et al, 1992).
The a i-response  of hum an heart is not as marked as that of the rabbit (Bing 
et al, 1990). H ow ever, there is evidence for an increased response to 
a -ag o n ists  in the failing hum an heart and this has been supported  by 
evidence indicating an increase in the levels of a i-recep to r m-RNA (Bristow,
1993). This m ay be brought about by so-called cross-regulation betw een P- 
receptors and ai-receptors.
The overall effect of this redistribution of the adrenoreceptor population is 
decreased num bers of Pi-receptors, uncoupling of the p2-response and an 
increase in the a i-response.
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Excitation contraction coupling in the normal heart
Before discussing abnormalities of excitation contraction coupling in heart 
failure it would seem appropriate to review the main features of the process 
as it occurs in the normal heart. In lower vertebrates, such as the frog, Ca2+ 
influx during the action potential raises intracellular Ca2+ sufficiently to 
produce contraction (Morad & Goldm an, 1973). In m am m alian cardiac 
m uscle, Ca2+ entry triggers a further release of Ca2+ from an intracellular 
store, the sarcoplasmic reticulum. The mechanism which allows this is a 
C a2+-activated Ca2+ release channel in the SR m em brane - the ryanodine 
receptor (Fabiato, 1983). There is considerable experim ental evidence to 
support this mechanism including studies using photolytic release of caged 
C a2+. Flash photolysis causes a small, step-increase in intracellular [Ca2+] 
which stimulates the SR to release stored Ca2+ thus producing contraction. In 
the presence of ryanodine this process fails to produce contraction (Naebauer 
& Morad, 1990).
The Ca2+ transient
D uring a single activation Ca2+ rises and falls w ithin the cytosol and this 
transitory rise in Ca2+ is now commonly termed the Ca2+ transient. However, 
a lthough  the Ca2+ transient, as an experim ental m easurem ent, is now  
discussed widely in the literature as a standard m easure of Ca2+ release 
within the cell, in fact, there are a number of factors which may influence its 
am plitude and duration. The conditions under which the Ca2+ transient is 
m easured  vary w idely from study to study and from  p repara tion  to 
preparation. In the intact cell, Ca2+ entry via the slow inw ard current and SR 
C a2+ release contribute to the rising phase while SR Ca2+-reuptake and the 
N a+/C a 2+ exchanger contribute to the decline phase. The sarcolemmal Ca2+ 
pum p, m itochondral Ca2+ uptake and binding of Ca2+ to intracellular sites 
(troponin C, calmodulin, (Cheung, 1980)) will also act to reduce [Ca2+]i.
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Possible variation in these factors is often ignored in the description of the 
Ca2+ transient.
The sarcoplasmic reticulum
The sarcoplasmic reticulum  (SR) is the m ain source of activator Ca2+ in 
m am m alian myocytes and contributes m ost to the Ca2+ transient (Fabiato, 
1983, N aebauer et al, 1990, M arban & W eir, 1985). The SR has a well 
c h a rac te rise d  A T P -dependen t C a2+ pum p that is d istinct from  the 
sarcolem m al Ca2+ pump. There appears to be two skeletal SR Ca2+-p u m p  
proteins with 84% homogeneity. One is from fast twitch skeletal muscle and 
the other, similar to that of cardiac muscle, is from slow tw itch skeletal 
muscle (MacLennan, Brandi, Bozena & Green, 1985). The transport reaction 
occurs with two Ca2+ ions transported and one ATP molecule hydrolysed by a 
process involving -
(i) binding of Ca2+ to high affinity sites on the cytosolic surface (ii) transfer of 
the terminal phosphate of the ATP molecule to an aspartate residue on the 
SR pum p (iii) reduced affinity of the receptor for Ca2+ on the lum inal side of 
the SR and extrusion of Ca2+ into the lumen.
Regulation of the SR Ca2+-pump
The main difference between the skeletal muscle SR Ca2+-pum p and that of 
cardiac muscle is that the latter is regulated by the protein phospholamban. 
W hen phosphorylated  by cAM P-dependent protein  kinase this protein 
stimulates the Ca2+-pump by producing a 3 to 5 fold decrease in the Km (Ca2+) 
(Shamoo, Ambudkar & Jacobson et al, 1985). Hicks et al (Hicks, Shigekawa & 
Katz, 1990) proposed that phospholam ban has an inhibitory effect on the 
C a2+-pum p which is diminished after phosphorylation thus allowing it to 
work at rates similar to that observed in skeletal muscle. This enhanced Ca2+- 
up take has been show n to be the dom inant m echanism  by w hich 
catecholamines produce an increase in force and relaxation in cardiac muscle
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by increasing the total Ca2+ content of the SR and the rate of sequestration 
(Kranias & Solaro, 1982).
The activity of the SR Ca2+-pum p is regulated by a num ber of other factors 
including [ATP], [ADP], pH and inorganic phosphate (Pi). The Kd for ATP is 
of the order of lpM  and so during ischaemia ATP would have to fall to very 
low levels before there was a significant decline in SR Ca2+-pum ping. Low 
pH  has also been shown to reduce the activity of the pum p in isolated single 
myocytes (Fabiato & Fabiato, 1978) which is consistent w ith  the effects of 
acidosis in multicellular preparations. Inorganic phosphate reduces the Ca2+ 
content of the SR probably by inhibiting the Ca2+-pump. This reduction in SR 
content occurs over a concentration range similar to that observed in isolated 
rat and  ferret hearts during ischaemia (Smith & Steele, 1992). Suko et al 
(Suko, Heilman & Winkler, 1977) have shown, in isolated SR vesicles, that 
raising the levels of ADP in the bathing solution can reverse the direction of 
the Ca2+-pum p probably by the process of product inhibition.
Calsequestrin
Calsequestrin is a protein of ~45,000 molecular weight localised prim arily in 
the junctional SR (Meissner, 1975). This protein is highly acidic and can bind 
around 35 to 40 Ca2+ ions with an affinity constant of ~500|iM (Mitchell, 
1988). This corresponds to a total Ca2+ binding ability of 70 to 150pmol Ca2+ 
per kg wet weight of tissue, assuming a yield of 40m g/kg wet w eight of 
calsequestrin from cardiac tissue (Campbell, MacLennan, Jorgensen et al, 
1983). This is obviously a considerable source of Ca2+ buffering w ithin the 
lumen of the SR and acts to maintain low intraluminal [Ca2+].
The SR Ca2+ release channel
The SR Ca2+ release channel is also described in the literature as the 
ryanodine receptor because of the specific affinity of this p lant derived 
alkaloid for the channel. The structure of the release channel is described
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later in this thesis but there are a few points which are important to discuss at 
this stage. The activity of the channel is affected by a num ber of factors 
including  cytosolic [Ca2+], SR luminal [Ca2+], Mg2+, [ATP], caffeine and 
ryanodine. Under physiological conditions, the release of Ca2+ is m ediated by 
C a2+ itself entering the cytosol during the action potential. However, there is 
evidence for a constant leak of Ca2+ from the SR distinct from that occurring 
during CICR. There are three main sources of this leak -
1. The ryanodine sensitive Ca2+ release channel
2. The ryanodine insensitive "Passive leak" channel
3. The SR Ca2+-pump itself (Feher & Briggs, 1983).
The net uptake of Ca2+ by the SR, during the cellular equivalent of diastole, is 
therefore the quantity loaded by the SR Ca2+-pum p m inus the quantity  
leaked by the various mechanisms listed above. In the saponin-treated 
trabecula, studied in this thesis, the relative contributions of leak and uptake 
to SR Ca2+-content may be im portant since the time periods involved in 
loading the SR are longer than those occurring physiologically.
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Sarcoplasmic Reticulum function in heart failure
There is now strong evidence suggesting abnormal Ca2+ regulation w ithin 
failing cardiac myocytes both in hum an tissue and in anim al models of 
hypertrophy and failure (Morgan, 1992). The sarcoplasmic reticulum, as the 
m ain site of Ca2+ uptake and release within the cell, has been the focus of 
m uch attention.
SR function in animal models of heart failure
C a2+ overload has been implicated as a cause of contractile dysfunction in a 
num ber of animal models and many of the features of heart failure seen in 
the cardiomyopathic hamster can be prevented by treatm ent with the Ca2+ 
antagonist verapamil (Finkel, Shen, Oddis & Romeo, 1993). Studies using 
isolated SR vesicles from a number of animal models of hypertrophy and 
failure have demonstrated a variety of changes in the rate of uptake of Ca2+ 
by the SR (Lamers & Stinis, 1992, Afzal & Dhalla, 1979) These studies provide 
evidence of abnorm al cell Ca2+ regulation bu t are no t necessarily  
representative of how the SR is functioning in the intact cell. Studies using 
biolum inescent Ca2+ indicators in intact cells have shown prolonged Ca2+ 
transients suggesting a reduced re-uptake of Ca2+ by the SR (Gwathmey, 
Copelas, McKinnon et al, 1987). Such changes suggest that the reduced rate of 
relaxation seen in pressure-overload hypertrophy and heart failure are 
related to abnormal intracellular buffering of Ca2+.
Animal studies have largely concentrated on pressure-overload hypertrophy 
and subsequent transition to heart failure (Bing, Brooks, Conrad et al, 1991, 
Ito, Suko & Chidsey, 1974, Perreault, Bing, Brooks et al, 1990). H eart failure 
following pressure overload hypertrophy is now increasingly rare clinically 
and m ight be a different pathophysiological process from  heart failure 
produced by increases in preload alone.
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Human SR studies in heart failure
R educed SR Ca2+ uptake in isolated SR vesicles from  failing hum an 
m yocardium  has been reported by some authors (Movsesian, Bristow & 
Krall, 1989), while others have reported no difference from controls (Limas, 
O livari, G oldenberg et al, 1987). Reduced SR pum p function has been 
supported by evidence demonstrating lower levels of SR Ca2+-ATPase m- 
RNA in heart failure (Mercadier, Lompre, Due et ah, 1990). Interpretation of 
studies using human heart failure tissue has been limited by the large size of 
e x p e rim en ta l p rep a ra tio n s  (H asenfauss, M ulieri, Leavitt et al, 1990, 
Gwathmey, Copelas, McKinnon et al, 1987) and the methods used to prepare 
the tissue which can damage substantial portions of the p reparation  
(Gwathmey et al, 1987).
Further studies are limited by the paucity of normal hum an control tissue. 
M any studies have used control tissue from patients with ischaemic heart 
disease, post mortem specimens with long warm-ischaemic times and from 
variable sites of the myocardium. In addition, tissue used for these studies 
have, predom inantly, come from patients w ith end-stage heart failure. 
Further studies are required to evaluate changes earlier in the developm ent 
of heart failure since mortality remains high even in m ild-m oderate heart 
failure when there is, arguably, compensated contractile function (Ho et al, 
1993). The underlying basis for this may be related to arrhythm ogenic 
mechanisms, which predispose to sudden death and occur before contractile 
function has deteriorated significantly. There is, therefore, a need to address 
cellular processes relating to contractile function at all stages in heart failure 
and not only those occurring in end-stage disease.
Methods of assessing SR function
Some of the differences observed in Ca2+ regulation between studies have 
been related in part to the method used to assess SR Ca2+-uptake and release.
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Isolated SR preparations represent homogenised vesicles which are isolated 
by a crude process by which separation of a mixture of m em brane vesicles is 
brought about by ultra-centrifugation. The limitations of this technique are 
related to the fact that firstly the SR is anatomically d isrupted  and secondly 
that the uptake of Ca2+ is 'oxalate-supported'. Oxalate anions, when added to 
the incubating medium, passes into the SR and binds to C a2+ form ing an 
insoluble precipitate which therefore reduces the effective intra-SR free- 
[Ca2+]. The SR Ca2+ pum p is never inhibited by a high intra-lum inal SR [Ca2+] 
which therefore allows SR Ca2+-uptake to continue and furtherm ore does 
not allow Ca2+ to leak from the SR, as occurs physiologically. The resulting 
rate of uptake is therefore a measure of the absolute m axim um  rate of Ca2+- 
uptake which is not how the SR functions in the intact cell. Furtherm ore, 
w hen oxalate is applied to a saponin-skinned preparation Ca2+-uptake is 
initially increased but this is rapidly followed by a fall in tension responses 
and SR function (DS Steele, personal communication). This result implies 
that SR vesicles behave differently from in-situ SR and m ay be more stable 
to internal Ca2+ oxalate precipitation. This in turn m ight suggest an inherent 
difference in the SR in this isolated state.
Many studies have utilised fluorescent Ca2+-indicators to dem onstrate Ca2+ 
transients in failing and non-failing m yocardium . In early  experim ents, 
m icro-pipettes were used to inject aqueorin into cells often dam aging a 
significant part of the preparation. The resulting Ca2+ transient therefore 
consisted of an averaged signal from damaged and undam aged cells. Other 
earlier techniques employed high concentrations of EGTA in the bathing 
m edium  to introduce aequorin into the cells (Gwathmey et al, 1987). Bathing 
the preparation in such strong Ca2+ buffering conditions can dam age a 
significant proportion of the muscle fibre.. Use of agents such as Fura-2 and 
Indo-1 have allowed fluorescent indicators to be introduced into the cell by 
less damaging chemical means.
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Evidence supporting a change in SR Ca2+ uptake in heart failure has been 
obtained by calculating the exponential decay of the Ca2+ transient signal that 
follows activation of the preparation (Vahl, Bonz, Timek & Hagl, 1994). 
While a delay in the decay phase of the Ca2+ transient would suggest reduced 
Ca2+ uptake by the SR there are a number of factors, other than an intrinsic 
change in SR function (discussed earlier in this chapter), which can give rise 
to changes in the Ca2+ transient.
Multi-cellular vs single cell techniques
Isolation of single cardiac myocytes has provided an im portant and useful 
technique to examine cellular function w ithout added com plications of 
changes in the extracellular matrix and problems associated w ith  multi- 
cellular preparations. However, although this is an advantage in some ways 
it also represents conditions further removed from physiological conditions. 
For example, myocytes may function differently when arranged in the cardiac 
architecture where they may be influenced by a num ber of local factors such 
as endothelium  derived factors (Wang & Morgan, 1992) com pared with in 
the isolated state. There are problems related to cell survival during the 
isolation procedure and subsequent selection of viable cells which may also 
influence experimental findings. Most studies using isolated myocytes have 
used amplitude of unloaded shortening as a measure of contractile function. 
The sarcomere length cannot be m easured therefore and the am plitude of 
contraction, rather than the tension response, is assessed. This is a less 
controlled and less well defined measure of contractile function.
Experimental data obtained from multi-cellular preparations are obviously 
the collective response of a number of cells which reduces sam pling errors to 
a certain extent. However, even selecting a single trabecula from  a viable 
region of myocardium in a failing heart creates a sampling bias and therefore 
interpretation of results should not be sweepingly extended to the heart as a 
whole. There are additional diffusion problems which tend to slow response
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times and in larger preparations may be limiting enough to create central 
areas of anoxia and rigor. In the saponin-treated preparations used in this 
study the trabeculae are typically elliptical with major diameters in the region 
of 150-200|xm and m inor diameters of 60-1 OOpm. The critical size in these 
p reparations, w ith respect to diffusion, is the m inor diam eter since a 
substance (such as ATP) must pass through one half of this distance to reach 
the centre of the trabecula and therefore in preparations of this size there are 
no problems with regions of central anoxia.
Ventricular chamber differences in heart failure
Few studies have addressed possible differences in the cellular aspects of 
contractile function between left and right ventricles in heart failure. This 
m ay be more im portant in ischaemic heart disease where the initial damage 
occurs in the LV and progresses to produce RV hypertrophy and failure. 
There is some evidence for a differential response between left and right 
ventricles during progression to heart failure. Perreault et al (Perreault, Bing 
, Brooks, Ransil & Morgan, 1990) dem onstrated a differential response to 
hypertrophy in the LV and RV of the spontaneously hypertensive rat during 
the progression to heart failure. In norm otensive rats they found an 
increased Ca2+ sensitivity of papillary muscles from the left ventricle. The 
hypertrophied  left ventricle dem onstrated an increase in maximal Ca2+ 
activated  force which reduced back to control levels as heart failure 
developed with no change in the sensitivity of the myofilaments for Ca2+. In 
contrast, right ventricular preparations dem onstrated an increase in Ca2+ 
sensitivity and an increase in maximum Ca2+ activated force as failure 
developed. The authors interpreted these findings as progression of LV 
hypertrophy to LV failure and progression to subsequent RV hypertrophy.
There m ay also be differences in SR function between ventricular chambers 
during the development of heart failure. In a rat model of coronary ligation 
Afzal et al (Afzal & Dhalla, 1992) demonstrated that in control animals Ca2+-
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uptake was greater in SR vesicles isolated from the LV compared with RV. 
There was a decrease in SR Ca2+-uptake in the LV over a period of 16 weeks 
following infarction and an increase in RV Ca2+-uptake at 8 weeks. Ca2+- 
uptake returned to control values in the RV at 16 weeks after infarction. This 
d ifferential response between left and right ventricles suggests that we 
should be more cautious in interpreting experimental findings lim ited to 
one chamber and, additionally, that temporal changes in SR function may be 
im portant during the development of heart failure.
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CHAPTER 2 
Methods
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METHODS 1
ANIMAL MODELS OF HEART FAILURE 
Adriamycin-induced cardiomyopathy in the rabbit 
Background
Adriamycin is a widely used anthracycline antibiotic with im portant clinical 
uses in the treatment of a range of malignancies. It is useful for both solid 
and haematological malignancies but unfortunately possesses cardiotoxic 
properties which limit the total dose to which the patient can be exposed. A 
dose dependent cardiomyopathy is a well recognised problem  in clinical 
practise. The risk of developing cardiac side-effects increases greatly after a 
total dose exceeding 550m g/m 2 (Von Hoff, 1979). This toxic side-effect has 
been utilised in a num ber of studies to induce chronic heart failure in a 
num ber of species including rabbit and rat (Wanless, Anand & Poole-Wilson, 
1987, Jensen, Acton & Peters, 1984). The method involves administration of a 
toxic dose of adriamycin over a prolonged time period sufficient to produce 
heart failure w ithout inducing further toxic effects which are linked to this 
drug e.g. renal and hepatic impairment, bone marrow suppression, intestinal 
m alabsorp tion , m ucositis, anorexia and alopecia. The anim als m ust, 
therefore, be closely observed for these side-effects and a scoring system used 
to assess the general condition and distress of the animal.
Method
M ale N ew  Z ealand w hite rabbits (2.5-3kg) w ere given adriam ycin  
intravenously 1 m g /k g  twice weekly for 8 weeks via the marginal ear vein. 
Injection of adriamycin into the marginal ear vein produced significant local 
irritation w ithout visible evidence of extra-vasation of the drug during the 
injection. This was improved by giving the adriamycin into the side-port of a 
concurrent saline infusion as is recommended in humans. The animals were
23
assessed three times weekly for signs of toxicity and distress using a scoring 
system proposed by Morton and Griffiths (Morton & Griffiths, 1985). Specific 
features noted were anorexia, weight loss, diarrhoea, mucosal ulceration, 
conjunctivitis, alopecia and nasal discharge. If the anim al scored above a 
threshold level on this scale then it was humanely and prom ptly killed. Once 
the 8 week series of injections was complete the anim al was allowed to 
develop chronic heart failure over the next 2-4weeks while the rabbit 
recovered from the acute effects of the adriamycin. Norm ally, during this 
period, the rabbits would regain their appetite and start gaining weight 
rapidly. Control animals were given saline injections and infusions twice 
weekly for 8 weeks and observed for a further 4-6 weeks after this.
At the end of this period echocardiography and haem odynam ic assessment 
were ^ performed as explained in later in this chapter.
20 animals were started on adriamycin using this protocol but final data 
were obtained in only 12. Six animals with high distress scores were killed 
before the end of the protocol. Two animals died while placing the catheters 
for haemodynamic assessment. Placement of the LV and femoral catheters 
was not w ithout risk and so 5 ADR animals, constitutionally less well, were 
assessed only by echocardiography. These results were in keeping with 
previous experience of this model in our departm ent (Doherty & Cobbe, 
1991).
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Coronary ligation in the rabbit 
Background
The rabbit coronary ligation model is a well characterised and relatively 
straightforward model of left ventricular dysfunction. The rabbit has a poorly 
developed collateral coronary circulation (Maxwell, Hearse & Yellon, 1987), 
similar to the hum an and the pig, and ligation of a single coronary artery 
produces a well defined myocardial infarction. The model is unaffected by 
additional factors which relate to the m ethod of producing heart failure 
which can have profound effects on the animals condition such as w ith 
adriamycin-induced cardiomyopathy.
The m odel has some clinical relevance in that it leaves a region of infarction 
which brings about ventricular remodelling in a similar way to that seen in 
the hum an. The severity of LV dysfunction is variable and this is beneficial 
since it provides a range of severity of LV dysfunction w hich can be 
correlated with cellular processes. Furthermore, the rabbit is of a convenient 
size to allow instrum entation and echocardiography to be perform ed with 
relative ease.
M ethod
Male New  Zealand White rabbits (2.5-3.Okg) were pre-m edicated with intra­
m uscular H ypnorm  (0 .3m g/kg fluanisone(10m g/m l): fentanyl citrate 
(0.315mg/ml)). The anterior and left lateral chest wall was shaved and 
cleaned with Hibidil in isopropyl alcohol. The animal was further sedated 
with intravenous m idazolam (0.25-0.5mg/kg) via the m arginal ear vein to 
allow  endotracheal intubation (size 3-4). Endotracheal in tubation  was 
perform ed using a Wisconsin paediatric straight blade (size 1) laryngoscope 
with the rabbit lying on its back and the head allowed to drape, supported, 
over the edge of the operating table. The tongue was pulled laterally and the 
laryngoscope introduced to allow visualisation of the vocal chords. Gentle
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crichoid pressure was applied and was extremely helpful in allowing clearer 
vision of the Vocal' chords. The chords were sprayed with 1% xylocaine and 
after a few minutes an uncuffed size 3-3.5 endotracheal tube was introduced 
over a soft-tipped plastic-coated wire introducer. The ET tube was secured by 
taping to the operating table and was attached to a H arvard small animal 
ventilator. The animal was ventilated (0.3-0.4L/min/kg) using mild positive 
end-expiratory pressure (l-2cm H 2O). Anaesthesia was m aintained using an 
inhaled mixture of 1% Halothane/1%  nitrous o x id e /1% oxygen. No muscle 
relaxants were given to allow possible distress to be recognised quickly by the 
operator. The animal was placed on a prewarmed table and body temperature 
m aintained by means of a thermostatically controlled heating mat.
The heart was exposed through a left thoracotomy, the pericardium  opened 
and a tie placed through the cardiac apex to allow easier manipulation of the 
heart. The coronary artery anatomy in the rabbit is somewhat different from 
that of other species in that the left anterior descending artery is small and 
supplies only a small area of the upper interventricular septum  (Flores, 
Davies, Penny et al, 1984). The left circumflex is dom inant and gives off a 
large left ventricular branch early in its course in the AV groove. This left 
marginal branch is easily seen running over the LV surface towards the apex 
and supplies the lower lateral LV wall, the LV apex and occasionally part of 
the RV apex. This artery was ligated using 6 /0  Ethicon suture with a 4mm 
curved needle at the m idpoint between the atrioventricular groove and the 
cardiac apex. The infarcted region rapidly becomes blue and is easily seen. 
The size of this infarcted region could be assessed and if it was not large 
enough a second suture was placed more proxim al to the first until a 
satisfactory infarct size was obtained.
Occasionally the infarct size was so large that cardiac output fell sufficiently to 
p roduce a m arked reduction in peripheral pulse volum e. Intractable 
ventricular fibrillation w ould follow soon after and only by untying the
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coronary ligature could there be any hope of the animal recovering. Such 
anim als rarely survived and are not included in analysis. Animals were 
treated w ith intravenous quinidine (15mg/kg, marginal ear vein) 5 minutes 
prior to ligation of the coronary artery as this has been shown to reduce the 
incidence of arrhythm ias with this procedure in rabbits (Connelly, Vogel, 
M ernandez & Apstein, 1982). Ventricular arrhythm ias were most commonly 
observed 10-12 minutes after coronary occlusion and were treated with DC 
shock (5-10J) using small, sterilised, curved defibrillation paddles applied 
directly to the myocardial surface using the apical suture to hold the heart 
away from the chest wall.
Once the animal was haemodynamically and electrically stable the left lung 
was examined for regions of lobar collapse. Such non-perfused and non­
ventilated regions could be re-inflated by occluding the outlet pipe on the 
ventilator and carefully observing the region of lung re-inflate w ith each 
respiratory cycle. The chest wall was closed using three 2 /0  interrupted catgut 
sutures placed through the chest wall around the ribs adjacent to the wound 
and draw n firmly together thus splinting the ribs. The subcutaneous layer 
was closed with 4 /0  catgut and the skin closed with continuous Dexon using 
a subcuticular stitch. Antibiotics were adm inistered at the end of the 
procedure by intramuscular injection (ampicillin 25m g/kg and cephalexidine 
15m g/kg). Intravenous fluids were administered at the end of the procedure 
(15-20ml norm al saline). Post-operative analgesia w as adm in istered  
(0.2m g/kg intra-muscular buprenorphine) at 30 minutes and 6-8 hours after 
the procedure. Animals showing signs of distress after this period were given 
further similar doses of analgesia as required. The animal was then allowed 
to develop chronic heart failure over the next 6-8 weeks. A further group of 
rabbits were studied at 15 weeks following coronary artery ligation. A typical 
infarction after 8 weeks is shown in figure 2.1.
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Sham -operated controls underw ent thoracotomy, the pericardium  opened, a 
tie placed through the apex and the heart manipulated in a similar fashion to 
the ligation animals but w ithout ligation of the coronary artery. Procedures 
were perform ed in pairs with one sham -operated and one ligation animal 
placed onto the protocol at weekly intervals so that they reached the end of 
the protocol at the same time.
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Figure 2.1 Photograph of an infarcted rabbit heart.This photograph shows a 
typical m yocardial infarction 8 weeks after ligation of the left m arginal 
coronary artery in the rabbit. The ventricles have been opened along the line 
of the interventricular septum, the apex is to the top of the picture and the 
opened aorta to the bottom (middle). The infarct m argin is defined by the 
dotted line. The infarct involves the lower part of the free wall of the LV and 
the lower part of the interventricular septum. The anterior papillary muscle 
is completely infarcted and replaced by white fibrous tissue. The base of the 
posterior papillary muscle is also infarcted but the distal portion remains 
viable.
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Chronic infusion of isoprenaline in the rabbit 
Background
Beta-receptor stimulation brings about an increase in the force of contraction 
by increasing intra-cellular levels of cAMP which activates a specific protein 
kinase. Protein kinase catalyses phosphorylation of a num ber of intracellular 
sites including the sarcolemmal Ca2+ channel and the regulatory protein, 
phospholam ban, on the sarcoplasm ic reticulum . Force of contraction 
increases as cytosolic Ca2+ rises secondarily to increased influx via the 
phosphorylated  surface m em brane Ca2+ channel. The increased influx is 
compensated for by an increase in SR Ca2+-uptake which increases the rate of 
relaxation. Phosphorylation of sites on Troponin-C increases the 'off-rate' of 
Ca2+ from the binding sites on the myofilaments and in this way also helps to 
bring about an increase in the rate of relaxation (Solaro, 1992).
Beta-receptor down regulation in myocardial cells is a recognised feature of 
heart failure (Bristow, 1993). This results from high circulating levels of 
catecholamines which are part of a wider neurohorm onal response to heart 
failu re. This results in a d im in ished  response to ad renaline  and 
noradrenaline and, therefore, loss of an im portant physiological inotropic 
mechanism . Diminished response to isoprenaline in heart failure can be 
dem onstrated both clinically and at a cellular level. A reduced num ber of 
beta-receptors has been reported but other evidence suggests an uncoupling 
of the beta-receptor from adenyl-cyclase by a G-inhibitory protein (Bristow,
1993).
Down regulation of adrenoreceptors observed in heart failure can be 
mim icked in animal models by chronically infusing catecholam ines. The 
model used for this study has been previously validated and has shown 
evidence of functional down-regulation of adrenoreceptors (Jones, Kirby,
30
H arding et al, 1990). The method used is simple and reliable and produces 
minimal discomfort to the animal.
Mini-osmotic pumps
Isoprenaline was administered at a dose of lO O pg/kg/hr for 7 days. Mini- 
osmotic pum ps were obtained from Alzet, Charles River, UK Ltd. The 
pum ps chosen for this model allowed a final volume of 2ml to be delivered 
over a period of 7 days at an infusion rate of 10pl/hr. The desired dose of 
isoprenaline was dissolved in saline with O.lmM ascorbic acid and injected 
into the m ini-pump under sterile conditions. The rabbit was lightly sedated 
and a small area on the back, between the scapulae, shaved. A 1% mixture of 
oxygen/nitrous oxide and halothane was used to maintain brief anaesthesia 
while a small (2cm) incision was made on the back. A subcutaneous pouch 
was created by blunt dissection and the mini-pump inserted with the pum p 
outlet tow ard the inner section of the pouch. The skin was closed by 
subcuticular stitch and intram uscular antibiotics given at the end of the 
procedure. This procedure takes only around 10 minutes to perform  and the 
animals recover rapidly after only very brief anaesthesia.
Six days following pum p implantation, a fluid-filled catheter was placed in 
the left ventricle and a thermodilution catheter placed in the femoral artery 
under general anaesthesia. After a recovery period of 24 hours, cardiac 
output, left ventricular systolic pressure and left ventricular end-diastolic 
pressure were measured at rest and after a challenge with a standardised dose 
of intra-cardiac isoprenaline. In addition the heart rate reponse to increasing 
doses of isoprenaline was recorded as an index of beta-receptor dow n 
regulation. Control animals were implanted w ith m ini-pum ps w ith vehicle 
(norm al saline w ith O.lmM ascorbic acid) only for 7 days before being 
similarly implanted with LV and femoral artery catheters 24 hours prior to 
sacrifice.
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METHODS 2 
ASSESSMENT OF LEFT VENTRICULAR FUNCTION 
Echocardiographic assessment of LV function 
Background
Left ventricular ejection fraction is recognised as a useful clinical m easure of 
LV systolic function (Nelson, Cohn & Gorlin, 1975). Echocardiographic 
m easurem ent of LVEF has been validated in hum an  stud ies against 
rad ionuclide  studies w ith good cross-correlation. There are num erous 
m ethods used to m easure EF, some based on single p lane, M -m ode 
techniques with others involving more complicated m ulti-plane m ethods. 
For the reasons of convenience and reproducibility, a com bined single 
p lane/area  trace method was used for this study as it was found to be reliable 
and minimised inter- and intra-observer variation.
M ethod
The rabbit was lightly sedated using H ypnorm  (0.25m g/kg for ligation 
animals and 0.3m g/kg for shams) and a small area of the anterior chest wall 
was shaved to allow a satisfactory echo-window. The animal was placed in 
the left lateral position and allowed to settle for a period of 5-10 m inutes 
before the examination commenced. All examinations were perform ed using 
a Toshiba SSH160A sonograph with a 5MHz short focus, wide angle, phased 
array, paediatric probe with a small (1 cm) diameter head which allowed full 
contact with the rabbit chest wall. Images were acquired "real tim e' as M- 
m ode and 2D images and analysed at the time of exam ination and again, 
from the video after the examination was completed. The clearest echo- 
w indow  was obtained in region of the lower left sternal edge. A conventional 
parasternal long axis image could be obtained by angling the ultrasonic beam 
in a longitudinal/sagittal axis and from this it was possible to obtain clear
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views of the left ventricular diameter (systole and diastole) at the tips of the 
m itral valve (figure 2.2). By rotating the probe through 90° a standard short 
axis view was obtained and a second m easurem ent of LVEDD was made. 
Ejection fraction was calculated by acquiring images over a num ber of cardiac 
cycles and storing these on a 64 frame cine-loop facility incorporated into the 
software of the machine. These images could then be reviewed by 'tracking7 
back and forw ard w ith a tracker-ball and selecting a representative end- 
diastolic and end-systolic frame. The endocardial border w as then traced 
using a best-fit ellipse method to measure end-diastolic and end-systolic area 
at the tips of the papillary muscles. The ejection fraction is calculated as the 
percentage area reduction i.e. end-systolic area/end-diastolic area x 100% over 
at least 3 cardiac cycles. Intra-observer variation was assessed by repeated 
m easurements on 6 rabbits performed 2 days apart. M easurements of LVEDD 
and ejection fraction were made. LVEDD was found to vary by less than
0.1mm while EF was found to vary by up to 5%.
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Figure 2.2 Echocardiographic parasternal long-axis view of the heart of a 
rabbit 8 weeks after myocardial infarction. The left atrium, left ventricle and 
left ventricular outflow-tract are clearly seen. The cursor is placed across the 
tips of the mitral valve and the M-mode image on the left panel is used to 
measure  left ventricular end-diastolic diameter.
Measurement of cardiac output 
Background
Blood flow is often m easured by indicator dilution which is based on a
principle first proposed by Adolph Fick in 1870. The extension of this
principle to use thermodilution was developed by Fegler in 1953. Finally the
praithwaite & BradleyXl968) 
clinical application of this was developed by^ . The m ethod
encom passes the principle that the tem perature of blood is reduced by
injection of a quantity of cold fluid. Measurement of the tem perature change
at a point downstream  from the injection site allows the construction of a
relationship between temperature and time. This tem perature/tim e curve is
the result of firstly, a delay between injection and the time taken for the cold
injectate to reach the measuring point, secondly the tem perature falling as
the cold fluid passes and finally rising again as the cold injectate passes away.
By constructing a semilogarithmic plot of temperature(abscissa) against time
(ordinate) the integral of this curve will represent the m ean tem perature
change at the sampling site over the sampled time period. The m ethod for
calculating blood flow using a non-diffusible indicator can then be applied in
m odified form i.e.
Q b _ 60 x Vi x di x Sy x  (Tb-Ti) x k 
d b x Sb x [Tfr(t) dt ]
W here: Qfr = blood flow per minute
Vz = Volume of fluid injected minus catheter dead space 
outside the body.
db  ,d i = density of injectate and blood (respectively)
Sz ,Sb = specific heat of injectate and blood
Tz ,Tb = temperature of injectate and blood
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Tb(t) = change in temperature at the sampling site at time Ts 
Tb(t) dt = area of thermodilution curve calculated by 
extrapolation of the upslope.
k = correction factor to allow for loss of therm al indicator due to 
heat exchange in the injecting catheter.
When 5% dextrose is used as the injectate and the specific heats and densities 
of blood are assumed then the following expression holds:
ds_j_Si _ 1 og
db • Sb
In addition, for the purpose of the measurements perform ed in this study the 
catheter warming is assumed to be constant between animals (since identical 
catheters are used each time) and so an empirical correction factor of 0.825 is 
used for k. The formula can subsequently be modified to :
Qb  = 56.3 x Vi x (Tb - TO 
Tfc(t) dt
This equation makes a number of assumptions:
1. Uniform mixing of the cold injectate with blood
2. Minimal loss of cold injectate between injection and sam pling sites
3. Traversal time (at sampling site) of any given portion of the injectate m ust 
be representative of the whole injectate.
There are a num ber of advantages of therm odilu tion  cardiac ou tp u t 
m easurem ent. Firstly, a large num ber of m easurem ents can be m ade and 
secondly these can be performed in rapid succession since the recirculation of 
indicator is negligible.
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A pparatus
Previous work in this department has indicated that a 90% response time of 
0.15-6 seconds for a tem perature change of 1-2 °C  is required to m easure 
blood flow in the descending aorta in rabbits. Clinically used pulm onary 
capillary wedge catheters have a rapid response time and so a thermistor bead 
was salvaged from a discarded Swan-Ganz catheter attached to a 30cm length 
of its insulated connecting wire. This bead and wire were threaded into a 3F 
Portex catheter and the thermistor bead fixed to the distal end with Araldite. 
The insulation was stripped from 0.5 cm of the proximal end and the wires 
so ldered  to a small plug. The relationship betw een tem perature  and 
resistance in the thermistor beads is not linear and so a small 'linearising' 
W heatstone bridge designed in the physics departm ent was used to convert 
the resistance signal to a linear voltage signal. This provided a linear signal 
±1% over a tem perature range 32-44 °C. Each therm istor catheter was 
calibrated before insertion using two water baths of known tem perature to 
normalise the voltage output between catheters. Each catheter therefore had 
a value for the slope of the temperature voltage relationship(a) and the point 
at which it crosses the y-axis (c) which represent the simple algebraic relation:
y  = ax + c
The W heatstone bridge was connected to a BBC micro computer, installed 
w ith a com puter program  kindly lent by Professor Poole-W ilson. This 
program  calculated the area under the tem perature/tim e curve and, taking 
the previous mentioned factors into account along with the characteristics of 
the thermistor, calculated the cardiac output.
Surgical insertion of catheters
The rabbit was premedicated as described previously and the neck and left 
fem oral region shaved. U nder general anaesthesia (1% halo thane/1%  
nitrous o x id e /1% Oxygen), a small incision was made in the neck over the
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right carotid artery and the vessel exposed by blunt dissection. A catheter (4F) 
was introduced into the artery and advanced dow nw ard tow ards the LV. 
A rterial pressure was m onitored during this period by means of a Gould 
fluid-filled pressure transducer. The catheter was advanced and gently 
m anipulated until a ventricular pressure trace was obtained. The catheter 
was then fixed at the proximal end and the w ound closed in two layers with 
interrupted sutures. The catheter was then filled with heparin, a bung placed 
over the end and this was then taped to the dorsal surface of the rabbit. The 
left femoral artery was exposed by blunt dissection and carefully separated 
from the left femoral nerve. A thermo dilution probe (3 French gauge) was 
placed into the artery and advanced 8cm into the descending aorta. The 
proximal end of the catheter was fixed to the vessel and surrounding tissue 
and  the plug tunnelled subcutaneously onto the dorsal thoracic region 
th rough  a small incision on the back. Skin incisions were closed by 
subcuticular sutures and a small jacket placed on the animal over-night to 
prevent chewing and scratching of the catheter sites.
M ethod for m easuring Cardiac output
Cardiac output was measured by rapidly injecting a bolus (1ml) of cold saline 
(usua lly  19-22°C) of known tem perature into the left ventricle . This 
prov ided  a reproducible value for cardiac ou tpu t w ith some practise at 
injecting the cold saline with similar speed and force. This technique was 
previously validated in rabbits (Wanless, Anand Poole-Wilson & Harris, 
1987). A typical tem perature/tim e curve is shown in figure 2.3. A mean 
value of cardiac output was calculated from five injections.
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Figure 2.3 - Te m pe ra tu re / t im e  curve used for the calculation of cardiac 
output .  The body temperature (T(B)) is 39.4°C and the injectate temperature 
is 20.8°C. The sampling time (6 seconds) is given along the x-axis with the 
rela t ive tem pera tu re  change on the y-axis. The curve describes  the 
t e m p e ra tu re  fall and  rise as the bolus of cold dextrose  passes  the 
thermodilu tion catheter in the descending aorta. The cardiac o u tpu t  (1363 
m l /m inu te ,  bottom of the figure) is calculated from the area under  the curve. 
This was then divided by the animals body weight to give cardiac index. 
Measurement  of cardiac output  was repeated (mean of five injections) after 
the same fluid challenge described in the previous section. The percentage 
increase in cardiac index following fluid challenge is expressed as ACO.
Measurement of left ventricular pressures
Left ventricular systolic (LVSP) and end-diastolic pressures (LVEDP) 
M easurem ent of these pressures was performed with the rabbit held in a 
custom made holding-box. This was not obviously distressing for the rabbit 
but it became clear that a significant period of time was necessary between 
placing the rabbit in the box and measurement of pressures. Left ventricular 
systolic pressure (LVSP) could reduce from values of 150mmHg to 110 
m m Hg simply by allowing the animal to settle and become accustomed to 
the box. In the majority of cases the rabbit had been in the box on a previous 
occasion and so was not as stressed by the experience. A fu rther 
consideration, which became clear, was the fluid-balance status of the animal 
in this early post-operative period. This could vary depending on fluid loss 
during  the previous days placement of catheters and the intake of fluid 
during  the intervening 24 hours. By assessing the overnight fluid intake 
from the water bottles on the cages it was clear that some animals would 
drink very little water during this early post-operative period. This was 
probably due to difficulties reaching the water bottle while wearing the 
protective jackets or slow recovery from the anaesthetic. In an attem pt to 
com pensate for this, all animals were given a m inim um  of 30mls of 
intravenous saline at the end of the catheter placement procedure and on the 
m orning of haemodynamic assessment a further 20mls of saline if there had 
been little or no water consumption overnight.
As previously indicated, the animal was allowed to recover from the 
anaesthetic for at least 24 hours before recordings of left ventricular end- 
diastolic pressure (LVEDP), left ventricular systolic pressure (LVSP) and 
cardiac output were made. Left ventricular pressure was m easured with a 
fluid filled pressure transducer connected to the catheter by a short fluid 
filled w ide bore tube. The pressure trace was recorded on a Siemens
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M ingograph 7 ink-jet chart recorder. Representative traces from sham and 
ligation animals are shown in figure 2.4. The measurements were repeated 
following a standard fluid challenge of 15m l/kg of saline administered over 
30 seconds into the left ventricle. 4 control animals im planted with an 
additional right atrial catheter, given this fluid-challenge, dem onstrated a 
twofold increase in right atrial pressure. The trace was analysed, in a blinded 
fashion, by hand and  pressure values calculated by using the recorded 
calibration marks.
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Figure 2.4 - (facing page) Left ventricular pressure trace from a sham  and 
ligation rabbit. The upper panel dem onstrates a typical LV pressure trace 
from a sham  operated rabbit at baseline and after infusion of 15m l/kg of 
norm al saline over a period of 30 seconds directly into the left ventricle. The 
systolic pressure does not change significantly w ith a small increase in left 
ventricular end-diastolic pressure. The lower panel shows a similar trace in a 
rabbit 8 weeks after coronary ligation. The baseline trace shows a higher 
LVEDP and this rises significantly after infusion of saline. The systolic 
pressure also rises slightly.
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Heart failure score
Each coronary ligation animal was assigned a score reflecting the severity of 
heart failure produced by myocardial infarction. The score was calculated 
using the ejection fraction, LVEDD, change in cardiac output in response to a 
fluid challenge and LVEDP at rest. The categories shown in table 1 are based 
on the following scheme i.e. a LVEDP value for a LIG animal which fell 
w ithin the normal range (for shams) scored zero points, if the value fell in 
the lower two quartiles of the LIG data then this scored 1 point and in the 
upper two quartiles scored 2 points. This principle was applied to each of the 
four parameters in the table and a total heart failure score calculated for each 
LIG anim al (maximum 8, minimum 0). For some aspects of analysis, LIG 
animals were arbitrarily separated into two groups : m oderate heart failure 
w ith a score of 1-4 (score<4) and more severe failure w ith a score of 5-8 
(score>5).
Table 2.1 - Heart failure scoring system
LVEDP ACO LVEDD EF
(mmHg) (% change) (mm) (%)
1 1 1 ! 10-15 >15 >26 1 1 1 ! I I I ! 16-19 >20 >60 40-5$ <40
Score 0 1 2 0 i 2 0 1 2 0 1 2
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METHODS 3 
ISOLATED VENTRICULAR TRABECULAE EXPERIMENTS
This chapter describes the general protocol followed for the m ajority of 
experim ents on isolated cardiac trabeculae described w ith in  this thesis. 
Specific details of some experimental conditions and techniques have been 
described within the appropriate chapters.
Isolation and mounting of trabeculae for force measurement
All animals were killed by a lethal dose of intravenous Euthatal (0.5ml/kg).
The heart was rapidly excised via a m edian sternotom y and placed, still
modified Tyrodes
beating, in solution (composition: 150mM NaCl, 5mM KC1, ImM
MgCl2, 2mM CaCl2, 5mM HEPES at pH7.0). The right ventricle was opened by 
a single cut, close to the intraventricular septum, running from the base of 
the heart to the apex. Experiments were perform ed on free running  
trabeculae isolated from both right and left ventricle. The right ventricle is 
m ore trabeculated than the left and so free-running trabeculae of suitable 
proportions were more readily found in the right. However, every attem pt 
was m ade to find a suitable preparation in the LV and in a few animals 
trabeculae were used from both LV and RV. Preparations ranged from 1 to 
3mm in length and 80 to 200mm in diam eter and w ere m ounted  for 
isom etric force m easurem ent in an assembly described as follows: the 
preparation was suspended between a fixed point and an Akers AE 875 force 
transducer by nylon monofilament snares (figure 2.5). The snares were held 
within stainless steel tubing (Goodfellows Metals Ltd, Cambridge; o.d. 200pm, 
i.d. 100pm) and were form ed by double threading a 3-4cm length of the 
stainless steel tube w ith the 25pm m onofilam ent so that a snare was 
produced at the base of the tube that could
44
T ransducer Fixed
Poin t
V4
Figure 2.5 Diagram of the system for mounting the trabecula. The trabecula is 
held by nylon monofilament snares which are threaded through the stainless 
steel tubes in such a way as to form a loop at one end. The separation 
betw een the force transducer and the fixed point can be adjusted by the 
micro-manipulator which is held firmly by a magnet base.
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be tightened by pulling the m onofilam ent from the top of the tube. 
Additional rigidity was provided to the system by glueing further pieces of 
tubing to those forming the snares (as shown in figure 2.5). The compliance 
of this system has previously been calculated and measured at less than 1 % of 
preparation length at maximum tension (for a preparation of 2mm in length 
producing 60 m g.w t). The assembly was m ounted on a Narashige MM3 
m icrom anipulator. This allowed fine movement in three planes to allow 
accurate positioning of the muscle within the bath change system and the 
m icroscope changer. The force transducer was supported  by a further 
m icrom anipulator which allowed fine adjustment of separation between the 
tubing to adjust sarcomere length.
Chemical skinning of ventricular trabeculae
The saponin-treated preparation has been extensively studied  and has 
characteristics which make it ideally suited to assessing possible changes in 
SR Ca2+-loading resulting from heart failure. Endo and Kitazawa (1978) first 
described the use of saponin, a plant derived glycoside, to skin cardiac muscle 
preparations chemically. At low extracellular Ca2+ concentrations, saponin 
combines with cholesterol in the sarcolemma and induces small perforations 
which allow small ions and molecules (<c.2000 Da) to perm eate (Noireaud, 
B right & Ellis, 1989). However, the sarcoplasm ic reticu lum  and the 
m itochondrial inner membrane have a lower cholesterol content than the 
sarcolemm a and so the preparation retains functional contractile proteins, 
sarcoplasm ic reticulum  and m itochondria. After chemical skinning, the 
bathing solution surrounding the preparation becomes an extension of the 
in tracellu lar environm ent. The SR is anatomically und isrup ted  and can 
function in a manner close to that in the intact cell. The conditions imposed 
by the bathing medium are such that the SR can load and leak Ca2+ in a way 
sim ilar to that in vivo and so it is possible to study factors controlling both 
up take and release of Ca2+. The conditions of excess ATP and an ATP-
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regenerating system in the bathing solution removes possible differences in 
energy conditions which may underlie contractile abnorm alities in heart 
failure in the intact cell. The permeable nature of the mem brane allows free 
access to ions and small molecules and so addition of drugs or chemicals to 
the bathing medium allows a direct assessment of their effects on the SR. As 
a further consideration this method is a relatively cheap and simple way of 
estim ating SR Ca2+-loading since no expensive biolum inescent dyes are 
requ ired  w ith the tension produced being the index for Ca-release from 
evoked from the SR.
Treatm ent with the non-ionic detergent Triton X-100 results in the complete 
d isruption  of surface and intracellular membrane diffusion barriers, while 
the myofilaments are functionally retained (Miller, Elder & Smith, 1985). The 
residual membrane micelles do not support ATPase activity (Kurebashi & 
Ogawa, 1991). Therefore, any intervention which influences the contractile 
response of a Triton-treated preparation can be attributed to a direct action on 
the m yofilam ents. A schem atic represen ta tion  of the sta tus of the 
components relevant in EC coupling as a result of the most commonly used 
techniques to disrupt muscle membranes is shown in figure 2.6.
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Figure 2.6 Diagram of the cell membrane after saponin and Triton treatment
M easurem ent of sarcomere length
It is crucial to m easure sarcomere length accurately and consistently in 
experim ents such as these since a num ber of physiological param eters, 
p a rticu la rly  Ca2+-sensitivity, are influenced by sarcom ere length. In 
preference to the laser diffraction system used in most other laboratories, a 
m odified Vickers M-16 microscope with Differential Interference Contrast 
(DIC) optics (Smith, 1969) was used to examine the preparation and set 
sarcom ere length to the desired value (2.1-2.2|im). The microscope lies 
supine, the stage has been replaced by a m ounting for the transducer 
assembly and an observation chamber (so that the preparation can be lowered 
into the optical path of the microscope, figure 2.7). The preparation is viewed 
on a television m onitor via a video camera which further enhances the 
contrast of the DIC image. A graticule was placed in the video camera 
m ounting tube allowing accurate m easurement of the preparation from the 
m onitor screen.
M easurem ent of preparation cross-sectional area
Accurate measurement of cross-sectional area is im portant in order to be able 
to express the maximum force production relative to unit cross-sectional area 
by a given trabecula. Measurement of cross-sectional area was perform ed 
using light microscopy with DIC optics. Once the sarcomere length was set at 
2.1-2.2pm, the w idth of the preparation was m easured from the graticule 
displayed on the TV monitor. The depth of the preparation was measured by 
focusing backw ards and forw ards through the trabecula and using a 
m icrom eter on the microscope stage to assess the distance moved by the 
preparation. The trabeculae were typically elliptical in cross-section and so, 
using major (D) and m inor (d) diam eters, the cross-sectional area was 
calculated from the formula for the area of an ellipse i.e.
(See page 52)
Area = (n x D x d ) /4.
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F ig u re  2.7 Diagram of the chamber used to perm it the m easurem ent of 
sarcomere length. The bath is created using two standard cover-slips sealed at 
the edges with vaseline. The preparation is lowered into the field of view of 
the microscope from above.
Autom ated Solution Change System
Many of the experiments described in this thesis require accurate control of 
the duration of exposure to the experimental solutions. For this reason a 
computer-controlled solution change system was employed (Miller, Sinclair, 
Smith & Smith, 1982). Solutions were contained w ithin a series of wells cut 
into a perspex block and were continuously stirred by a small stainless steel 
paddle driven by an electric motor to maintain circulation of the solutions. A 
solution change was made by low ering the perspex block, m oving it 
horizontally under the preparation and raising it to immerse the preparation 
in the required solution. Horizontal and vertical m ovem ents of this bath 
were made by two stepper motors under control of an Apple He computer. 
The speed of these stepper motors was such that, optim ally, a solution 
change could be made within 200ms. The software accompanying this system 
allowed the program m ing of a large num ber of accurately tim ed solution 
changes. Amongst the many advantages of this solution change system is a 
reduction  of 'carry-over' and, subsequently, contam ination of the new 
experim ental solution.
Solution composition
The rationale for solution composition, the m ethod for calculating free ion 
levels and ionic strength, the choice of ion binding constants for the various 
ligands, precautions for EGTA purity, Ca2+ contamination determ ination, the 
m easurem ent of pH and other details of the experimental solution are given 
in detail elsewhere (Harrison, Lamont & Miller, 1988; Miller & Smith, 1984) 
b u t are described  briefly here. C om ponents and  the ir respective  
concentrations in experimental solutions are given in detail in Table 2. These 
solutions were m ade by mixing the appropriate volum e of the following 
stock solutions, which were freshly prepared on a regular basis, 1M KC1, 1M 
M gCl2, lOOmM EGTA, lOOmM CaEGTA, lOOmM HDTA and 500mM HEPES.
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The EGTA and HDTA were dissolved by adding twice the molar am ounts of 
KOH, heating to 50-60°C and stirring before adding more distilled w ater to 
bring to the desired volume. CaEGTA was prepared in a similar way but with 
CaCC>3 and KOH added to the EGTA resulting in CO2 being produced during
warming. ATP and CrP were added in solid form, at pH 6.5, and the solution 
titrated to pH 7.0 with KOH. ATP, CrP and all other chemicals were obtained 
from the Sigma Chemical Company, Poole, Dorset, UK unless otherwise 
stated. Solutions with different Ca2+ concentrations were obtained by mixing 
solutions A and B. CaCl2 was added to aliquots of solution B to achieve pCa 
4.00 which, under our standard conditions, ensures m axim al activation. 
R apid  and  uniform  activation th roughou t the cross-section of the 
preparation was ensured by use of the /Ca2+-jum p/ m ethod. This m ethod 
produces a rapid increase in [Ca2+] by increasing the Ca2+ buffer concentration 
at the same time as the free Ca2+ concentration (Miller, 1975 ; Moisescu, 1976; 
Ashley & Moisescu, 1977) i.e. the preparation is m oved to the test pCa 
solution after prior equilibration in solution C (Table 2), which has its ionic 
balance (0.2M) maintained by addition of HDTA or KC1.
* Reproducibility of w idth and depth measurements
The measurement of width and depth of preparations was repeated by an 
independent observer on a number of occasions. Variation between observers was 
found to be less than 10% for both width and depth.
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Table 2 Composition of solutions (in mM except where stated; pH 7.0).
Soln K +* A T P CrP N a t EGTA Hepes pCa
A 140 7 5 15 40 10 25 9.03
B 140 7 5 15 40 10 25 4.25§
C 140 7 5 15 40 0.2 25 7.29
* Potassium ions added as KC1 and KOH. ‘•’Magnesium added as 1M MgCl2;
free M g2+=2.1-2.5mM in solutions A, B and m ixtures of these solutions. 
tS od ium  ions from  the salts N a2ATP and N a2CrP. The Ca total  in all
solutions was 0.02mM, except solution B where it was lOmM. §An additional 
O.lmM CaCh was added to aliquots of solution B to yield 'Tull activating" 
solution (pCa 4.0). Total chloride concentrations varied from about 110 to 
120mM. *111,6 diaminohexane N ^N ^N '-te traacetic  acid (9.8mM) was added 
to this solution to maintain equivalent ionic strength.
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pH  m easurem ent and buffering
pH  of solutions used in these experiments was accurately m easured and 
tightly buffered. Within our laboratory, separate reference and pH  electrodes 
are used (Ciba Corning Diagnostics Ltd., Essex, England) to give a reliable 
m easure of pH (Illingworth, 1981). The pH of experimental solutions was 
adjusted  using a null point m ethod. The electrodes w ere allow ed to 
equilibrate in a standard solution (6.08mM KOH, 197mM KC1 and 25mM 
HEPES) calculated to have the same pH a (pH activity) and ionic strength as
the experim ental solutions (Harrison, Lamont & M iller, 1988). HEPES 
(25mM) was included in all experimental solutions, at pH a 7.0, to minimise
changes in pH  that may occur during contraction (local acidosis principally 
resulting from hydrolysis of ATP by myofilaments).
Calculation of free metal concentration and ionic strength
EGTA binds metal ions other than Ca2+ and therefore, the affinity constants 
of EGTA and the other ligands (ATP, CrP and HEPES) in these experimental 
solutions m ust be known. In order to calculate free [Ca2+ ] it is im portant to 
take account of the concentration of other ionic species and other 
experimental variables such as pH and temperature.
The REACT computer program (Smith & Miller, 1985) was used to assess free 
ion concentrations of experimental solutions. The free m etal concentration 
of the various commonly used mixtures of solutions A and B are given in 
Table 2. Ionic strength was defined using the following equation (see Miller 
& Smith, 1984):
Ie = V 22cjZj
where Ie is ionic strength, defined as the total of the ionic equivalents and cj 
is the concentration of the jth ionic species and zj is its valency.
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Simultaneous measurement of Ca2+ release from the sarcoplasmic reticulum 
and tension measurement
The preparation was m ounted between a tension transducer (Akers 46136, 
SensorNor a.s. Norway) and a fixed point by means of nylon monofilament 
snares in a similar way to that previously described (Figure 2.8). In contrast to 
the previous method of supporting the preparation, however, the steel pins 
containing the snares lay in the same plane as the preparation . The 
preparation was continuously perfused with solutions of low Ca2+ buffering 
capacity, solution C (Table 2), at a flow rate of lm l/m in . This perfusing 
solution was pum ped down the centre bore of a 5mm diam eter perspex 
column into a perspex bath whose base was formed from a glass coverslip. 
The column was lowered to within 5-10|im from the top of the preparation 
in order to minimise the volume of the perfusing solution above the 
preparation . The volume of solution surrounding the p reparation  was 
estimated at approximately 4 iu  and excess solution was collected from the 
edge of the column. Aliquots of the perfusing solution containing 20mM 
caffeine were injected onto the preparation via the manifold at the base of 
the colum n. A solenoid-controlled pneum atic system  ensured  that a 
uniform  volume of the solution (approximately lOOpj) was applied to the 
preparation during a 50ms injection period. The bath was placed on the stage 
of a Nikon Diaphot inverted microscope.
Ca2+ release from the sarcoplasmic reticulum was detected by addition of the 
C a2+-sensitive fluorescent probe Fura-2. The preparation was illum inated 
with light alternately at 340 and 380nm wavelength and the ratio of emitted 
light intensities (at 510nm) was measured. The light emitted from areas of 
the microscope's field not occupied by the image of the muscle was reduced 
by shuttering on the side port of the microscope. These experiments were 
performed in collaboration with Dr GL Smith and Dr DS Steele.
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Figure 2.8 Diagram of apparatus used to make simultaneous m easurem ent of 
C a2+ and tension in saponin-treated trabeculae. The trabecula is m ounted 
betw een the fixed point and the tension transducer by m eans of nylon 
m onofilam ent snares. The perspex column is lowered to w ithin 5-10fim of 
the upper surface of the muscle. The preparation is perfused by pum ping 
solution through the central bore of the column. This solution could be 
sw itched using a series of valves positioned above the column allowing the 
bath volume to be changed within 10-15 ms .
'Fall-off' in  force generation
Cardiac preparations, skinned with non-ionic detergents such as Triton X- 
100, have previously been shown to deteriorate with time (Jewell & Kentish, 
1981). Prolonged exposures to high concentrations of EGTA and low 
concentrations of Ca2+ cause the myofilament lattice to become disorganised 
and, in skeletal muscle, results in a rapid decay in tension generation (Steele, 
1990). In these experiments, therefore, the muscle was bathed in a low power 
C a2+-buffering solution for the majority of the time (solution C, Table 2). 
Saponin-treated fibres rarely exhibit significant functional decay w ith time 
and using the protocol described in figure 3.1, the fall-off in tension could be 
m onito red  by evoking caffeine contractures u n d e r s tan d ard  control 
conditions throughout the experiment. The mean fall-off in peak tension 
response to caffeine averaged 25% over 3-4 hours and was not different in 
ligation or sham operated animals (figure 2.9).
Effect of temperature
All experiments were done at room temperature which is a steady 20-22°C in 
this laboratory throughout the year. The rate constants relating to calcium 
binding and rates of consum ption of ATP have previously  been well 
docum en ted  at room  tem peratu re  and have been app lied  to the 
interpretation of data in this thesis. Previous studies have suggested that 
myofilament function is affected by temperature (Harrison & Bers, 1989; see 
page 241) but that SR calcium release may not be affected significantly 
between 23°C and 35°C (Vornanen, Shepherd & Isenberg, 1994; see page 241). 
In this study I cannot exclude the possibility that differences or lack of 
differences in the param eters m easured in chem ically-treated trabeculae 
could have been affected by raising the temperature to physiological levels. 
However, there are no previous studies that indicate a differential effect of 
tem perature on failing and non-failing myocardium.
57
1.0 -
lo, -
o
-8s
=3 0.6 -
i
1
I  o-4 -o<u
•S
&
V
0 .2 -
Ligation±s.e.m
Sham±s.e.m
0 .0 -
40 60 80 100 1200 20
time (minutes)
Figure 2.9 Fall-off in tension production in a saponin-treated trabeculae 
during a 2 hour experiment. The mean fall-off was 25% over 2 hours and was 
not significantly different between ligation (n=7) and sham (n=7) rabbits. This 
rep resen ts  the fall-off in the control contractures used  at in tervals 
th ro u g h o u t the protocol (120s/200nM  [Ca2+]) and does not represent 
reduction in peak force production.
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Assessing Ca2+-sensitivity in Triton treated trabeculae
The T riton-treated trabeculae can be activated to produce tension by 
sequential stepwise increases in bathing [Ca2+] over the appropriate range. 
This approach has been widely used in pharmacological studies but has a 
num ber of disadvantages. In this laboratory, we occasionally find appreciably 
different force pCa curves with this protocol than w ith those derived from 
m aking a series of single activations (compare figure 4.1 w ith figure 8.4). 
Reasons for this difference may be due to local (i.e. at the m iddle of the 
preparation) increases in inorganic phosphate concentration and reductions 
in pH  as a consequence of the preparation m aintaining high levels of force 
for prolonged periods. In addition, prolonged activation can also accelerate 
the deterioration i.e. tension 'fall-off, of the preparation. For this reason, 
tension at a test pCa was achieved directly from the relaxed state in then 
present experiments sustained just long enough to ensure equilibration. The 
/Ca2+-jump/, as previously described, is also useful in diminishing the rate of 
deterioration in such preparations.
Calculation of myofilament Ca2+ sensitivity using the Hill equation
The relationship between steady-state force and Ca2+ concentration from all
otherwise satisfactory experiments is well described by the Hill equation,
allowing objective definition of the position and steepness of the curve
relating Ca2+ concentration and tension.
Cx _ [Cax]h
Cmax EC5q^ + [Cax ]^
where Cmax is the force at a saturating Ca2+ concentration which is [Ca*]; EC50 
is the Ca2+ concentration which gives 50% of Cmax and h is the Hill 
coefficient. It is generally thought that the Hill coefficient is an index of the 
cooperativity of Ca2+ binding to the regulatory protein troponin-C. However,
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although skinned-cardiac muscle appears highly co-operative (Riiegg, 1986) 
the mechanism underlying cooperativity is poorly understood and so small 
changes in the Hill coefficient are difficult to interpret.
The curves obtained from the Hill equation were fitted by a least mean 
square fitting procedure after Levenberg and M arquat (Brown & Dennis, 
1972). This yields values for Ki ^ (rec ip rocal of the Ca2+ concentration 
producing half-maximal Ca2+-activated force; log K1/2  =pCa5o) and the Hill 
coefficient. To avoid the distortions produced by pooling experimental data, 
curves were fitted on an individual basis so that K1/2  could be determined 
for each preparation. The data within the text are presented as means of Hill 
coefficients and pCaso values calculated from the individual curves for each 
animal while the curves shown in the various figures represent the curves 
fitted to the mean Hill coefficient and mean pCaso for sham  and ligation 
anim als.
Data handling and analysis
In isolated trabecular experiments the output of the tension transducer was 
displayed on a thermal array chart recorder (Astromed Dash 8), after being 
pre-amplified and filtered at 25Hz. The signal was sim ultaneously digitised 
using an Apple Macintosh, MacLab and the commercially available Chart 
software. These signals can be transferred to Macintosh graphics programmes 
such as Igor and MacDraw II, within which they can be scaled and annotated 
prior to obtaining a hard copy via an Apple LaserWriter. The experimental 
traces were analysed on computer screen using the MacLab software package 
and the data transferred to a spread sheet (Microsoft Excel) for final analysis. 
Curves and regressions were fitted using Igor (Wavemetrics).
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Statistical analysis
Il
Data are presented as mean±SEM unless otherwise stated. A Students two- 
i  sam ple, unpaired t-test was used for continuous variables if the data were 
i norm ally distributed. For data that were not normally distributed, from the 
appearance on scatter plots, a non-param etric test was applied (Mann- 
W hitney test). Significance (rejection of the null hypothesis) was accepted at 
P<0.05. Correlation coefficients (Spearman's r) were used to estimate the 
association beteween two independent variables. Statistical significance was 
accepted at P<0.05. Data points were plotted as scattergrams and a simple 
regression analysis performed.
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CHAPTER 3
Sarcoplasmic Reticulum Ca2+-loading 
in Ventricular Trabeculae from Rabbits 
with Adriamycin-induced Cardiomyopathy
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INTRODUCTION
Adriamycin is an anthracycline antibiotic used commonly for the treatm ent 
of a num ber of hum an malignancies including solid and  haem opoetic 
cancers. How ever, repetitive doses exceeding a total of 550m g/m 2 are  
associated with significant cardiotoxic effects and can produce chronic and 
irrev e rs ib le  m yocard ial dam age. The m echanism  by w hich  this 
cardiom yopathy occurs is essentially unknow n despite num erous studies 
describing a wide range of structural and functional abnormalities.
Cellular changes can be divided into those occurring acutely and those 
occurring after chronic treatment. At low doses an increase in myocardial 
contractility, in isolated chick myocytes, has been described which is probably 
related to a digoxin-like effect (Kim, Akera & Brody, 1980). M yocardial 
contractility is depressed at higher doses in the early phase after acute 
adm inistration in humans (Applefielg & Egorin, 1984). Chronic treatm ent is 
associated  w ith  structural abnorm alities including  m yofibrillar loss, 
vacuolisation of the tubular network and mitochondral swelling. There are 
direct effects on the cell membrane which result in increased permeability 
b rough t about by electrostatic interactions w ith  negatively  charged 
phospholipids allowing incorporation of the drug into the lipid phase of the 
b ilayer (Goorm ightigh, Chatelain, Caspers & Ruyschaert, 1980). O ther 
m em brane effects include changes in the catecholamine receptor/adenylate 
cyclase system (Azuma, Sperelakis, Hasegawa et al, 1981) and changes in the 
action of a variety of membrane pum ps (Boucek, Olsen, Brenner et al, 1986). 
Adriamycin is known to be a potent source of free-radicals. Under aerobic 
conditions adriam ycin can readily donate its unpa ired  electron to a 
m olecular oxygen to produce superoxide (Kalyanaram an, Perez-Reyes & 
Mason, 1980) which in turn can initiate the production of a num ber of other 
oxygen free-radicals. Vitamin-E deficiency has been shown to accentuate the
cardio-toxic effect of adriamycin (Singpal & Tong, 1988), thought to be related 
to the anti-oxidant activity of vitamin E. Thus, the generation of free-radicals 
is though t to be an im portant mechanism by which adriam ycin induces 
cardiotoxicity  (Singpal, Deally & W einberg, 1987). Singpal et al also 
dem onstra ted  lysosom al activation induced  by adriam ycin , in rats, 
accom panied by an increase in lipid peroxides which induce release of 
lysosom al enzym es. Release of these enzym es dam ages in tracellu lar 
organelles including the sarcoplasm ic reticulum  and can produce Ca2+ 
overload and energy depletion within the myocyte which act in combination 
to depress contractile function.
A dd itiona lly , adriam ycin  is know n to have specific effects on the 
sarcoplasm ic reticulum. The metabolite of adriamycin, doxorubicinol is a 
potent inhibitor of the SR Ca2+ ATPase and during  acute exposure can 
produce a m arked reduction in SR Ca2+-loading (Boucek, Olson, Brenner, 
O gunbunm , Inui & Fleischer, 1987). However, adriam ycin has also been 
show n to prom ote the open state of the ryanodine sensitive Ca2+ release 
channel on the SR rendering it more leaky with a faster rate of Ca2+ release 
(Pessah, Durie, Schiedt & Zimanyi, 1990). This w ould tend to predispose the 
cell to Ca2+ overload in the acute phase of d rug  adm inistration. This 
phenom enon is readily reversible in in-vitro models and is brought about by 
an increased sensitivity of the Ca2+ release channel for Ca2+, m easured 
experimentally as an increased rate of occupancy of the ryanodine receptor by 
C a2+. However, multiple acute exposures of the SR to adriamycin sensitises 
the process such that even at lower doses, after repeated exposures, the 
'leakiness' of the release channel becomes more m arked (Pessah et al, 1990). 
These authors suggest that this might explain why cardiotoxic effects appear 
in hum ans after multiple treatments despite the use of low doses . However, 
long-term  treatm ent of rabbits with adriamycin has been shown to reduce 
chronically the num bers of SR Ca2+ release channels, while the SR Ca2+
uptake pum p rem ained unaffected (Dodd, Atkinson, Olsonef al, 1993). This 
reduction in ryanodine receptors could produce a net increase in the Ca2+- 
loading ability of the SR since less leak w ith the same quantity of loading 
would result in increased total SR Ca2+ content.
Therefore, adriam ycin-induced cardiom yopathy represents a complicated 
model of heart failure which is aetiologically different from the other model 
of heart failure studied  in this thesis, nam ely, coronary ligation. The 
combination of direct adriamycin toxicity and secondary response to heart 
failure provide potential difficulties in in terpretation . H ow ever, this 
represented an interesting opportunity to compare the two models.
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METHODS
Animal model and assessment of heart failure
The model was produced by the protocol described in chapter 2. As indicated, 
this adm inistration regime produced a significant m ortality and, from 20 
rabbits started, only 12 were finally studied. This reflects a low threshold for 
killing the animal if signs of distress developed. The adriam ycin-treated 
(ADR) animals were assessed haemodynamically by echocardiography in all 
cases and seven ADR animals were assessed by invasive m easurem ents, 
before being killed. This was the first group of animals to be studied my 
relative inexperience and the general condition of the ADR animals had 
initially produced a high mortality from the catheter placement procedure. It 
was therefore decided to perform echocardiography alone in 5 ADR animals 
w ith a clinically poor constitutional state. All saline-treated (SAL) animals 
had echocardiography and invasive haemodynamic assessment perform ed 
(n=7).
Isolated trabeculae experiments
The heart was excised rapidly and a trabecula isolated from the right ventricle 
usually situated close to the tricuspid valve annulus or occasionally at the 
RV apex. This was m ounted for isometric tension measurement and treated 
with saponin for 30 minutes.
The protocol for assessing SR function is illustrated in figure 3.1. The SR, in 
saponin-treated trabeculae, was allowed to load [Ca2+] in solution A (table 2.2) 
w ith aliquots of Ca2+ chloride (lOmM) added to provide a range of [Ca2+]. 
Caffeine-induced contractures were evoked by solution A (table 2) containing 
lOmM caffeine. Between contractures the muscle was exposed to a [Ca2+] 
sub-threshold  for tension production. During this period  the SR can 
accum ulate Ca2+ which is subsequently released by the next challenge with 
caffeine. After a standard sequence of 5 control contractures at constant [Ca2+]
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(200nM) and loading time (120s), the trabecula was exposed to a different 
loading [Ca2+] for a series of 10 loading time periods ranging from 15s to 150s, 
arranged in a random  order. After each test protocol, the standard sequence 
was repeated to check for any significant deterioration in the caffeine-induced 
contracture amplitude. The test loading [Ca2+] was increased at the end of 
each protocol by 50nM increments from 150nM to 300nM. This range of [Ca2+] 
was chosen to allow an assessment of the ability of the SR to load at levels 
sim ilar to those in diastole and also under conditions approxim ating 
cytosolic Ca2+ overload. This combination of loading times and [Ca2+] proved 
appropriate to cover the full range of SR Ca2+-loading under our conditions. 
The am plitude of the caffeine contracture was used as a quantitative gauge of 
releasable Ca2+ content of the SR. The caffeine-induced contractures are 
expressed (figures 3.2 and 3.3) as a percentage of the first Cmax measured i.e. 
immediately after Triton treatment was completed.
After the SR loading protocol was completed, the preparation was treated 
w ith Triton-xlOO for 30 minutes and measurements of myofilam ent claim 
sensitivity  and m axim um  Ca2+ activated force (Cmax) were made. This 
protocol was followed rigidly in each experiment over a very similar time 
period w ith identical stepwise increases in loading [Ca2+] for both SAL and 
ADR animals.
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Figure 3.1 Protocol for loading the SR in saponin-treated rabbit ventricular 
trabeculae. Panel A shows a complete loading protocol over a period of 30 
minutes. Arrowheads represent 5 s application of caffeine (lOmM). A train of 
3 control caffeine-induced contractures (CIC) is followed by the test loading 
[Ca2+] (150nM in this case) for various loading periods (15-150 s) arranged in 
random  order. The preparation is then returned to the standard  control 
conditions for a train of 5 CIC before starting another random  time file at a 
higher loading [Ca2+]. Panel B shows three expanded CICs from the upper 
panel after loading for 45 s (closed circle), 90 s (closed square), 120 s (open 
circle). Note how the contractures peak within 1-2 s and that the amplitude of 
the contracture is affected by the loading period.
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RESULTS 
Assessment of heart failure 
Clinical features
Adriam ycin animals had significantly lower body weights than the saline
treated controls (ADR 3.02±0.37 vs SAL 3.68±0.25kg; P=0.001) and although
they had tended to show an increase in w eight after the adriam ycin
injections had stopped they always lagged behind the controls. 75% of the
ADR animals had scrotal oedema and, although this included all of those
w ith low LVEF (<45%), it was probably a feature of m alabsorption and
hypoalbuminaemia (M Pye, Personal communication). 4 ADR animals had a
tachycardia at rest of >240min'l and tachypnoea of >50m in'l. Liver weights
**
were slightly lower in ADR animals (69±13 vs 78±17g) and lung weights were 
not different (7.7±1.6 vs 7.9±0.6g).
Echocardiography
Left ventricular end-diastolic diameter was significantly greater in the ADR 
animals (ADR 1.63±0.11 vs SAL*1.50±0.16cm;P=0.048) although 50% of these 
animals had values which fell within the control range (1.2-1.6cm).
Left ventricular ejection fraction was significantly lower in the ADR animals
4c 4c
(54.2±9.5%) compared with SAL *(70.5±6.5%; p<0.01). How ever, there was 
considerable overlap of values (ADR range 35-70%, SAL range 60-80%).
Left ventricular pressures
* *
Left ventricular systolic pressure was not significantly different in ADR (93.4 
±11.8mmHg) com pared w ith SAL *(101.5±14.1) trea ted  anim als. Left 
ventricular end-diastolic pressure at baseline was also no t significantly
i * *  *
different in ADR compared with SAL (6.2±4.1 vs 5.1±3.4mmHg) with no
* *
differential response to fluid challenge betw een g roups (11.7±7.6 vs 
11.5±7.2mmHg).
4c
:(n=7) (n=12)
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Cardiac output
Resting cardiac output was slightly lower in ADR (292±71.2m l/kg/m in) 
com pared with controls *(332±53.5ml/kg/min; P=0.1) but this did not reach 
statistical significance. The response of cardiac output to fluid challenge was 
also not significantly different between groups (31.2±10.1 vs 35±16.8; P=NS). 
Once again the range of values in the SAL group was smaller compared with 
the ADR group (SAL 303-387 vs ADR 211-344m l/kg/m in) indicating that 
some ADR animals had significant LV dysfunction while others had norm al 
haemodynamic function as assessed by this method.
Isolated trabeculae experiments
SR function
There was no significant difference in SR Ca2+-loading at short or at longer 
loading times between ADR and SAL rabbits at lower loading [Ca2+]s (150nM, 
200nM). At 250nM loading [Ca2+] ADR animals dem onstrated enhancedCa2+- 
loading at short and at longer loading times compared with SAL. At 300nM 
loading [Ca2+] caffeine contractures were larger in ADR animals at longer 
loading times, bu t were not significantly different from  SAL anim als at 
shorter loading times (figure 3.2). By separating the ADR animals into two 
groups on the basis of left ventricular ejection fraction, animals with an EF of 
less than 45% (n=4) dem onstrated an enhanced uptake of Ca2+ com pared 
w ith both the SAL trabeculae and the ADR group with an EF of greater than 
45% (figure 3.3). This difference between ADR animals, w ith and w ithout 
significant LV dysfunction, was not observed at other loading [Ca2+]s. At 
higher loading [Ca2+]s and at loading times longer than 120s the amplitude of 
caffeine contractures tended to reduce in ADR trabeculae.
*  * *
(n=7) (x\=l2)
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Spontaneous tension oscillations
Enhanced SR Ca2+-loading was associated with an increased tendency for
spontaneous tension oscillations in trabeculae from ADR rabbits. A typical
example of oscillatory behaviour in a saponin-treated trabecula is illustrated
in figure 4.4 (chapter 4). These spontaneous tension transients were observed
more frequently in trabeculae from ligated hearts and are dealt with in more
detail in chapter 4. However, they were defined for purposes of analysis as a
spontaneous increase in resting tension lasting longer than 2-3 seconds and
of an am plitude greater than 3 times the baseline noise level. This pattern of
spontaneous release was observed in 4 ADR trabeculae and  in 2 SAL
trabeculae under the SR-loading conditions examined. No formal statistical
analysis of these data was possible because of low num bers in each group but
the relative numbers give some information as to the occurrence in the ADR
and SAL trabeculae. The [Ca2+] • time product at which these oscillations first
appeared  in the loading protocol was lower in the adriam ycin treated 
** *
anim als (31.6±3.6 vs 39.7±2.1 pM.min). W hen these oscillations appeared 
there tended to be a fall in the amplitude of subsequent caffeine contractures. 
This feature c&n be clearly seen in the SR loading curve at 300nM [Ca2+] 
(figure 3.2).
* **
(n=7) (n=12)
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Figure 3.2 (this and facing page) SR loading curves for 4 loading [Ca2+]s in 
trabeculae from adriamycin and saline treated rabbits. ADR animals (closed 
circle, n=12, mean±sem) dem onstrate greater SR Ca2+-loading than SAL 
(open circle, n =7) only at higher [Ca2+]s.
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Figure 3.3 SR loading curves at 250nM loading [Ca2+] for adriamycin treated 
rabbits separated on the basis of ejection fractions. ADR with EF<45% (closed 
circles, n=4, mean±sem) had enhanced Ca2+-loading com pared w ith  ADR 
w ith EF>45% (closed squares, n=8) and SAL animals (open circles, n=7).
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Cmax anc* myofilament Ca2+ sensitivity
There was no significant difference in the cross-sectional area of trabeculae 
from  ADR and SAL animals (0.079±0.008 vs 0.080±0.007mm2). M aximum 
C a 2+ activated force per unit cross-sectional area was not significantly 
d if fe re n t be tw een  ADR (m ean±SD, 7 .4 2 ± 3 .0 g .w t/m m 2) and  SAL 
(6 .08± 2 .93g .w t/m m 2; P=NS) animals. The curves representing the mean 
C a2+/force  relationship in ADR and SAL treated animals are illustrated in 
figure 3.4. The [Ca2+] required for half maximal activation (pCaso) was not 
significantly different between groups (SAL 5.55±0.103 vs ADR 5.49±0.086). 
The mean Hill coefficient was slightly greater in ADR animals with a greater 
spread of values compared with controls (SAL 3.56±0.65 vs ADR 3.95±1.41).
Group with ejection fraction<45%
In view of the small number of animals in the adriamycin study it was not 
possible to correlate haemodynamic variables with SR function. There were 
four animals with an echo ejection fraction of <45% and these animals also 
dem onstrated clinical evidence of significant adriam ycin cardiotoxicity 
(tachycardia, oedema, tachypnoea). While this chosen ejection fraction 
appears arbitray the clinical impression of adriamycin toxicity was consistent 
with the clinical findings and therefore it is valid to analyse the SR loading 
characteristics of these four animals as separate group.
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Figure 3.4 M yofilament Ca2+ sensitivity of adriamycin and saline treated 
rabbit trabeculae. ADR (closed circles) pCaso 5.49±0.086, Hill 3.95±1 41(n=10, 
m ean±SD );SA L (open circles) pCaso 5.55±0.103, H ill 3.56±0.65 (n=6, 
mean±SD).
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DISCUSSION
The severity  of heart failure produced by chronic adm in istra tion  of 
adriam ycin in this study was limited by non-cardiac toxic side-effects of the 
drug and resulted in only a small number of animals with significant LV 
dysfunction. Haemodynamic assessment indicated that only 4 animals in the 
ADR group had ejection fractions of less than 45% and a significantly greater 
LVEDD. How ever, invasive assessment of left ventricular pressures and 
cardiac ou tpu t failed to dem onstrate significant differences in the ADR 
animals compared with controls at baseline and following challenge with an 
intra-ventricular fluid load. This result is in keeping w ith other studies 
w hich also reported  a high rate of attrition using this m odel (Shenasa, 
C alderone, Verm eulen et al, 1990). These animals were killed because of 
significant non-cardiac side-effects including weight loss, mucosal ulceration, 
diarrhoea and conjunctivitis and so it is possible that these were the animals 
m ost sensitive to adriam ycin and therefore m ost likely to develop 
cardiomyopathy. However, 6 animals which were killed before the end of the 
protocol had echocardiography performed and only one had evidence of left 
ventricular dilatation and depressed systolic function. It is possible that they 
were still at an early stage of myocardial toxicity before echocardiography 
could detect an abnormality. Increasingly stringent guidelines for animal 
welfare and suffering may limit the use of this model in future.
Despite the lack of evidence for significant LV dysfunction there were 
differences in SR function in trabeculae isolated from  ADR animals. At 
higher loading [Ca2+] there was enhanced SR Ca2+ -loading revealed as larger 
caffeine-induced contractures in the ADR trabeculae. However, since the 
differences in SR loading tended to occur at longer and not shorter loading 
times this w ould suggest an increase in total loading capacity rather than an 
increase in the rate of SR Ca2+ -loading. This increased buffering capacity of
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the SR for Ca2+ could be due to an increase in the volume of SR within the 
myocytes or possibly an increase in intra-SR calsequestrin. Both of these 
changes would bring about an increase in the Ca2+ buffering capacity of an 
isolated trabecula. Previous studies had indicated a reduction in the num ber 
of SR Ca2+ release channels following chronic adriamycin adm inistration in 
rabbits (Dodd et al, 1993). In the saponin-skinned preparation the SR can load 
and leak Ca2+ in a manner similar to the physiological setting. A reduction in 
the num ber of leak channels in the presence of the same num ber of SR Ca2+ 
pum ps might result in a net increase in the quantity of Ca2+ loaded by the SR 
during any given loading period. This hypothesis is compatible with the 
findings of this study: similar SR Ca2+-loading at shorter loading times, 
im plying a similar rate of uptake, but enhanced SR Ca2+-uptake at longer 
loading times, when the SR is in a steady state, when the balance of leak and 
uptake becomes more im portant. These results are, therefore, sim ilar to 
previous observations of a decrease in the num ber of SR Ca2+ release 
channels in rabbits treated chronically with adriamycin.
The finding of an increase in the tendency for spontaneous oscillations in the 
ADR trabeculae is not consistent with the notion of greater SR volume or an 
increase in the intra-SR Ca2+-buffering protein, calsequestrin. An increase in 
the total SR Ca2+ content would provide more for release and subsequently 
larger caffeine contractures bu t w ould not increase the likelihood of 
spontaneous release. Spontaneous release of Ca2+ by the SR has previously 
been described in skinned cardiac muscle preparations after acute exposure to 
Adriam ycin (Asayama, Yamahara, Tatsumi et al, 1992). These authors argue 
that by maintaining the SR Ca2+ release channel in an open state, adriamycin 
w ould  increase the tendency for spontaneous release. This is a rather 
sim plistic  in te rp re ta tion  since it assum es th a t the m echanism  of 
spontaneous release is related to the open probability of the channel which is 
increased in the presence of adriamycin. However, caffeine also acts at the
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sam e ryanodine receptor on the SR and has been show n to reduce 
spontaneous Ca2+ release from the SR (Bers, 1991) probably also by increasing 
the open probability of the ryanodine receptor. In the chronic adriamycin 
model the cause of spontaneous oscillatory behaviour is likely to be Ca2+ 
over-load brought about by a reduction in Ca2+ leak which allows the SR to 
load to a greater extent. The previously observed increase in sensitivity of the 
release channel for Ca2+ (Pessah et al, 1990), if present in the chronically 
treated animal, would tend to increase Ca2+ leak and reduce the tendency for 
spontaneous Ca2+ release. Such differences seem to be related to the length of 
time of exposure to the drug.
Enhanced SR Ca2+ -loading was more marked in the animals w ith echo EF of 
less than 45% (figure 3.2). There are three different ways of interpreting this 
finding. Firstly, that these animals were the most sensitive to adriamycin and 
had the greatest degree of cardio-toxicity resulting in a m arked reduction in 
the Ca2+ leak pathw ay and therefore a larger Ca2+ -loading capacity. The 
second is that these animals had significant heart failure and that this was 
producing a increase in SR Ca2+ -loading on its own. The third is that heart 
failure and adriamycin were acting in combination to produce a change in SR 
Ca2+ -loading. Some workers have reported that the effects of adriamycin on 
the SR can persist for up to 4 weeks following adm inistration (Pessah et al, 
1990) and so it is possible that we were observing persistent direct effects of 
adriamycin despite waiting for 2 weeks after the last dose.
There was no difference in the absolute force production between ADR and 
SAL trabeculae. This is not entirely consistent with previous work indicating 
that adriamycin induces myofibrillar loss (Iwasaki & Suzuki, 1991). However, 
Jenson (1986) also failed to dem onstrate a reduction in the peak tension 
response in papillary muscles isolated from rats chronically treated w ith 
adriam ycin . In teresting ly  he also dem onstra ted  a reversa l of the 
negative-staircase phenomenon in a number of ADR rats (perhaps as a result
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of enhanced SR function). Other workers using the rabbit ADR m odel 
dem onstra ted  a reduction in peak tension in isolated papillary muscles 
(Shenasa et al, 1990). The lack of reports in the literature on Triton treated 
trabeculae from animal models of adriamycin cardiomyopathy might reflect 
the lack of positive experimental findings. This is itself interesting since 
electron microscopy evidence of myofibrillar loss m ight be expected to 
produce some m easurable change in myofilament function. Previous work 
has dem onstrated a change in the myofibrillar protein, F-actin, when isolated 
cardiac contractile proteins are exposed acutely to adriamycin in vitro (Lewis, 
Kleinerman & Puszkin, 1982) but no such changes have been dem onstrated 
after chronic administration.
This study  dem onstrated no difference in the Ca2+/fo rc e  re la tionsh ip  
betw een ADR and SAL rabbits. Although this indicates that there has been 
no significant change in the response to Ca2+, we can make no definitive 
statem ents of possible changes in the m yofilam ent regulatory proteins. 
However, this result is important since it indicates that the myofibrils, acting 
as Ca2+ sensors, were equally as sensitive in ADR and SAL animals. The 
mean Hill coefficient was slightly greater in the ADR group. This can be seen 
in figure 3.4 as a reduced slope of the pC a/tension curve and although the 
Hill (h) coefficient can be used to describe the curve it is debatable whether 
this infers a change in the number of Ca2+ binding sites on troponin- C(as is 
im plied from the Hill equation).
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Conclusions
This p art of the study has therefore indicated that SR Ca2+ -loading is 
increased in saponin-skinned trabeculae from rabbits w ith adriam ycin- 
induced  cardiom yopathy and evidence of significant LV dysfunction. As 
discussed, these changes may have been brought about by a direct effect of 
adriamycin on the SR or possibly by the LV dysfunction which resulted from 
adriam ycin-induced m yocardial dam age. H ow ever, previous w ork on 
isolated SR vesicles indicated a reduction in the num ber of Ca2+ release 
channels and so the SR Ca2+ -loading assessed in these saponin-treated 
trabeculae might be reflecting reduced SR Ca2+ leak with maintained SR Ca2+ 
uptake which results in a net increase in Ca2+-loading.
This concept of differences in SR leak and uptake recurs throughout this 
thesis and these results in ADR rabbits provide an interesting background for 
those obtained in the coronary ligation model of heart failure.
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CHAPTER 4
Cardiac sarcoplasmic reticulum Ca2+-loading 
in rabbits 8 weeks after coronary artery ligation
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INTRODUCTION
Previous work using the rabbit coronary ligation model in this departm ent 
had indicated that significant left ventricular dysfunction developed 8 weeks 
after coronary ligation. Few studies of Ca2+ handling have used the rabbit as a 
m odel of heart failure and, of those which have used the rabbit, none have 
studied the coronary ligation model. The rabbit is suitable since its large size 
allows easy instrum entation and previous work has indicated that the SR 
may be more like the human in contribution to myofilament Ca2+ activation. 
The initial experiments in this study were performed 8 weeks after coronary 
ligation. The general m ethods used are described elsewhere bu t further 
details of experimental protocol relating to the isolated trabeculae studies are 
described.
METHODS 
Animal model and heart failure assessment
These methods are detailed in chapter 2. All ligation rabbits (LIG, n=17) and 
all sham -operated controls (SH, n = ll)  had echocardiography and invasive 
haem odynam ic measurements performed.
Protocol for assessment of SR function
The m ethods for m ounting preparations and the tension m easurem ent 
techniques are detailed in chapter 2. The SR was allowed to load Ca2+ in 
solution A with aliquots of Ca2+ chloride (lOmM) added to provide a range of 
[Ca2+]. Caffeine-induced contractures were evoked by solution A (table 2) 
containing lOmM caffeine.
A protocol identical to that described in the adriamycin experiments (figure 
3.1) was used to assess SR function in the this part of the study. Between 
contractures, the muscle was exposed to a [Ca2+] sub threshold for tension 
production. During this period, the SR can accumulate Ca2+ which is released
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by the next challenge with caffeine. A range of loading periods (15-150 s) and 
[Ca2+]s (150-300nM) were studied. The amplitude of the caffeine contracture 
was normalised to C max determined in the Triton-treated state imm ediately 
after the last caffeine-contracture. This protocol was followed rigidly in all 
experiments.
Spontaneous tension oscillations in saponin-treated trabeculae
At higher loading [Ca2+] and longer loading times, the trabeculae exhibit 
spontaneous tension oscillations. These were defined for the purpose of this 
study  as repeated, spontaneous tension transients (~2-3s duration) of 
am plitude greater than 3 times the baseline noise level. Once initiated, these 
oscillations occur random ly and are related to the bathing [Ca2+] and the 
length of time that the SR is exposed to this [Ca2+]. Quantitative analysis of 
these tension transients is rather difficult since the num ber and  the 
am plitude  of oscillations can vary considerably, even in any single 
preparation. The MacLab software was used to calculate, by integration, the 
area under the tension oscillations during any given loading period. Since 
the baseline tension also often changed during the oscillations it was often 
difficult and time consum ing to m easure this accurately even w ith  the 
software available. The critical loading conditions (loading time and loading 
[Ca2+]) at which these oscillations first appeared in the protocol were recorded 
as an easier and more definitive m ethod of assessing probability  of 
oscillations. These conditions are quantitatively referred to as the [Ca2+] • time 
product.
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Assessment of Cmax and myofilament Ca2+-sensitivity
After assessment of SR function, each trabecula was exposed to 1% Triton- 
XI00 for 30 min to disrupt all membranes and leave only the myofilaments 
functionally intact. Seven solutions with different [Ca2+] were m ade by 
mixing solutions A and B in appropriate proportions. These were used to 
define myofilam ent Ca2+ sensitivity (expressed as the negative log of the 
[C a2+] required to produce 50% of maximal activation i.e. pCaso) under 
conditions of strong Ca2+ buffering. M easurement of Cmax at the beginning 
and end of the sequence was made using solution A with Ca2+ chloride added 
providing a final pCa of 4. A typical sequence of activations is illustrated in 
figure 4.1. The activations are arranged in random  order to m inim ise 
accumulation of phosphate within the preparation and minimise fall-off in 
tension.
Effects of caffeine on Ca2+ sensitivity
The effects of caffeine on the myofilament responsiveness to Ca2+ was also 
assessed in 8 week LIG (n=5) and SH (n=5) animals. Seven solutions with 
different [Ca2+]s were created by mixing solutions A and B in appropriate 
proportions. Each solution was divided into two aliquots and caffeine 
(lOmM) was added to one. The caffeine-free solutions were used first to assess 
baseline myofilament Ca2+ sensitivity (expressed as the [Ca2+] required to 
produce 50% of maximal activation i.e. pCaso). Each test [Ca2+] was applied 
after prior equilibration of the preparation in solution A. M easurem ent of 
Cmax at the beginning and end of the sequence was made using solution A 
w ith Ca2+ chloride added providing a final pCa of 4. This allowed the 
calculation of the mean fall-off in tension throughout the protocol. The same 
sequence of activations was then repeated w ith the set of solutions 
containing caffeine lOmM.
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Figure 4.1 Ca2+-activations in a Triton-treated ventricular trabecula used to 
assess Ca2+ sensitivity. The first and last activations are maximal activations 
(C max)/ note the fall-off in tension throughout the protocol. Caffeine 
contractures from the SR loading protocol are normalised to the first Cmax.
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RESULTS
Haemodynamic assessment
A lthough coronary artery ligation using this technique produced a 25-35% 
infarct of the left ventricle, there was some variation in severity of left 
ventricular dysfunction which resulted. Full thickness infarction occurred in 
the majority of animals (>90%) with infarction of a large papillary muscle in 
75%. Mitral regurgitation could not be detected on echocardiogram by colour 
or pulsed-wave doppler but there was obvious dilation of the left atrium  in 
these anim als and occasionally a suggestion of mitral valve prolapse (see 
figure 2.2). Results discussed below are summarised in table 3.
Clinical evidence of heart failure
47% of the ligation group (8/17) had clinical evidence of heart failure 
including peripheral oedema, ascites, resting tachycardia, tachypnoea and 
lung crepitations. 6 of these animals had ejection fractions of 40% or less on 
echocardiography. Further indirect evidence of left and right heart failure 
was provided by the significantly greater lung wet weights (0.43±0.11 vs 
0.36±0.06% body weight; P=0.03) and liver wet weights (2.59±0.48 vs 2.26±0.35 
% body weight; P=0.04) in the LIG. Total body weights were not significantly 
different between ligation and sham animals either before ligation surgery 
(2.98±0.21 vs 3.02±0.22kg) or at the time of haem odynam ic assessm ent 
(3.75±0.46 vs 3.71±0.40kg).
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Table 3 Haemodynamic indices 8 weeks after coronary ligation (mean±SD)
Sham s (n= ll) Ligations (n=17)
Bodyweight (kg) 3.71±0.4 3.75±0.46 N S
Liver(% body  w t)  2.26±0.35 2.59±0.48 P=0.04
L\m gs(% body w t)  0.36±0.06 0.43±0.11 P=0.03
LVEDD (cm) 1.55±0.08 1.86±0.19 P=0.0001
EF (%) 68.3±3.9 41.9±9.5 P=0.001
LVSP (mmHg) 117.9±15.5 102.9±10.1 N S
LVEDP (mmHg) 5.8±2.7 15.1±6.9 P=0.001
CO (m l/k g /m in )  354.3±32.9 275.2±63.1 P=0.001
ACO (% increase) 35.1 ±8.7 21.1±13.2 P=0.004
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Echocardiography 
Ejection Fraction (LVEF)
In coronary ligation anim als (n=17) the m ean left ventricular ejection 
fraction w as significantly low er than sham  operated  (n = ll)  controls 
(mean±SD; 41.9±9.5 vs 68.3±3.9%; P=0.001). Within the controls there was 
little variation but in ligation animals there was a greater spread of LVEF 
reflected in the larger standard  deviation (SD). The range of values in the 
control group was 65-80% with a median value of 70%. In the ligation group 
the range was 30-65% w ith a m edian value of 50%. 6 animals had ejection 
fractions of <40% with a further 6 having an EF of <50%. 2 anim als had 
significant pericardial effusions noted on echocardiography which were later 
confirmed at the time of heart excision.
Left ventricular end-diastolic diameter (LVEDD)
This was an easily performed measurement in all rabbits by M-mode and was 
com parable in both the short and long axis. The ligation g roup  had 
significantly larger LVEDD (1.86±0.19 vs 1.55±0.08cm;P=0.001) and once again 
the range of values was greater in the ligation group reflecting the variation 
in LV function. LVEDD correlated well w ith LVEF (r=0.81) indicating that 
progressive left ventricular dilatation was associated w ith im pairm ent of 
contractile function.
Invasive measures of LV dysfunction 
Heart rate
At the time of haem odynam ic assessment, with catheters in-situ, resting 
heart rate was significantly higher in ligation anim als (220.4±32.6 vs 
198.1±23.2min"l; P=0.04) and showed a more pronounced increase following 
fluid challenge (increased to 265.6±29.8 vs 220.1±45.6min"l; P=0.05).
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Ventricular pressures
Left ventricular systolic pressure, at rest, was slightly lower in the ligated 
anim als (102.9±10.1 vs 117.9±15.5mmHg; P=NS) and was not significantly 
d ifferent after fluid challenge (119.6±12.2 vs 122.3±10.8mmHg; P=NS) 
compared with controls. Baseline left ventricular end-diastolic pressure was 
significantly higher in the ligation animals (15.1±6.9 vs 5.8±2.7mmHg; P=0.01) 
and demonstrated a more marked increase in the ligation animals following 
fluid challenge (increased to 24.9±7.8 vs 14.1±3.8mmHg: P=0.01).
Therm odilution cardiac output
Resting cardiac output was lower in ligation anim als (275.2±63.1 vs 
354.3±32.9ml/kg/min; P=0.01) and dem onstrated a dim inished response to 
fluid challenge (% increase (ACO) 21.1±13.2 vs 35.1±8.7) compared with sham 
operated controls. The mean peak cardiac output m easured after the fluid 
challenge was therefore significantly reduced in the LIG group (332.75±37.9 vs 
477.9±48.7ml/kg/min;P=0.01). There was a considerable spread of values 
w ithin  the ligation group (range 172-344m l/kg/m in) w ith  some ligated 
anim als having a cardiac index w ithin the norm al control range. This 
reflected the range of left ventricular dysfunction produced. The increase in 
cardiac index (ACO) correlated well with other measures of LV dysfunction 
including echocardiographic ejection fraction (r=0.68; P=0.01).
Heart failure scores
Using the heart failure scoring system described in table 1, the LIG animals at 
8 weeks following coronary ligation were divided into two groups (score>5, 
n=7 and score<4, n=10) w ith different heart failure scores (mean scores 
6.5±1.11 vs 2.25±1.29).
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Isolated trabeculae experiments 
Preparation size and shape
Trabeculae were typically elliptical in cross-section with a mean diam eter of 
150±56pm (mean±SD) and thickness of 85+12|im. There was no difference 
between the size of trabeculae obtained from ligated hearts (major diam eter 
148±52fim, m inor d iam eter 78±14|im) com pared w ith  control hearts 
(158±46pm x 90±18|im). Preparation length w hen m ounted at the desired 
sarcom ere length was typically 2-3mm. The preparations were examined 
carefully, once m ounted, to ensure they were not Purkinje fibres. Purkinje 
fibres are typically thinner in the rabbit than the trabeculae used here. They 
are also often surrounded by a sleeve of fibrous tissue which could be clearly 
seen on light microscopy. Purkinje fibres also tend to have a capillary plexus 
on the surface and such preparations were discarded. Additional evidence to 
support the fact that these preparations were trabeculae rather than Purkinje 
fibres is that the absolute force produced per unit cross sectional area was 
sim ilar to that of other studies and was not significantly different between 
groups.
Time course of caffeine contractures
The time-course of individual caffeine-induced contractures (CIC) was not 
significantly different between LIG and SH animals ; m ean time to peak- 
tw itch for 5 contractures at 25-30% Cmax was sim ilar in a representative 
sam ple of LIG (n=6) and SH (n=6, 1.26±0.23s vs 1.43±0.38s, respectively, 
P=NS). The form of the SR Ca2+-loading curves (illustrated in figure 3.1) was 
found to be similar using either force*time integral or peak force (amplitude) 
of the CIC which, again, reflects the similar nature of the time-course of CICs 
between LIG and SH animals.
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Figure 4.2 (this and facing page) SR Ca2+_-loading in LV trabeculae at 4 [Ca2+]s 
in SH (n=5, open circle) and LIG anim als w ith m oderate heart failure 
(score<4, n=7, closed circle) and more severe heart failure (score>5, n=4, 
closed squares). Values are plotted as mean±sem.
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Figure 4.3 (this and facing page) SR Ca2+-loading at 4 [Ca2+]s in RV trabeculae 
from SH (n=8, open circles) and LIG animals w ith m oderate (score<4, n=6, 
closed circles) and more severe heart failure (score>5, n=4, closed squares). 
Values are mean±sem.
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SR function in LV trabeculae
The SR loading behaviour of LV trabeculae from 8 week sham  and ligated 
anim als is sum m arised in figures 4.2. At short loading periods (e.g. 30 
seconds) LV trabeculae from anim als w ith m ore severe heart failure 
(score>5) produced significantly larger caffeine contractures than controls at 
all [Ca2+]s studied while those animals with less heart failure (score<4) 
produced contractures significantly different from controls only at higher 
[Ca2+]s (250nM, 300nM). At longer loading periods (e.g. 120 seconds) the 
pattern  of SR Ca2+ -loading in LV trabeculae was similar to that observed at 
short loading times except that at higher [Ca2+]s (250nM, 300nM) the 
difference between the high and low scoring LIG animals became less m arked 
bu t both continued to demonstrate significantly enhanced SR Ca2+ uptake 
com pared w ith the control group. The m axim um  caffeine contracture 
obtained (relative to Cmax) for any condition of loading time or [Ca2+] in LV 
trabeculae was significantly greater for LIG (87.9±5.0%) com pared w ith 
controls (27.2±6.5%; P<0.01).
SR function in RV trabeculae
For RV trabeculae (figure 4.3) a similar pattern em erged but differences 
betw een high and low scoring heart failure groups were less obvious. 
Com pared w ith controls, RV trabeculae from anim als in both m oderate 
(score<4) and more severe (score>5) heart failure groups dem onstrated 
significantly larger caffeine contractures at low [Ca2+]s (150nM, 200nM) and at 
short (30s) loading periods. At longer loading periods and at higher [Ca2+]s 
(250nM, 300nM) the difference in loading patterns between the three groups 
became less marked. The maximum caffeine contracture obtained (relative to 
Cmax) for any condition of loading time or [Ca2+] for RV trabeculae was 
significantly greater for LIG (86.0±10.5%) com pared w ith  SH (53.9±10.1; 
P<0.05).
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SR function in RV vs LV trabeculae
For control preparations, RV trabeculae demonstrated a significantly greater 
peak caffeine contracture than the LV trabeculae (53.9±10.1% vs 27.2±6.5%; 
P<0.04). In the moderate heart failure group (score<4), RV trabeculae were 
not significantly different from LV (72.7±10.3% vs 56.2±7.6%) and for the 
more severe heart failure group there was also no significant difference (RV 
86.0±10.5 vs  LV 87.9±5.0%). In control animals, RV trabeculae dem onstrated 
increased SR loading compared with LV preparations at all loading [Ca2+]s 
tested. This finding is illustrated in figure 4.4 where LV and RV preparations 
were obtained from the same heart for a control and a heart failure rabbit. 
This difference also occurred in the animals w ith m oderate heart failure at 
low loading [Ca2+]s (150nM, 200nM) but was less obvious at higher [Ca2+]s. In 
those anim als w ith a high heart failure score there w as no significant 
difference in tension responses, at all the [Ca2+]s tested, between RV and LV 
preparations.
Correlation of SR function w ith LV dysfunction
The enhanced Ca2+-loading ability of the SR, in individual preparations, was 
found to correlate well with a number of indices of LV dysfunction m easured 
by echocardiography and in vivo haemodynamic assessment (figure 4.5). The 
SR loading conditions used in this correlation are 150nM [Ca2+] and 120 
seconds loading period. This loading condition was chosen because it 
represents the nominally accepted diastolic [Ca2+] in cardiac myocytes (Bers, 
1988) and the SR is known to be in equilibrium after 2 m inutes loading in 
saponin-skinned preparations (Orchard and Allen 1989). Using these loading 
conditions there was a clear spread of SR function between the three groups. 
The strongest correlation was found with LV ejection fraction (r=0.79; P<0.01) 
but there was also a relationship with LVEDD (r=0.68; P<0.01), LVEDP (r=0.70;
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PcO.Ol) and resting cardiac output (r=0.54; P<0.05) suggesting that, w ith 
increasing severity of heart failure, the ability of the SR to load Ca2+ increases.
Spontaneous tension oscillations
In association with increased SR Ca2+-loading capacity there was increased 
susceptib ility  to SR Ca2+-overload revealed as spon taneous tension 
oscillations occurring during the loading period. A typical exam ple of 
spontaneous oscillations in a ligated animal is illustrated in figure 4.6. The 
final caffeine contracture in the ligation animal trace (single arrow) is of 
lower am plitude than the preceding contracture despite a longer loading 
period (150s vs 60s) indicating that the SR Ca2+ pool available for the next 
activation has been depleted by spontaneous release. Oscillations occurred 
more commonly in LIG animals (14 of 17, 83%) than in SH (5 of 11, 45%) and 
tended to occur at lower [Ca2+] and shorter loading times. This is summarised 
in figure 4.6, where the cumulative probability of oscillations is plotted 
against the [Ca2+]*time product at which oscillations first appeared in the 
loading protocol for RV and LV trabeculae. In addition, RV trabeculae from 
the LIG group dem onstrated spontaneous oscillations at lower [Ca2+]*tim e 
products compared with LV trabeculae from LIG animals (26.1±2.6 vs 34.3±6.2 
pM seconds; P<0.03) while there was no significant difference in the 
occurrence of spontaneous oscillations between LV and RV preparations 
from controls.
Myofilament force production and Ca2+ sensitivity
There was no significant difference in cross-sectional area (XSA) of trabeculae 
isolated from ligated and control animals (0.09 ± 0.002 vs 0.08 ± 0.003mm2). 
There was also no difference in the XSA of preparations obtained from left 
and right ventricles (0.08±0.0025 vs 0.08±0.003mm2). In the same preparations 
used for SR loading studies, after treatm ent w ith Triton-XlOO, m axim um  
force per unit cross-sectional area was not significantly different between RV
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and LV preparations in controls (RV: 5.40±2.56 vs  LV: 5.76±3.27 g.w t./m m 2; 
P=0.33). In ligation animals RV trabeculae produced significantly less force 
per unit cross sectional area than LV trabeculae (RV 3.05±1.58 vs LV 5.98±3.70 
g .w t/m m 2; P=0.023). This change was produced by a significant reduction in 
Cmax in RV trabeculae (P=0.04) rather than a increase in LV trabecular force 
production.
The sensitivity of the myofilaments to Ca2+ was not different between the 
combined RV and LV trabeculae from control and LIG animals (figure 4.8). 
There was also no significant difference in myofilam ent Ca2+ sensitivity 
between RV and LV trabeculae in both groups (pCaso: SH: RV 5.58±0.07 vs LV 
5.55±0.08; LIG: RV 5.47±0.08 vs  LV 5.48±0.09). There was no correlation 
between the severity of heart failure (ejection fraction) and the pCaso (r=0.09). 
Effects of caffeine on myofilament Ca2+-responsiveness 
The baseline values for Ca2+ sensitivity of the myofibrils were not different 
between the five LIG and five SH animals studied (pCaso SH 5.504±0.086 vs 
LIG 5.455±0.141; P=0.19). The Hill values were also not significantly different 
at baseline (SH 2.71±0.61 vs LIG 2.18±0.89; P=0.33).
The increase ift myofilament Ca2+-sensitivity produced by lOmM caffeine was 
similar in the LIG and SH animals studied (figure 4.9). The mean Hill curves 
were shifted to the left equally in both groups (mean shift pCa LIG 0.16±0.07 
vs SH 0.17±0.07; P=NS) w ith a slight but non-significant reduction in the 
mean Hill value in the LIG group (SH 2.39±0.57 vs LIG 1.82±0.57).
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Figure 4.4 SR Ca2+-loading in LV and RV trabeculae (at 200nM [Ca2+]) from 
the same animals: comparison of SH and LIG. There is enhanced SR loading 
in the control RV compared w ith LV bu t this is not seen in the LIG 
preparation.
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Figure 4.5 - Correlation of indices of heart failure with SR Ca2+-loading. The 
graph plots four measures of left ventricular dysfunction against maximum 
caffeine contracture amplitude produced after loading the SR at 150nM [Ca2+] 
for 120seconds (expressed as a percentage of Cmax). The curves are l in ea r  
regressions w ith the correlation coefficient show n above each (note log 
ordinate). Each abscissa value represents a single animal and includes RV 
and LV trabeculae from LIG (n=ll) and SH animals (n=9).
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Figure 4.6 Spontaneous tension oscillations in a saponin-treated trabecula. 
Experimental traces showing part of an SR Ca2+-loading protocol (at 150nM 
[Ca2+]) where the applications of caffeine (lOmM) are indicated by the double­
headed arrows. The preparation from a ligation animal (lower trace) shows a 
num ber of spontaneous tension transients (*) indicating spontaneous Ca2+ 
release from the SR occurring during the loading period. Note how the final 
caffeine-contracture (single arrow) is reduced in am plitude, despite a longer 
loading period, as oscillations occur.
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Figure 4.7 C um ulative probability  of spon taneous oscillations. The 
percentage of trabeculae demonstrating spontaneous tension oscillations at a 
given [Ca2+]*time product throughout the protocol. A greater proportion of 
trabeculae from LIG animals (n=17) demonstrated this spontaneous activity 
com pared w ith controls (n= ll) and were more likely to oscillate at lower 
[Ca2+]*time products.
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Figure 4.9 Effects of caffeine (lOmM) on Ca2+ sensitivity of Triton-treated LIG 
(n=5) and SH (n=5) trabeculae.
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DISCUSSION
This study  has dem onstrated an increased Ca2+ -loading capacity of 
sarcoplasmic reticulum  in saponin-treated isolated cardiac trabeculae from 
rabbits 8 weeks following left coronary artery ligation. Haem odynam ic 
perform ance, assessed in the conscious animal by echocardiography, LV 
pressures and therm odilution cardiac ou tpu t m easurem ent (table 3) 
dem onstrated clear differences between the controls and the ligated animals 
indicative of significant left ventricular dysfunction in the ligation group. 
This assessment of heart failure in each animal allowed changes in the SR 
function to be correlated with the severity of left ventricular dysfunction. 
H eart failure was found to correlate strongly w ith the SR Ca2+-lo ad in g  
capacity (figure 4). In those animals with a myocardial infarction bu t with 
little or no heart failure, SR Ca2+ uptake was similar to controls in the LV but 
was enhanced in RV trabeculae (figures 2 and 3). Clear differences between 
SR Ca2+-loading of LV and RV trabeculae present in the controls at lower 
loading [Ca2+] were less obvious at higher [Ca2+]. With more severe heart 
failure RV and LV trabeculae demonstrated a differential enhancement of SR 
C a 2+ uptake such that these differences between LV and RV were not 
observed.
SR function in heart failure 
Anim al studies
The indications of enhanced Ca2+ uptake in heart failure reported in this 
study contrast with a number of studies where SR Ca2+-uptake was reported 
to be reduced or unchanged (Lamers & Stinis, 1979, Movsesian, Bristow & 
Krall, 1989, Limas, Olivari, Goldenberg, Levine, Benditt & Simon, 1987). A 
depression of SR Ca2+-uptake has been reported in a num ber of studies using 
anim al m odels of heart failure including the cardiom yopathic Syrian 
hamster (Nagano, Takeda & Dhalla, 1994) the spontaneously hypertensive rat
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(Bing, Brooks, Conrad, Sens, Perreault & Morgan, 1991) and pacing-induced 
heart failure in dogs (Perreault, Shannon, Komamura, Vatner & Morgan, 
1992). Idiopathic cardiomyopathy in dogs (Dobermans) appears to reduce the 
SR Ca2+-uptake and also reduces the SR Ca2+-release channel resulting in a 
possible net increase in SR Ca2+-content (Crory, McCutcheon, O'Grady, Pang, 
Geiger & O'Brien, 1993). Enhanced SR Ca2+ uptake has been reported in mild 
cardiac hypertrophy produced by constriction of the descending aorta in dogs 
(Limas, Spier & Kahlon, 1980). Surprisingly, few studies of SR function have 
used the rabbit as a heart failure model. The rabbit SR is less extensive than 
that of the rat (Fabiato, 1982) and might, therefore, be more like the hum an 
(Bers, 1991). Ito et al (Ito, Suko & Chidsey, 1974) using a volume overload 
model in rabbits, demonstrated no difference in SR Ca2+-uptake in the early 
stages of hypertrophy with a reduction as heart failure occurred.
Myocyte hypertrophy was not measured directly in our rabbit model but LIG 
hearts were significantly heavier and additionally the haem odynam ic data 
suggest significant left ventricular dysfunction. Therefore it seems likely that 
we had  produced significant hypertrophy. Chronic pressure overload 
hypertrophy of either the left or right ventricles by aortic or pulm onary 
banding has been extensively studied as a method of inducing heart failure. 
However, chronic pressure overload sufficient to provoke heart failure may 
represent a different patho-physiological process from that produced by 
infarction.
Undoubtedly, some of the observed differences between studies are related to 
species and model while the technique used to measure SR Ca2+-uptake may 
also give rise to variable results. Assessment of Ca2+ uptake in isolated SR 
vesicles is expressed per mg protein which, if different in heart failure, could 
give rise to errors in such measurements. A dditionally, Ca2+-uptake is 
oxalate-supported in isolated SR experiments, allowing only a measurement 
of Ca2+-uptake and not the total or net loading capacity. In the present study,
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the caffeine-induced contracture, admittedly, represents an indirect m ethod 
of assessing the SR Ca2+ content. H ow ever, in the sapon in -sk inned  
preparation, the SR is anatomically undisturbed and can load and leak Ca2+ 
in a similar way to that occurring in the intact cell.
SR function in hum an heart failure
The bulk of evidence suggests that in hum an heart failure SR Ca2+-loading is 
reduced (Hassenfauss, Mulieri, Leavitt, Allen, Haeberle & A lpert, 1991,
G w athm ey et al, 1987, Mercadier, Lompre, Due et a l ,  1990, Feldman et al,
1987). Studies using heat measurements to assess the ATP consum ption by 
the SR have indicated a reduced activity of the SR Ca2+-ATPase pum p  
(Hassenfauss et al, 1990) While one study using isolated SR preparations 
dem onstrated no significant change in SR Ca2+-up take  (Limas et al, 1987), 
sim ilar preparations in the hands of other w orkers have dem onstrated  
reduced  rates of Ca2+ uptake (Movsesian et al, 1989) Brillantes et al 
(Brillantes, Allen, Takahashi, Izumo & Marks, 1992) reported that mRNA for 
the SR Ca2+ release channel was significantly reduced  in  ischaem ic 
cardiomyopathy but not in idiopathic dilated cardiomyopathy, while the SR 
Ca-ATPase mRNA was reduced in both. This result is similar to that found 
in dog heart failure where changes in the balance of Ca2+ release and uptake 
mechanisms could produce a net increase in SR Ca2+-loading in the intact 
myocyte. Other factors which might give rise to variable results in such 
studies on hum an tissue from end-stage heart failure patients include the 
use of antiarrhythm ic and immuno-suppressive drugs im m ediately prior to 
organ removal. These drugs are known to affect Ca2+ regulation in myocytes 
(Watson, Balke & Gold, 1993, Banijamali, ter Keurs, Paul & ter Keurs, 1993). 
Additionally, hum an control tissue used in these studies is often from donor 
hearts deem ed unsuitable for transplantation because of excessive inotropic 
support and frequently is from patients w ith cranial and  in tra-cranial 
pathology which can produce profound effects on m yocardial function prior
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to organ removal. Furthermore, while most studies have used myocardial 
preparations from patients with end-stage heart failure SR function m ay be 
different in m ild to m oderate heart failure or earlier in the process of 
development of contractile dysfunction. This rabbit model of heart failure at 
8 weeks following coronary ligation may represent such a compensated state 
which could also be present in hum an heart failure but is not observed in 
end-stage disease.
Left vs Right ventricle SR Ca2+-loading
Differences of Ca2+ transport between isolated SR vesicles from RV and LV 
have previously been reported by Afzal et al (1992) suggesting that the RV 
had diminished rates of SR Ca2+ uptake compared to the LV. As heart failure 
developed SR Ca2+-loading reduced in the LV but increased in the RV. These 
authors argue that this could reflect the different haem odynam ic stress to 
which the ventricles are exposed. This is different from my finding, where 
the RV Ca2+-loading was greater than LV in controls bu t both showed 
enhancement as failure ensued such that there was no significant difference 
betw een chambers in animals w ith more pronounced heart failure. The 
finding of an increase in the SR Ca2+-loading in the RV preparations prior to 
changes in the LV in the moderate heart failure group (score<4) suggests that 
circulating factors such as catecholamines or angiotensin/renin products may 
be acting on the RV during moderate LV dysfunction since at this stage it is 
unlikely that significant right heart failure has occurred. Alternatively, the 
RV SR responds more rapidly or is more sensitive to subtle changes in LV 
performance, perhaps related to alterations in wall stress in the LV. 
Spontaneous Ca2+-release
The finding of increased probability of spontaneous release of Ca2+ from the 
SR in this model represents a possible arrhythmogenic mechanism in heart 
failure. Tension oscillations, as a result of spontaneous Ca2+-release, occurred
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during the protocol and were not present before the experiment commenced. 
Each preparation was treated in an identical manner for each experiment and 
was exposed to a standard set of solutions with stepwise increases in [Ca2+]. 
Therefore, the probability of Ca2+ overload developing in these experiments 
m ust be related to some difference in the intrinsic properties of the SR in LIG 
anim als. Possible m echanism s underly ing  this phenom enon m ight be 
related to a change in the balance of SR Ca2+ influx and efflux or an increase 
in the sensitivity of the Ca2+-induced Ca2+-release m echanism  in LIG 
anim als. This phenom enon of spontaneous oscillatory  activ ity  has 
p rev io u s ly  been described  in  L angendorff p e rfu sed  hearts  from  
card iom yopath ic  ham sters by dem onstra tion  of increased  laser-light 
scattering in response to catecholamine challenge (Hano O, Lakatta E, 1991). 
Capogrossi et al (Capogrossi, Houser, Bahinski & Lakatta, 1987) have shown 
that large, synchronous spontaneous releases of Ca2+ from the SR can 
produce localised depolarisations sufficient to produce an action potential. 
This has therefore been proposed as an arrhythmogenic mechanism in heart 
failure since failing hearts appear more likely to exhibit spontaneous 
oscillations both under standard  conditions, as in this study, or w ith 
catecholamine stress as in the study by Lakatta et al, 1991. A spontaneous 
action potential w ould therefore represent triggered spontaneous activity 
which, provided w ith re-entry substrate, could give rise to a sustained 
arrhythm ia.
Spontaneous release of Ca2+ from the SR may also contribute to contractile 
dysfunction in heart failure. Spontaneous release during a diastolic period 
depletes the SR store and w ould therefore reduce the am ount of Ca2 + 
available for a subsequent activation. This point is illustrated in figure 6 
where the final contracture (single arrow) in the LIG preparation trace shows 
a fall in am plitude despite a longer loading period than  the preceding 
contracture because the SR has spontaneously released some of its store
im m ediately prior to the "caffeine activation'. This phenom enon could not 
only reduce systolic contractile force but would also tend to increase diastolic 
tension producing slower relaxation and a rise in resting tension i.e. a so 
called negative lusitropic effect
Possible mechanisms for enhanced SR Ca2+-loading capacity
SR Ca-ATPase rate was not measured in this study but a reduced SR Ca2+- 
ATPase rate in the rabbit ligation model could still be consistent w ith an 
enhancement of net Ca2+-loading. This apparent paradox can be explained by 
considering that the net uptake of Ca2+ by the SR during any given loading 
period is a function of the relative magnitudes of Ca2+-influx and Ca2+-efflux. 
Reduction in the leak of Ca2+, via the so-called SR Ca2+ leak channel, during 
the loading period  could significantly increase the total or net Ca2 + 
accumulated by the SR. In dogs with heart failure, one study indicated a 25% 
reduction in SR Ca2+-ATPase activity but a 75% reduction in the Ca2+ release 
channel (Crory et al, 1993). Such a change could produce a net increase in the 
C a2+-loading ability of the SR. A reduction in the num ber or a change in 
function of SR Ca2+ release channels are mechanisms which could explain 
enhanced SR Ca2+-loading in this model.
Enhanced SR Ca2+-loading could also result from an increased Ca2+ buffering 
capacity of the SR in heart failure, due, either to an increase in intra-SR 
calsequestrin or an increase in the total volume of SR. Time did not perm it a 
quantitative electron microscopic study of the SR in these preparations 
which w ould be required to answer the latter question. Previous studies of 
the calsequestrin gene have not suggested enhanced activity in heart failure 
(Masahi, Alpert, McLennan, Barton & Periasamy, 1993). Furtherm ore, an 
increase in buffering capacity, alone, would reduce and not increase the 
probability of Ca2+-overload as demonstrated in this study by the prevalence 
of spontaneous oscillations. Enhanced Ca2+-loading at shorter loading 
periods (i.e. <60s, figure 4.2) does suggest that the SR is, in fact, loading faster
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in LIG preparations. However, a faster rate of SR Ca2+ pum ping could not 
fully explain the current results since, under these conditions, once the SR 
w as filled to capacity, the Ca2+-pum p w ould be inhibited by the SR 
intralum inal [Ca2+] and Ca2+-uptake would cease. Therefore, both an increase 
in the total buffering capacity and an increase in SR Ca2+-uptake rates must 
p lay  a role in the enhanced SR-loading capacity observed in these 
preparations.
M yofilam ent force production
The time-course of the caffeine-induced contractures was not significantly 
different between LIG and controls. This suggests that the rate of SR-Ca2+ 
release and the subsequent activation of the m yofilam ents was not 
significantly different in LIG preparations since the rate of diffusion of 
caffeine in these preparations is known to be rapid (W endt & Stephenson, 
1983) and can be assum ed to be similar in both groups. However, since 
caffeine sensitises the myofilaments to Ca2+ and diffuses into the preparation 
rapidly then even during a twitch there will be an increase in myofilament 
C a2+ sensitivity. Subsequently if a greater increase in m yofilam ent Ca2+ 
sensitivity  occurred in LIG animals com pared w ith controls this could 
produce an apparent enhancement of caffeine induced contractures in the 
ligated group. Differential enhancement of myofilament Ca2+ sensitivity has 
been described in a rat model of hypertrophy by Baudet et al (1990). However, 
I have clearly shown that the change in responsiveness to Ca2+ produced by 
caffeine was not different in SH and LIG animals (figure 4.9).
M axim um  Ca2+ activated force per unit XSA was not different between LV 
trabeculae from ligated and control animals but was significantly lower in the 
LIG RV trabeculae. This might partly explain the apparent enhanced Ca2+ 
uptake in the RV at m oderate levels of heart failure since the same SR 
function w ith a reduced Cmax would result in an apparent increase in Ca2+ 
uptake because the data are normalised to Cmax. The absolute force produced
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was similar to that described in a num ber of studies (Maughan, Low, Litten, 
Brayden & Alpert, 1970, Perreault et al, 1990). This result is im portant since it 
suggests that there was no untoward fall-off in myofilament force production 
th roughout the experim ent (Cmax was first assessed at the end of the SR 
testing protocol). In addition the preparation was assessed by control 
contractures at standard intervals through the protocol (see figure 2.9) and no 
significant fall-off in force production was observed (approximately 25% fall- 
off over 2 hours). Preparation size was carefully measured in this study using 
light microscopy to measure the w idth and depth of the trabecula while 
m ounted  at the sarcomere length at which tension m easurem ents were 
made. This method may also have improved the accuracy of the calculation 
of force per unit area. The finding of a reduction in m axim um  isometric 
force development in the RV in LIG animals is in contrast to Perreault et al 
(1990) where an increase in force development was reported in RV trabeculae 
from rats w ith heart failure. Reduced force production, found in this study, 
could be related to an increase in myocardial interstitial collagen which 
occurs in response to heart failure but these findings w ould require more 
significant fibrosis in the RV com pared with LV since m axim um  force 
production was unchanged in LV trabeculae from failing hearts.
C a2+ sensitivity of the myofilaments was not significantly different between 
RV and LV trabeculae or between sham and LIG anim als even for those 
assessed to have the most severe heart failure. For the purpose of this study 
this was an im portant finding for a number of reasons. Firstly, tension was 
used  as an index of Ca2+ release and any underly ing  difference in 
myofilament response to Ca2+ could have been interpreted as a change in SR 
C a 2+-loading. Secondly, tension oscillations w ere taken to indicate 
spontaneous release of Ca2+ from the SR sufficient to cause activation of the 
myofilaments. This approach cannot detect sub-threshold releases of Ca2+ 
from the SR but since Ca2+-sensitivity of the myofilaments was the same in
n o
both ligation and control animals then the [Ca2+] at which activation of the 
myofilaments occurred would be comparable.
Contractile dysfunction and enhanced SR function
Enhanced SR Ca2+-loading in heart failure contrasts with a num ber of animal 
and hum an studies and gives rise to the question as to w hat m echanism 
could produce contractile dysfunction in the intact LIG heart in the presence 
of this enhanced SR function. Metabolic factors, such as inorganic phosphate 
(Pi) and pH, could give rise to contractile abnormalities in the intact cell, SR 
C a2+ overload (as demonstrated in this study) or changes in beta-receptor 
responses could each contribute to contractile failure in the presence of 
enhanced SR function. The apparent enhanced SR Ca2+-loading in saponin- 
treated preparations could therefore represent a physiological adaptation by 
w hich  the SR com pensates for red u ced  levels of in tra c e llu la r  
phosphorylation (resulting from chronic beta-receptor dow n regulation) by 
increasing Ca2+-loading capacity. U nder our experim ental conditions 
(saturating ATP, creatine phosphate and controlled pH) the 'com pensated' 
SR pum p could then load Ca2+ to a greater extent than control tissue. In the 
intact myocyte, however, in the presence of low levels of cA M P^, raised Pi 
and lower pH, Ca2+ transients may be of similar am plitude (Vahl, Bonz, 
Timek & Hagl, 1994, Bing et al, 1991) to those in control tissue.
Conclusion
In summary, therefore, isolated RV and LV trabeculae from rabbits w ith LV 
dysfunction 8 weeks after coronary ligation dem onstrated an increase in 
sarcoplasmic reticulum Ca2+-loading capacity. At this stage in the study there 
were a num ber of questions which had arisen concerning the possible 
reasons for this rather paradoxical and previously unreported finding:
1. Is the SR Ca2+ release channel different in the LIG animals ?
i l l
2. Is there a difference in the phosphorylation state of phospholamban on the 
SR ?
3.Was this an earlier stage of heart failure than had previously been studied 
where the SR was in a compensated state ? Does SR function change later in 
the development of heart failure ?
The following chapters describe a series of experiments which set out to 
examine these questions.
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CHAPTER 5 
Sarcoplasmic reticulum Ca2+-loading 
in rabbits 15 weeks after 
coronary artery ligation
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INTRODUCTION
The reasons for allowing a separate group of animals to proceed to 15 weeks 
after coronary ligation were mainly that the results from the 8 week animals 
were in direct contrast to other studies of SR function in heart failure. It was 
possible that I had chosen a window during the development of heart failure 
where there was compensation of SR function and that later, either as heart 
failure became more severe or with increasing duration of heart failure, then 
SR function w ould change further. One previous study  in dogs w ith 
pressure-induced left ventricular hypertrophy had indicated enhanced SR 
function during mild cardiac hypertrophy (Limas et al, 1980). T herefore , 
although I had dem onstrated significant LV dysfunction at 8 weeks after 
ligation there could be additional factors operating later in the course of heart 
failure which could change SR function. Few studies have addressed the 
question of linear changes in SR function in heart failure.
METHODS
Anim al model and assessment of heart failure
Coronary ligation was performed as in chapter 2 and the animals allowed to 
develop heart failure over the following 15 weeks (LIG n=12, SH n=7). 
Echocardiography was perform ed 2 days before invasive haem odynam ic 
assessm ent. A left ventricular catheter and a fem oral therm odilu tion  
catheter were inserted under general anaesthesia as w ith 8 week animals. 
M easurem ents of haem odynam ic function were m ade in the conscious 
animal and were repeated after a fluid challenge.
Isolated trabeculae experiments 
In all of the 15 week anim als only RV trabeculae were isolated for 
assessment of SR function. Unfortunately, no data were obtained from LV 
trabeculae due to difficulties in obtaining suitable preparations and also due 
to the length and technical nature of experiments at this stage in the study
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which only allowed one experiment per day to be performed. The SR loading 
protocol was shortened to include only 5 loading times ranging from 30-150 
seconds (instead of 10 ranging from 15-150 as in the 8 week animals). 
However, the protocol was once again followed stringently for LIG and Sh 
anim als with Triton treatm ent at the end of the SR protocol and assessment 
of Cmax and myofilament Ca2+ sensitivity at the end of the experiment.
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RESULTS 
Assessment of heart failure 
Clinical features
4 of 12 animals had clinical signs of heart failure in this group including 
scrotal oedema and tachypnoea compared with no animals in the SH group. 
These features had, however, appeared within 8 weeks of ligation and did 
not progress significantly during the following 7-8 weeks. There were no 
sudden deaths in 15 week SH or LIG animals. The mean total body weight of 
LIG anim als was not significantly different from SH animals (3.80±0.24 vs 
3.64±0.51kg). Mean lung wet weight was significantly greater in the LIG group 
(14.4±2.3 vs 12.8±1.3g; P=0.048) mean liver wet weight was not significantly 
different between groups (99.3±15.8 vs 94.8±14.7g). After excision of the hearts 
the size and extent of infarction was examined macroscopically. The overall 
size of infarction was, on average, similar to that in the 8-week animals, 
often involving a large papillary muscle. However, it was noted that the 
organisation of the infarct appeared more complete w ith a more clearly 
defined margin between infarcted and healthy tissue com pared w ith the 8 
week infarcts. In addition, the infarct site appeared thinner walled and 
almost aneurysmal in a few cases.
Echocardiography
Left ventricular ejection fraction was significantly lower in LIG animals 
(51.3+7.6 vs 67.2±4.1%; P=0.001). Left ventricular end-diastolic diam eter was 
significantly greater in LIG animals (2.0±0.26 vs 1.63±0.11cm; P=0.002).
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Cardiac output and left ventricular pressures
M ean left ventricular systolic pressure at baseline was not significantly 
different between LIG and SH animals (141.316.6 vs 145.1±7.4mmHg) and was 
not significantly different after fluid challenge (140.7±3.4 vs 148.6±8.8mmHg). 
Mean left ventricular end-diastolic pressure was significantly greater in LIG 
animals at baseline (15.5±4.9 vs 9.3±2.6mmHg; P=0.001) and also increased to 
a g rea ter extent after the s tandard  flu id  challenge (26.4±6.21 vs 
18.0±4.4mmHg; P=0.002).
Mean baseline cardiac output was significantly lower in LIG compared with 
controls (260±45 vs 320123ml/kg/min;P=0.001). The peak cardiac output in 
response to a fluid challenge was also significantly lower in the LIG animals 
com pared with SH (343169 vs 465±22ml/kg/min;P=0.01). This represents a 
significantly reduced increase in cardiac output in response to the standard 
fluid challenge of 15ml/kg (30.7113.3 vs 45.818.8% increase; P=0.03).
Heart failure scoring
Using the same scoring system employed to assess the 8 week rabbits there 
were only 3 rabbits with scores>5 at 15 weeks. The remaining 9 animals had 
scores<4 and therefore fell into the category of moderate heart failure using 
the criteria laid down in chapter 4. The general impression was that although 
these rabbits had significant LV dysfunction com pared w ith the sham 
animals they had less heart failure than the group produced for the 8 week 
study.
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Isolated trabeculae experiments 
SR function
The m ean data for SR loading curves in 15 week animals are sum m arised in 
figure 5.1. These curves represent all data and are not separated into groups 
w ith differing severity of heart failure. There was a tendency for the LIG 
anim als to produce larger caffeine contractures than the SH group but this 
was not significantly different at any of the loading conditions of time or 
[Ca2+] studied. At low loading [Ca2+]s (150nM,200nM) the loading curves for 
both groups were very similar but at higher loading [Ca2+]s the LIG animals 
produced slightly larger caffeine contractures. Attempting to separate the LIG 
animals into moderate and more severe heart failure groups was not possible 
since of the 3 with score>5, 2 produced peak caffeine contractures which were 
100% of Cmax while the other produced only 10% of Cmax • Therefore, two 
behaved very sim ilarly to the anim als at 8 weeks while one produced 
contractures which were even smaller than the controls. For the rem aining 9 
anim als w ith scores<4 the mean SR loading curves were virtually identical 
to SH SR loading curves with no significant differences at any of the [Ca2+] or 
times studied. The mean peak caffeine contracture obtained for any condition 
of [Ca2+] or time was slightly larger for the LIG group as a whole compared 
with SH animals (59.5±12.6 vs 45.4±12.8% Cmax) but this was not significantly 
different. For those animals in the LIG group with a heart failure score<4 the 
m ean peak caffeine contracture was not significantly different from  SH 
animals (46.1111.8 vs 45.4112.9% Cmax)-
Correlations of SR function w ith heart failure
There were no significant correlations of SR function (at a num ber of 
d ifferent loading conditions) w ith various indices of LV dysfunction  
including: EF; r=0.19, LVEDD; r=0.24, resting CO; r=0.11.
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Figure 5.1 (this and facing page) SR Ca2+-loading in RV trabeculae from 15 
w eek ligation rabbits. Values are m eanlsem . 15SH (n=7) anim als are 
indicated by the open circle and 15LIG (n=12) by the closed circle.
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Spontaneous Oscillations
There was no significant difference in the incidence of spontaneous tension 
oscillations between ligated and control rabbits. 3 of 7 SH and 4 of 12 LIG 
anim als dem onstrated oscillations during the standard  loading protocol. 
Oscillations tended to occur at longer loading times and higher [Ca2+] in both 
groups com pared w ith the oscillations seen in the 8 week study  w ith 
[Ca]*time products that were not significantly different between groups (SH 
37.6±3.1 vs LIG 38.714.7 pMseconds).
Cmax and myofilament Ca2+ sensitivity
All trabeculae were obtained from the right ventricle. The m ean cross- 
sectional area of trabeculae was not significantly different betw een groups 
(0.01110.007 vs 0.008510.002mm2). The maximum force produced per unit 
cross sectional area was slightly greater in the SH animals (LIG 5.614.3 vs SH 
8 .5413 .86g .w t/m m 2; P=0.31) but this did not reach statistical significance. 
There was also no difference in the Ca2+ force relation between groups (pCaso 
LIG 5.5610.09 vs SH 5.7610.10).
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DISCUSSION
Comparison of severity of LV dysfunction at 15 weeks and 8 weeks
A comparison of haemodynamic data obtained from the 15 week (15-LIG) 
and 8 week (8-LIG) coronary ligation groups are sum m arised in table 4. The 
overall impression is of significant LV dysfunction present in the 15-LIG 
group compared with the 15 week shams but the severity of heart failure was 
no worse than in the 8-LIG group. The mean left ventricular end-diastolic 
diam eter was slightly greater in the 15-LIG animals but the ejection fractions 
were also slightly higher. The baseline cardiac output was slightly lower but 
there was a very similar response to fluid challenge.
There are a number of possible ways of interpreting these findings:
i) A sm aller size of myocardial infarction in the 15-LIGs and we were 
observing the progression of LV dysfunction after a longer time period.
ii) there was a similar degree of initial myocardial damage in the 8 and 15-LIG 
groups but there was no further progression of LV dysfunction after 8 weeks.
iii) A further possibility is selection bias i.e. sick rabbits w ith more severe 
heart failure were removed from the protocol at 8 weeks or died before 15 
weeks. Since no animals died between 8 and 15 weeks and since all 15 week 
animals completed the protocol, then, this latter suggestion is unlikely.
The absence of more severe LV dysfunction at 15 w eeks appeared  
disappointing since it was hoped that a longer period after ligation would 
allow study of a more advanced degree of cardiac failure. However, since a 
sim ilar degree of LV dysfunction was seen after 8 and 15 weeks then 
differences in SR function could be interpreted as occurring secondary to the 
'du ra tion  of heart failure' and not necessarily due to more severe heart 
failure.
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Table 4- comparison of LV dysfunction in 15 and 8 week ligations
8-LIG 15-LIG
Ejection fraction (%) 41.9±9.5 51.3±7.6 P=0.1
LVEDD (cm) 1.86±0.19 2.010.26 P=0.09
LVEDP (mmHg) 15.1+6.9 15.514.9 P=0.71
baseline CO (ml/kg/min) 275.2163.1 260.2145.3 P=0.53
Peak CO (ml/kg/min) 332.75137.9 343.8169.1 P=0.68
Body weight (kg) 3.7510.46 3.8010.24 P=0.9
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Figure 5.2 SR Ca2+-loading (120 second loading period) in 8 and 15 week LIG 
and SH rabbits (8 week SH (open circle, n=8) and LIG (closed circle, n=9) and 
15 week SH (open square, n =7) and LIG (closed square, n=12), values are 
m ean±sem ).
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Comparison of SR function at 8 and 15 weeks
There were no clear differences in SR function between the ligations and 
controls at 15 weeks following coronary ligation. However, the LIG group 
tended to dem onstrate enhanced SR function, although not statistically 
different, at all of the [Ca2+]s examined. The SR Ca2+-loading at 120s loading 
periods are sum m arised for both 8 and 15 week anim als in figure 5.2. 
Com pared with RV trabeculae from 8 week-LIG animals SR Ca2+-load ing  
re tu rned  tow ards control levels 15 weeks after ligation. This apparen t 
secondary reduction in SR function at 15 weeks, compared w ith 8 weeks post­
ligation, was most m arked at low loading [Ca2+] (150nM) w here 8-LIG 
animals produced caffeine contractures which were significantly larger than 
the 15-LIG group (49.9±12.1 vs 13.1±4.6%Cmax; P=0.001) but there was also a 
sign ifican t difference at h igher loading [Ca2+] (250nM, 73.8±7.0 vs 
54.2±4.2% Cmax; P=0.048). The sham -operated controls at 15 weeks also 
showed a tendency to have lower SR function compared w ith the 8 weeks 
controls but this did not reach statistical significance at any of the conditions 
of [Ca2+] or loading time studied.
These results suggest that the ability of the SR to load Ca2+ becomes depressed 
from an enhanced level at 8 weeks after coronary ligation to levels which are 
not different from non-heart failure controls at 15 weeks. The various 
m ethods of assessing LV dysfunction indicated significant decom pensation 
in the 15-LIG group but this did not represent more severe heart failure than 
that observed in the 8-LIG group. This would indicate that further depression 
of SR function at 15 weeks was related to duration of heart failure and not 
progression of LV dysfunction.
Previous studies have suggested that the process of ageing alone m ay have 
effects on myocardial contractility (Harding, Jones, O 'G ara, del Monte, 
Vescovo & Poole-Wilson, 1992, Bristow et al, 1982). In SH hearts, there was a
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slight bu t non-significant reduction in SR function at 15 weeks compared 
w ith the 8 weeks. The reduction in SR function in 15-LIG compared with 8- 
LIG, w ithou t the developm ent of m ore severe LV dysfunction, could, 
therefore, represent the process of ageing which may occur more rapidly in 
heart failure animals. The changes occurring at a cellular level in heart 
failure might represent an accelerated form of presbycardia.
There was no difference in the incidence of spontaneous tension oscillations 
in the 15-LIG group compared with controls which is in contrast to the 
findings at 8 weeks. This result suggests that spontaneous release of Ca2+ 
from the SR is dependent on the intra-SR [Ca2+] and not on a change in the 
sensitivity of the Ca2+ release channel to cytosolic [Ca2+], since in the 8-LIG 
group the SR was loading to a greater extent the intra-luminal [Ca2+] reaches 
a h igher level which predisposes the SR to spontaneous release. An 
alternative theory is that the SR is qualitatively different and that the Ca2+ 
release channel is more sensitive to cytosolic [Ca2+] w hich produces 
spontaneous releases of Ca2+ by way of the mechanism of Ca2+-induced Ca2+ 
release. However, more recent work using isolated SR Ca2+ release channels 
incorporated into liposomes has indicated that the open probability of the 
channel is related to the luminal SR [Ca2+] (Tripathy & Meissner, 1994). This 
is in keeping with the result found in this study where the degree of loading 
of Ca2+ by the SR predicts the probability of spontaneous release. In the intact 
heart this w ould mean that, at 8 weeks, enhanced SR Ca2+-loading w ould 
tend  to over-fill the intracellu lar Ca2+ stores and so predispose to 
spontaneous release. This could then act in an arrhythm ogenic way by 
activating the transient inward current and give rise to triggered activity. 
However, at 15 weeks the SR Ca2+-loading has returned to control values and 
therefore the risk of this as an arrhythm ogenic m echanism  w ould be 
dim inished. Extrapolating this (with perm ission) to the clinical setting 
suggests that the underlying mechanisms for arrhythm ic death in heart
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failure m ay change during the course of developm ent of chronic left 
ventricular dysfunction. In the early stages, triggered activity m ay play a 
significant part, while later, the development of fibrosis and scarring may 
allow re-entry to play a more important role.
M yofilam ent force production and Ca2+ sensitivity
M aximum force production per unit cross sectional area was lower in RV 
trabeculae from 15-LIG animals com pared w ith the respective controls 
although this did not reach statistical significance (15-SH-8.54±3.86.vs 15-LIG 
5.6±4.3g.w t/m m 2; P=0.31). This result is similar to the 8-LIG group where RV 
trabeculae from heart failure animals produced significantly less force than 
control trabeculae (8-SH-5.40±2.56 vs 8-LIG 3.05±1.58; P=0.043). The apparent 
reduction in maximum force between the sham  animals at 8 and 15 weeks 
does not reach statistical significance but does suggest some loss of force 
production with age at the level of the myofilaments. However, previous 
workers have reported no difference in maximum am plitude of contraction 
w ith increasing age in isolated myocytes from patients w ith heart failure 
although changes in (3-receptor responses have been noted with age (Harding 
SE et al, 1992, Fan & Banerjee, 1985.).
The Ca2+ force relationship was not different in 15-LIG rabbits compared with 
respective controls. There was also no significant difference from the 8 week 
animals. This would suggest that no significant change in the expression of 
the myofilament regulatory proteins has occurred.
Conclusions
The results from rabbits allowed to develop LV dysfunction over a longer 
time period suggest that SR function returns to values sim ilar to control 
anim als at 15 weeks. The enhanced SR Ca2+-loading ability observed at 8 
weeks following coronary ligation m ay therefore represen t a period of 
compensation for the initial myocardial insult. With increasing duration of
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heart failure, the SR loading ability returns to baseline levels. The question 
which remains to be answered is whether, after more prolonged duration of 
LV dysfunction, SR function would decrease below control levels, as has 
been reported in a number of other studies. This could certainly be studied in 
this m odel but the cost of keeping animals for lengthy intervals becomes 
prohibitive. All of the animals used for both groups (8 and 15 weeks) in this 
study  were of a very similar age and w eight w hen entered onto the 
experim ental protocol. One further possibility, which w ould represent an 
interesting future study, would be to examine the effect of age at the time of 
infarction on the severity and rate of developm ent of LV dysfunction 
following a myocardial infarction.
127
CHAPTER 6 
Studies on the sarcoplasmic reticulum 
Ca2+-release mechanism in the rabbit coronary 
artery ligation model of heart failure
128
INTRODUCTION
The SR Ca2+ release channel has been identified as a 30 S tetrameric complex 
protein comprising Mr 565,000 polypeptides as determined by cDNA cloning 
and sequencing (Otsu, W illard, Khanna et al, 1990).The p lan t alkaloid, 
ryanod ine , b inds specifically to this Ca2+ channel and  not to the 
voltage-sensitive Ca2+ channel of the sarcolemma. Single channel recordings 
have indicated  that purified  ryanodine receptor conducts Ca2+ and 
m onovalent cations. It is activated by Ca2+, ATP and caffeine, inhibited by 
M g2+ and ruthenium  red and m odulated by ryanodine (Lai & Meissner,
1989). D uring Ca2+ release there is charge-com pensation across the SR 
m em b ran e  by cations from  the cy tosol. C a n d id a te s  fo r th is 
charge-com pensating current include Mg2+, K+ and the Ca2+ channel itself 
(Lindsay & Williams, 1991). Ca2+ influx during the action potential "triggers" 
Ca2+ release from the SR by Ca2+-induced Ca2+ release (Fabiato, 1983).
A num ber of studies have reported a reduction in the num ber of SR-Ca2+ 
release channels in heart failure. However, the main m ethod of assessing 
this is by analysis of m-RNA (Brillantes et al, 1992, Arai et al, 1993) for the 
C a2+ release channel or by measurement of [H^]-ryanodine binding (Crory, 
McCutcheon, O'Grady, Pang, Geiger & O'Brien, 1993). These measurements 
provide information about the num ber of channels but do not represent a 
m easure of functional activity. The functional activity of the SR Ca2+ release 
channel is extremely difficult to assess under conditions which are close to 
physiological. Fabiato (1983) dem onstrated that the m echanism  for Ca2+ 
release in cardiac muscle cells was by the process of Ca2+-induced Ca2+ release 
(CICR). That is, Ca2+ enters the cell during the action potential and reaches a 
sufficiently high concentration, sufficiently quickly in the region of the 
cytosolic surface of the SR and activated the ryanodine receptor causing 
release of Ca2+. This was previously dem onstrated in single, mechanically
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skinned myocytes and requires that cytosolic [Ca2+] rises very rapidly. Some 
workers have reproduced CICR by using caged Ca2+ com pounds which 
release their bound Ca2+ when illuminated with certain wavelengths of light 
(Kentish, Barsotti, Lea et al, 1990). CICR is difficult to produce in multi- 
cellular, chemically-skinned preparations because of problem s related to 
diffusion. Placing the preparation into a high [Ca2+] causes a large increase in 
the cytosolic [Ca2+] which should be able to induce CICR. However, because 
diffusion in large preparations is slow relative to that in single cells the rate 
of rise of [Ca2+] is insufficient to produce CICR. Some workers have been able 
to isolate SR Ca2+ release channels into lipid bilayers and study their activity 
under modelled conditions. There was no difference found in the way the 
channel from failing myocardium behaved (Holmberg & W illiams, 1992). 
However, these conditions are far removed from the physiological setting 
and interpretation of this negative result must be made bearing this in mind.
Aims of the chapter
The aim of this part of the study was to examine possible differences in Ca2+ 
release mechanisms in multi-cellular preparations in a functional way. This 
was examined,by:
1. A ssessing the response of Ca2+ release m echanism  to various 
concentrations of caffeine under a standard set of SR-loading conditions.
2. Examining the sensitivity of the SR Ca2+ release channel to ryanodine.
3.Assessing SR leak of Ca2+ by constructing SR Ca2+ 'unloading' curves.
4. Assessing Ca2+-induced Ca2+ release in failing and control hearts.
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METHODS
Haemodynamic assessment
Coronary ligation rabbits (LIG) were produced in the way described in chapter
2. Sham-operated rabbits (SH) were used as controls. All data presented relate 
to tissue derived from animals 8 weeks after ligation. Animals were assessed 
by echocard iography and invasive haem odynam ic m easures p rio r to 
experiments on isolated trabeculae. The LIG rabbits had significantly lower 
ejection fractions (43.2±6.9 vs 68.3±5.8%; P=0.01) and low er peak cardiac 
o u tpu t following a fluid challenge (309.6±39.8 vs 515.7±87.9m l/kg/m in; 
P=0.002) than SH.
Response of SR Ca2+ release to various [caffeine]
In a separate set of experiments using LIG (n=7) and SH (n=5) anim als the 
effect of various concentrations of caffeine ([Caff]) on SR Ca2+ release was 
assessed in saponin-skinned trabeculae. A train  of 5 caffeine-induced 
contractures was elicited under a standard set of SR loading conditions (120 
seconds, 200nM [Ca2+]) at each of 7 caffeine concentrations: 0.1-50mM applied 
for 5 seconds. The various [Caff]s were applied in a random  order and the 
protocol was followed strictly in each experiment. A dose-response curve was 
constructed where the mean amplitude of the final 3 contractures (at each 
applied [Caff]) was normalised to the peak contracture obtained during this 
protocol. Kcaff was calculated as a m easure of the sensitivity of the calcium 
release mechanism to caffeine and represents the concentration of caffeine 
required to release 50% of the total SR Ca-content loaded under the standard 
set of conditions applied.
Effects of ryanodine on SR Ca2+ release
R yanodine acts specifically on the SR Ca2+ release channel. A t low  
concentrations (10'7M) it binds to the channel causing it to rem ain in the 
open state, thus m aking the SR more leaky. A t h igher concentrations
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ryanodine is believed to block the Ca2+ release channel. One other feature of 
ryanodine is that its effect on SR calcium release is dependent on the activity 
of the release channels i.e. the more active the channels, the m ore become 
blocked. Ryanodine has been used in a num ber of previous studies to 
examine the contribution of the SR to contraction in both skeletal and cardiac 
m uscle (Bers, 1991). Ryanodine has previously  been show n to block 
oscillatory behaviour of the SR at low concentrations probably by rendering 
the SR m ore leaky and preventing the accum ulation of a high intra-SR 
[Ca2+].
The aim  of this protocol was to determ ine possible differences in the 
sensitivity of the SR Ca2+ release channel to ryanodine. Because of the 
use-dependent nature of the drugs action and the differing actions at low and 
high concentrations it was not possible to perform a simple dose-response 
curve. An alternative way of examining its action was to use the same 
concentration of the drug (10_7M) and assess its effects over time. To do this, 
saponin-treated trabeculae were placed in a solution B containing l|iM  added 
Ca2+ (oscillating solution) until there were clear tension oscillations observed 
(see figure 6.2). Ryanodine (10"7M) was added to the bath and the time taken 
for the oscillations to cease was recorded. Once the oscillations had  stopped 
com pletely, caffeine was applied and the am plitude of the resu lting  
contracture m easured. This protocol was perform ed only once since the 
effects of ryanodine are use-dependent and although they are partially  
reversible it was not possible to assess whether the preparation had  returned 
to a comparable baseline state.
Ca2+-leak from the SR
As previously discussed, the net loading capacity of the SR is dependent on 
the quantity loaded minus the quantity leaked during any given time period. 
D uring the SR loading protocols described previously, in chapter 3, the 
trabecula is placed in a relaxing solution with a low free [Ca2+]. The SR
132
therefore begins the loading protocol w ith (nominally) zero Ca2+ content. 
Once ATP and Ca2+ are provided, the pum p becomes active and loads the SR. 
The conditions are such that they favour Ca2+-uptake rather than Ca2+-leak. 
How ever, in this experiment the SR was, firstly, loaded with Ca2+ under 
standard conditions and was then placed in solution B with no added Ca2+, 
i.e. under conditions which favoured leak rather than uptake. The trabecula 
was placed in solution B for various time periods ranging from 15-360 
seconds. Caffeine was applied for 5s at the end of each 'leak-period' and the 
am plitude of the resulting contracture measured. At the end of this protocol 
the net-uptake of Ca2+ in the leak solution (solution B with no added Ca2+) 
was assessed by attempting to evoke a caffeine-contracture after 120s loading 
period in solution B. In all cases no response was observed.
Ca2+-induced Ca2+ release (CICR)
CICR is difficult to produce in multi-cellular preparations for the reasons 
discussed earlier in this chapter. The reasons for this are m ainly related 
diffusion which is relatively slow in large multi-cellular preparations but in 
a few cases, where thinner trabeculae (clOOpm) were obtained, this was 
attem pted. The preparation was placed in solution B containing 200nM 
added Ca2+ for 2 minutes to allow the SR to load Ca2+ and was then rapidly 
switched to solution B containing [Ca2+]s ranging from 0.6-1.5 pm.
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RESULTS
Caffeine dose-response curve
For the standard set of loading conditions studied, the relationship between 
applied [Caffeine] and Ca2+ release (assessed by contracture amplitude) was 
similar in sham and LIG animals (Figure 6.1, LIG Kcaff 1.80±0.16mM vs SH 
Kcaff 1.98±0.19mM ). The contracture am plitude peaked at lOmM in both 
groups although there was a tendency for a slight fall-off in tension in the 
LIG anim als at higher [Caff]. There was no significant difference in the 
response of SR Ca2+ release to low concentrations of caffeine.
Effects of ryanodine
Ryanodine produced cessation of spontaneous oscillations in all preparations 
studied (Figure 6.2). During continuous oscillations resting tension rises and 
the observed oscillations are superimposed on this increased resting tension. 
A ddition  of ryanodine initially caused a decrease in the frequency of 
oscillations and subsequently a fall in resting tension. Oscillatory behaviour 
becomes infrequent and finally stops altogether. At this point, it is clear from 
the trace shown (figure 6.3) that the SR still contains a significant quantity of 
releasable Ca2+, since the application of caffeine produces a large contracture. 
The time taken for oscillations to stop and resting tension to retu rn  to 
baseline was significantly shorter in the ligations com pared w ith shams 
(136.2±35.4 vs 385.1±94.7 seconds; P=0.001). The size of the post-ryanodine 
caffeine-contracture was slightly greater in the ligation group (38.4±8.1 vs 
26.9±7.3 %Cmax; P=0.2).
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Figure 6.1 Effect of different caffeine concentrations on the Caffeine-induced 
contracture in saponin-treated SH and LIG rabbit trabeculae.
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Figure 6.2 Effect of cAMP and ryanodine on tension oscillations in a saponin- 
treated ventricular Trabecula. The preparation is allowed to oscillate in a 
solution containing high [Ca2+]. cAMP (10"^M) is added and produces a 
m arked increase in the frequency and amplitude of oscillations. Ryanodine is 
added later and produces a gradual reduction in the frequency of oscillations 
and eventually resting tension falls to baseline levels and oscillations cease 
totally. The large caffeine-induced contracture, evoked at this stage, indicates 
that although the oscillations have stopped a significant quantity of Ca2+ 
rem ains w ithin the SR. In addition, ryanodine clearly has not completely 
blocked the Ca2+ release channel.
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SR Ca2+ leak
The leak curves for both LIG and SH animals are show n in figure 6.3. 
Contractures fell rapidly during the first m inute to 49.1±8.1% of control 
contractures in the ligation group and to 33.9±8.3% in the shams. After 150s 
leak time period the ligations had fallen to 38.1±7.3% of controls and shams 
to 22.2±7.7% of control values. At longer leak periods (6 m inutes) the same 
pattern  emerged but although the mean caffeine contractures were slightly 
greater in the ligation group this failed to reach statistical significance. 
C a2+-loading, assessed in the leak solution (solution B with no added Ca2+), 
was zero after 120s in all cases for both LIG and SH animals studied.
Ca2+-induced Ca2+ release
As expected, there were no consistent results produced in attem pting to 
induce CICR in a total of 6 different preparations from 3 LIG and 3 SH 
animals. However, in one SH preparation there was a definite release of SR 
Ca2+ produced by the high bathing [Ca2+] (figure 6.4). There was no release 
produced until 0.8pM [Ca2+] with a larger release produced at lpM  [Ca2+]. This 
was clearly not produced by mechanical perturbation since the bath-change at 
0.6pM [Ca2+] failed to induce release. The twitches appeared more brief and 
were of lower am plitude than the caffeine-induced contractures. In other 
preparations studied in this way, when a contracture was produced, there was 
a delay of approximately l-2s before tension rose. This was interpreted as 
sufficient time for the SR to start loading in the solution containing the high 
[Ca2+] and the resulting contracture could equally well be in terpreted as a 
large spontaneous release of Ca2+ rather than true CICR.
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Figure 6.3 Leak of Ca2+ from the SR in saponin-treated trabeculae from LIG 
and SH rabbits.
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Figure 6.4 Ca2+-induced Ca2+ release (CICR) in a saponin-treated ventricular 
trabecula. A train of four caffeine-induced contractures (0.2|iM [Ca2+] /  2 
m inute loading period) is followed by a similar loading period then a 2.5 
second exposure to a * 0.6p.M, ** 0.8|iM, *** ljiM  [Ca ] (no caffeine) solution. 
There is no CICR at 0.6jiM (*) but there is a release at 0.8pM and I jiM [Ca2+] 
w hich is attributable to CICR. Note how the CICR contractures are much 
briefer than the caffeine contractures.
139
DISCUSSION
A reduction in the num ber of SR Ca2+ release channels has previously been 
reported in heart failure (Crory et al, 1993, Brillantes et al, 1992). However, 
these studies provided no evidence for a functional change in the SR as a 
result of a reduced num ber of channels. It is possible to speculate that a 
reduced num ber of channels will produce a slower rate of release of Ca2+ 
from the SR and will also reduce the amount of Ca2+ leak.
Caffeine-induced Ca2+ release
There was no significant difference in the response of the SR in failing hearts 
to various concentrations of caffeine compared with controls in this study. 
This m ight suggest that the response of the SR to caffeine does not alter in 
heart failure and therefore that there has been no significant qualitative 
change in the function of the caffeine-sensitive SR Ca2+ release channel. It is 
an im portant finding in interpreting the results from chapters 4 and 5, since 
it indicates that the net Ca2+ release in response to caffeine was similar in 
both LIG and SH animals. Additionally, it dem onstrates that lOmM (the 
concentration used in all experiments testing SR function) was sufficient to 
induce maximal release of calcium from the SR with no further increase in 
tension responses in both LIG and SH animals at higher [Caff]s.
In ligation animals mean tension responses tended to decrease at caffeine 
concentrations greater than 20mM. This was not a distortion produced by 
averaging the data and can be seen as a clear effect in a num ber of individual 
LIG animals. Caffeine has previously been shown to depress maximum Cmax 
at high concentrations (Miller, Lamont & O 'Dowd, 1993) and this m ight 
explain w hy this was more obvious in the ligation animals. That is, since 
these values are normalised to CmaX/ and LIG trabeculae tended to produce 
contractures closer to Cmax, then the effect of high concentrations of caffeine 
on force production was more pronounced.
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Effect of ryanodine on SR function
Ryanodine was found to halt oscillations more quickly in trabeculae from 
LIG animals. Since the effect of ryanodine is greater when channels are more 
active then this could be interpreted as a higher level of channel activity 
during oscillations in LIG trabeculae. Alternatively, it could suggest that the 
calcium content was lower in the LIG trabeculae during the oscillations and 
so were stopped by locking-open, proportionally, fewer channels. However, 
this is not consistent with the findings that SR Ca-content was greater in LIG 
trabeculae. A further possible explanation is that the Ca-release channel is 
more sensitive to ryanodine in LIG trabeculae, although, there is no evidence 
for this in isolated SR-release channel studies (Holmberg & Williams, 1992). 
It is, therefore, difficult to resolve these experimental findings w ith  the 
hypothesis that the num ber of Ca-release channels is reduced  in LIG 
trabeculae. However, if the process of halting oscillations by ryanodine was a 
stochastic process, then the effect of locking-open a few channels w ould be 
more likely to halt oscillations completely than in control trabeculae where 
the effect would be lost in background noise. Therefore, although these 
results are do not directly indicate a reduction in the num ber of calcium 
release channels in failing trabeculae they are consistent with this hypothesis.
It is clear that despite the cessation of oscillations the SR still contains a large 
quantity of releasable Ca2+ and the Ca2+ release channels are not completely 
blocked since we know that caffeine can induce release. This w ould suggest 
that oscillations can be stopped by a quantity of ryanodine, sufficient to 
switch-off those channels involved in spontaneous release, bu t not enough 
to cause the SR to leak all of its Ca2+ content. The difference in the size of the 
post-ryanodine contracture between LIG and SH trabeculae may simply be the 
result of greater leak of Ca2+ in the SH preparations during  the period 
ryanodine was acting which was longer in the SH trabeculae. Alternatively, it
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may reflect a greater SR Ca2+ content in the LIG trabeculae as suggested by the 
Ca2+-loading experiments.
Leak of Ca2+ from the SR
There was some evidence that the rate of leak in LIG trabeculae was slightly 
less than in controls (figure 6.3) although this failed to reach statistical 
significance. However, the LIG leak curve does rem ain consistently above 
that of the SH animals and perhaps with such a small difference we simply 
require to increase the number studied to make this significant. The protocol 
used to assess the leak of Ca2+ in these preparations was crude, in many ways, 
but still m anaged to reveal some evidence that the rate of leak of Ca2+ was 
different in heart failure animals. The conditions used to assess this were 
identical to the loading solutions used in earlier experiments but the bathing 
[Ca2+] was extremely low (~20nM) such that the gradient for Ca2+ movement 
was from the lumen of the SR into the bathing medium. The SR could still 
take up  Ca2+ but at a rate that could not counteract the rate of leak. This 
resulted in the net movement of Ca2+ from the SR into the bathing medium. 
An alternative m ethod to assess this would have been to allow the SR to 
load Ca2+, then to remove ATP from the bathing solution thus halting the 
action of the Ca2+ pum p altogether: this condition would also have favoured 
C a2+ leak. In fact, this was not attempted but judging from the rate of leak in 
the presence of ATP, the rate of leak in its absence may have been far too 
rapid to assess using this protocol.
The net loading of Ca2+ in the leak solution was zero in all cases. This 
indicates that for the conditions provided which favoured leak from the SR/ 
the curves for both LIG and SH would finally reach zero leakage was allowed 
for a sufficient time. However, there may have been very small releases of 
C a 2+ from the SR which were subthreshold for m yofilam ent activation. 
These experiments require to be repeated to m easure leak at even shorter 
time periods using Ca2+ indicators to measure Ca2+ directly.
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Ca2+-induced Ca2+ release
C a2+-induced Ca2+ release was difficult to obtain in these saponin-treated 
trabeculae. In the course of studying 6 separate trabeculae from  different 
anim als we were convinced of observing true CICR in only one (result 
shown, figure 6.4). The conditions required to observe this phenom enon 
need to be strictly controlled and so this result is not surprising . The 
contractures which did result in the example shown were of shorter duration 
and of lower am plitude than the caffeine contractures. Presum ably, this 
difference is a consequence of the properties of caffeine which sensitises the 
m yofilam ents, increasing peak force attained and  slow ing the rate of 
relaxation. In addition, in the CICR contractures, the absence of caffeine 
m ight allow the SR to contribute more significantly to the fall in [Ca2+] thus 
increasing the rate of relaxation and making the contracture m ore brief. 
There are certainly reasons for attem pting further experim ents using this 
m ethod although the preparation itself may well not be suited to assessment 
of CICR.
Conclusions
These data provide indirect evidence for a possible reduction in the num ber 
of Ca2+ release channels in failing ventricular trabeculae. A reduction in the 
num ber of Ca2+ release channels could provide a m echanism by which the 
SR m ight load more Ca2+ and consequently contain more for release by 
caffeine. Such a change could give rise to the enhanced SR Ca2+-lo ad in g  
ability observed in this study in ligation animals at 8 weeks.
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CHAPTER 7 
Sarcoplasmic reticulum Ca2+-loading 
in a rabbit model of adreno-receptor down regulation
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INTRODUCTION
There are a number of ways in which the heart can respond to dem ands for 
increased blood flow and oxygen delivery. EH Starling (1918) first described 
the relationship between force and end-diastolic volume in isolated working 
hearts. This intrinsic inotropic mechanism is thought to result m ainly from 
the m yofilam ent length /tension  relationship which allows a greater force 
production at cell lengths which favour a greater overlap of sarcomeres. 
H ow ever, additional changes in myofilam ent Ca2+ sensitivity 
l(Hibbert & Jewell, 1982> and changes in stretch activated membrane channels 
(Gamble, Taylor & Kenno, 1992) may also play a role in increasing the force of 
contraction of cardiac muscle. There are additional factors which increase the 
force of contraction in the heart in the whole animal. The heart is under 
d irec t influence of the autonom ic nervous system . Sym pathetic nerve 
endings in the ventricular wall can release noradrenaline locally bringing 
about an increase in the force of contraction. Circulating noradrenaline and 
adrenaline, released from the adrenal gland, will also produce both  an 
inotropic and chronotropic response.
Beta-receptor stimulation activates adenylate cyclase which brings about an 
increase in the formation of intracellular cyclic adenosine m ono-phosphate 
(cAMP). This activates a cA M P-dependent p ro te in  k inase  w hich 
phosphorylates a num ber of intracellular sites involved in the regulation of 
C a 2+. These include the voltage dependent Ca2+ channels on the cell 
m em brane, the regulatory protein phospholam ban on the SR and troponin- 
C on the myofilaments. This results in a greater influx of Ca2+ during the 
action potential, increased rate of Ca2+ sequestration by the SR and a decrease 
in the sensitivity of the myofilaments for Ca2+. The net result is more force 
and faster relaxation, an ideal physiological combination for producing an 
increase in cardiac output and dealing with an increase in venous return.
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H eart failu re  is accom panied by a w id esp read  ac tiva tion  of the 
neurohorm onal axis. Chronic activation of the sym pathetic nervous system 
brings about a decrease in the num ber of beta-receptors on the cardiac 
myocyte and results in a diminished response to catecholamines (Bristow, 
Kantrow itz, Minobe et al, 1982). The heart, therefore, loses an im portant 
inotropic mechanism which norm ally allows it to respond  to increased 
demands. This could be interpreted as a physiological protective mechanism 
since it lim its the inotropic response and hence the increased oxygen 
dem ands which follow catecholamine stimulation. How ever, a num ber of 
studies treating heart failure patients with beta-blockers have succeeded in 
dem onstra ting  significant im provem ents in m yocardial function  and 
sym ptom s accompanied by a return of beta-receptor response (Heilbrunn, 
Shaw, Bristol et al, 1989).
Since beta-receptor stimulation produces an increase in SR Ca2+ uptake it is 
possible that the observed enhancement of SR Ca2+ uptake in the rabbits with 
heart failure (at 8 weeks) in this study is the result of a change in the 
phosphorylation state of the SR. Down-regulation of P-receptors, however, 
w ould be expected to reduce the level of in tracellu lar cAMP, reduce 
in tracellular phosphorylation and so reduce the activity of the SR Ca2 + 
pum p. Such a change could explain the diminished Ca2+ uptake observed in 
failing hum an tissue but would not explain the enhanced Ca2+ uptake 
observed in the rabbit coronary ligation model after 8 weeks. However, if the 
rabbit model did not have beta-receptor down regulation but did have high 
levels of circulating catecholamines then increased beta-stim ulation at the 
time of removal of the heart might result in a more phosphorylated SR Ca2+ 
pum p and an enhanced Ca2+ -loading ability. For this hypothesis to be correct, 
the phosphorylated state, resulting from catecholamine stim ulation, would 
require to persist after removal of the heart and after the subsequent saponin- 
skinning procedure. To examine this hypothesis, we used  a previously
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validated model of adreno-receptor down regulation in the rabbit (Jones et al,
1990). The experimental protocol for assessing possible down-regulation of 
catecholam ine response allow ed us to exam ine the effect of acute 
adm inistration of isoprenaline immediately prior to removal of the heart in 
saline infused control animals. This protocol allowed us to assess the effects 
of dim inished beta-receptor stimulation in the chronic-isoprenaline infused 
animal and also the possible persistence of the acute effects of isoprenaline in 
control hearts on SR and myofilament function .
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METHODS
Animal model
The rabbit model of adrenoreceptor down-regulation was produced using the 
m ethod described in chapter 2 (after Jones et al, 1990). Isoprenaline filled 
m ini-osmotic pum ps (Iso-OP, n=7) were im planted for a period of 7 days. 
Saline-filled mini-osmotic pum ps were implanted for a period of seven days 
as controls (Sal-OP, n=5). On the sixth day, under general anaesthesia, a 
therm odilution catheter was placed in the descending aorta and a fluid filled 
4F catheter placed in the LV via the right carotid artery. The animal was 
placed in a protective jacket and allowed to recover from the anaesthetic 
overnight.
Haem odynam ic assessment
Haem odynam ic assessment was performed in the conscious animal on the 
m orning after implantation of catheters. The protocol followed was designed 
to minimise the general distress to the animal and so hopefully reduce the 
background level of sym pathetic activation secondary to handling and 
m oving around. The animal was placed in a quiet, isolated room  and 
allowed to settle for a period of 15-20 minutes. The LV pressure catheter was 
then connected to the Gould pressure transducer and the therm odilution 
catheter connected to the cardiac output computer. The initial LV pressure 
trace was observed for a further 10-15 minutes until the trace was stable with 
no ectopic activity. A baseline assessment of left ventricular systolic pressure 
(LVSP), end-diastolic pressure (LVEDP) and heart rate (HR) was made. The 
heart rate was measured by simply counting the peaks on the pressure trace 
over a period of one minute. Mean baseline cardiac output was calculated 
from five 1ml injections of cold dextrose (19-22°C). The peak heart rate 
response to increasing doses of isoprenaline (l-5|ig), given as bolus injections 
into the LV, was measured. The heart rate was allowed to recover to baseline
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levels (w ithin 10%) between injections of isoprenaline (generally  -10 
minutes). Immediately after the final bolus injection of 5|ig of isoprenaline, 5 
injections of 1ml cold dextrose were used to calculate the m ean cardiac 
output after isoprenaline. The Sal-OP animals were assessed in an identical 
w ay w ith increm ental doses of isoprenaline given to assess heart rate 
response and a similar bolus of 5|ig of isoprenaline given within 10 m inutes 
of the animal being killed. A lethal dose of Euthatal was given and the heart 
rap id ly  excised and placed in Ca2+ free ringer w ith  2 ,3-butanedione 
monoxime (30mM) added. A free-running trabecula was dissected from the 
righ t ventricle and m ounted for isom etric tension m easurem ent. The 
preparation was treated with saponin and exposed to a series of solutions at 
various [Ca2+] for various loading periods. At the end of the SR loading 
protocol, the preparation was treated with Triton-XlOO for 30 m inutes and 
m easurem ents of m yofilam ent Ca2+ sensitivity  and m axim um  force 
production made.
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RESULTS
Clinical features
Iso-OP animals appeared more anxious and agitated consistent w ith elevated 
circulating catecholamines. There were no wound infections in either group 
and no problems with erosion of the mini-osmotic pum p through the skin 
or the wound. However, two animals in the Iso-OP group died suddenly 
w ith  no obvious preceding clinical problems. Post-m ortem  exam ination 
revealed no abnormality and the pum ps contained the appropriate contents 
of isoprenaline (assessed by comparing the w eight of the pum p before 
im plantation and after death). The most likely cause of death  in these 
anim als was thought to be an arrhythm ia although this could no t be 
confirmed. At the time of excision of the heart, 2 of the isoprenaline animals 
were noted to have significant pericardial effusions. A lthough this could 
have resulted simply from placement of the LV catheter it is not a feature 
seen in any of the other rabbits except the coronary ligation anim als with 
more severe heart failure . The reason for this is unclear but could be related 
to discrete areas of myocardial necrosis which are known to result from large 
doses of intravenous catecholamines (Rona, Chapel, Balazs and Godfrey, 
1959).
Haem odynamic assessment
The haemodynamic results obtained at baseline and after isoprenaline are 
sum m arised in table 5. Total body weight was not significantly different 
betw een groups at the time of haem odynam ic assessm ent (3.13±0.15 vs 
3.18±0.15 kg: P=0.62). Baseline LVSP was significantly higher in Iso-OP 
anim als compared with Sal-OP (163.2±9.1 vs 140.5±5.4mmHg; P=0.01). The 
response of LVSP to the final bolus of isoprenaline was dim inished in the 
Iso-OP group (3.1±2.4 vs 14.2±5.6% increase; P=0.01). Baseline LVEDP was not 
significantly different between groups (7.5±1.9 vs 8.5±1.5mmHg; P=0.52).
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There was no significant difference in LVEDP after the final bolus of 
isoprenaline between groups (6.8±1.3 vs 7.0±1.6mmHg). Baseline heart rate 
was significantly greater in Iso-OP com pared w ith Sal-OP (259.6±41.3 vs 
212.3±21.3 min"l; P=0.01). The heart rate response to various bolus injections 
of isoprenaline, in increasing doses, was less marked in the Iso-OP compared 
w ith Sal-OP animals (figure 7.1). In addition to the difference at baseline, 
there was a significantly lower peak heart rate response to the maximum 
bolus of isoprenaline (5pg) in the Iso-OP animals (336.7±8.1 vs 368.6±6.3min'l 
; P=0.001). The dose-response curve was shifted to the right in keeping with a 
dow n-regulated response to isoprenaline in the Iso-OP group. The mean 
heart rate immediately before sacrifice was similar in both groups bu t was 
significantly higher than mean resting heart rate in both groups indicating 
p e rs is te n t chrono trop ic  s tim u la tion  (Iso-OP 296.2±11.1 & Sal-OP
311.8±8.3m in'1). Baseline cardiac output was higher in the Iso-OP animals 
(413.8±40.1 vs 306.2±15.6ml/kg/min; P=0.01) and was also significantly higher 
following intra-ventricular isoprenaline (506.5±55.9 vs 386.1±12.6ml/kg/min; 
P=0.01). However, the relative increase in cardiac output following the final 
bolus of isoprenaline was slightly lower in the Isoprenaline treated animals 
(22.9±6.7 vs 27.2±4.3%).
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Table 5 Haemodynamic results in isoprenaline and saline infused rabbits. 
Values given are those at baseline and after the final bolus injection of intra­
cardiac isoprenaline (mean±sem) for both saline infused (Sal-OP, n=5) and 
isoprenaline infused (Iso-OP, n=7) rabbits.
Iso-OP Sal-OP
LVSP(mmHg)
Baseline  163.2±9.1 140.5±5.4 P=0.01
Post- isoprenaline  168.3±8.6 159.9±10.2 P=0.21
LVEDP(mmHg)
Baseline  7.5± 1.9 8.5±1.5 P=0.52
Post-i soprenaline  6.8±1.3 7.0±1.6 P=0.48
Heart Rate(min_1)
Baseline 259.6±41.3 212.3±21.3 P=0.01
Post-isoprenal ine  336.718.1 368.616.3 P=0.001
CO (m l/kg/m in)
Baseline  413.8140.1 306.2115.6 P=0.01
Post-i soprenaline  506.5155.9 386.1112.6 P=0.01
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Isolated trabeculae experiments 
SR Ca2+-loading
There was no significant difference in the size of RV trabeculae taken from 
Sal-OP or Iso-OP animals (major diam eters 146±32 vs 155±36|im; m inor 
diam eters 75±26 vs 81±27p.m). The SR loading curves for all conditions of 
time and loading [Ca2+] are presented in figure 7.2. There was no significant 
difference in the ability of the SR to load Ca2+ between Iso-OP and Sal-OP 
groups. This relationship held at a range of loading periods and at all the 
[Ca2+] studied. The peak caffeine contracture obtained for any of the loading 
conditions studied was not different between groups (Iso-OP 34.3±10.6 vs Sal- 
OP 32.6±6.2% Cmax; P=0.65). Comparing the saline controls used in this part of 
the study (Sal-OP) with saline controls from the adriamycin study reveals no 
difference in the SR loading curves for any of the conditions of Ca2+-loading. 
There was also no difference between the Sal-OP and the Sham -operated 
controls in the coronary ligation study. The SR loading curves for all three of 
these control groups are plotted together in figure 7.3 for comparison. There 
was no difference in the incidence of spontaneous oscillations between Sal- 
OP and Iso-OP. 2 control animals and 3 isoprenaline treated  anim als 
dem onstrated oscillations but all occurred at high loading [Ca2+] and long 
loading periods.
M yofilam ent force production and Ca2+ sensitivity
There was no significant difference in the maximum force produced per unit 
cross sectional area in Triton-skinned trabeculae from Iso-OP and Sal-OP 
anim als (4.76±3.55 vs 5.21±3.88gwt/mm2). The myofilament responsiveness 
to Ca2+, expressed as the Ca2+ required for 50% full activation (pCaso), was 
slightly lower in the Iso-OP animals compared with Sal-OP controls (pCaso 
5.51±0.07 vs 5.61±0.05; P=0.053). This difference only just fails to reach 
statistical significance. The mean Hill fit curves for saline and isoprenaline
153
osmotic pum ps are plotted in Figure 7.4. This shift to the right of the Ca2+- 
tension  relationship  in the Iso-OP anim als represents a reduction in 
myofibrillar Ca2+ responsiveness.
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Figure 7.1 Heart rate response to intra-cardiac boluses of isoprenaline in 
saline (open circle, n=7) and isoprenaline (closed circle, n=5) infused rabbits.
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Figure 7.2 (This and facing page) SR Ca2+-loading in saponin-treated RV 
trabeculae from isoprenaline-infused (Iso-OP, closed circle, n =7) and saline- 
infused (Sal-OP, open circle, n=5) rabbits.
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Figure 7.3 Comparison of SR Ca2+-loading (200nM [Ca2+]) in RV trabeculae 
from  all three rabbit control groups from this thesis: saline (adriamycin 
study, open square, n=7), Sham -operated ligation (open circle, n=10) and 
saline (isoprenaline study, open triangle, n=5).
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Figure 7.4 Ca2+ sensitivity curves of ventricular trabeculae from saline (Sal- 
OP, open circle, n=5) and isoprenaline (Iso-OP, closed circle, n=5) infused 
rabbits.
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DISCUSSION
These results indicate that the ability of rabbit cardiac SR to load Ca2+ is not 
affected by chronic infusion of isoprenaline for a period of 7 days. Since it was 
possible to dem onstrate a dim inished response  of these hearts to 
isoprenaline, then this degree of adreno-receptor dow n-regulation does not 
appear to change the Ca2+-loading ability of the SR. Acute adm inistration of 
isoprenaline, within 10 minutes of death, did not appear to increase the SR 
C a2+-loading ability in the Sal-OP controls compared w ith Iso-OP animals, 
saline controls in the adriamycin study or sham -operated controls in the 
ligation study (figure 7.3). There is evidence indicating a raised heart rate 
im m ediately before sacrifice which suggests tha t there w as persisten t 
catecholamine stimulation at this time. This suggests that the previously 
dem onstrated effects of isoprenaline on SR function (Endoh & Blinks, 1988) 
do not persist after the animal is killed and do not persist after the 
myocardial preparation is treated with saponin. M aximum force production 
in Triton-skinned trabeculae was not significantly different between controls 
and chronically infused animals. However, Ca2+ responsiveness of the 
myofilaments Was reduced by chronic treatment w ith isoprenaline.
Evidence for adreno-receptor down-regulation in  th is model
In view of this lack of difference in SR Ca2+-loading between the two groups, 
the im portant question which arises is w hether adreno-receptor dow n 
regulation had occurred in the hearts of the chronically infused rabbits. 
Baseline values for cardiac output, LVSP and heart rate were significantly 
increased in the Iso-OP group indicating a persisten t response to the 
isoprenaline from the mini-osmotic pump. However, there is clear evidence 
suggesting a differing heart rate response to intra-cardiac isoprenaline in the 
chronically infused animals (figure 7.1). The rise in LVSP after a bolus of 5pg 
of intra-cardiac isoprenaline was diminished in the Iso-OP animals compared
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w ith controls. In addition, although peak cardiac output following a bolus 
injection of isoprenaline was greater, the relative increase was diminished in 
the Iso-OP animals. These features, in combination, would tend to suggest a 
dim inished adrenergic response and imply adreno-receptor down-regulation 
in the chronically infused animal.
P-receptor down-regulation: possible changes in SR Ca2+-loading
There was no difference in the Ca2+-loading ability of cardiac SR from rabbits 
chronically infused with isoprenaline compared with controls. This indicates 
that p-receptor down-regulation does not influence the ability of the SR to 
load Ca2+ and so the enhanced SR Ca2+-loading ability in ligation rabbits after 
8 weeks could not have been a consequence of P-receptor dow n-regulation 
(secondary to heart failure) and must be due to additional factors operating in 
the ligated rabbit heart.
Reduced P-receptor response is associated with reduced levels of intracellular 
cAM P (Feldm an et al, 1987) w hich results in reduced  levels of 
phosphorylation of phospholamban. This would tend to reduce the SR Ca- 
ATPase rate and reduce the loading ability of the SR. W hen these factors are 
considered, the hypothesis that this m echanism could be responsible for 
enhanced  SR Ca2+-loading appears flaw ed. H ow ever, ex tending  this 
argum ent further, one could suggest that as a consequence of chronically low 
levels of cAMP, there is a compensatory increase in the factors downstream  
from  cAMP which, w hen p rov ided  w ith  a contro lled  in tra-cellu lar 
environm ent (such as in the skinned-fibre), produce enhanced SR Ca2+- 
load ing . There is some evidence tha t the m echanism  of inotropic 
stim ula tion , dow n-stream  from the P-receptor, rem ains in tact, since 
previous work has shown that the tension response to forskolin and cAMP is 
s im ila r in failing and  control hum an  p ap illa ry  m uscles (Bohm, 
Beuckelm enn, Brown et al, 1988). However, there is no evidence for a 
compensatory increase in response to these type of agents in heart failure and
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so this suggestion, of a compensatory increase in down-stream  mechanisms, 
is unlikely to explain enhanced SR Ca2+ uptake in our rabbit heart failure 
m odel.
Adrenergic stim ulation - effects on SR Ca2+-loading
An alternative suggestion is that the 8 week-ligation animals d id  not have 
p-receptor dow n-regulation but did have increased circulating levels of 
catecholam ines as a result of heart failure. This persistent catecholamine 
stim ulation could produce chronic phosphorylation of the SR Ca2+ pum p 
and result in enhanced Ca2+-loading. This hypothesis is, however, strongly 
dependent on phospholamban remaining phosphorylated from the time the 
animal was killed until after the trabeculae were m ounted and treated with 
saponin. Previous work has dem onstrated that p re-treatm ent of single 
isolated cardiac myocytes with a  and p-agonists, before chemical skinning, 
could produce phosphorylation of the contractile proteins, m easured as 
changes in Ca2+ sensitivity, which persisted  after chem ical skinning 
treatm ent with Triton (Puceat, Clement, Lechene, Pelosin, Clapier & Vassort, 
1990). This implies that, at least, the chemical skinning procedure does not 
n e cessa rily  cause d e p h o sp h o ry la tio n  of in tra -c e llu la r  s ites b u t 
dephosphorylation could still occur in the period between death  and the 
chemical skinning procedure in the rabbits in our study. Indeed, Puceat et al 
(1990) demonstrated that incubation of skinned single cardiac myocytes with 
alkaline phosphatase could reverse the phosphorylation state induced by 
adrenergic stimulation. This raises the question of w hether phosphatase 
enzym es remain active w ithin the cytosol and reverse the phosphorylated 
state of phospholamban during the period between death and m easurem ent 
of SR Ca2+ uptake. It is possible that these enzymes may still be active even in 
the saponin-treated trabeculae since a num ber of other enzym e systems, 
including the m itochondria, are known to rem ain functionally intact in 
saponin-treated trabeculae (Miller & Steele, 1990, Steele & Miller, 1992). This
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m ight explain w hy there was no m easurable difference in the SR Ca2+- 
loading between control animals given boluses of isoprenaline and the saline 
controls from the adriamycin study. That is, despite phosphorylation of the 
SR C a2+ pum p im m ediately before death , induced by isoprenaline , 
phosphatase enzymes remain active and dephosphorylate the Ca2+ pum p 
before m easurement of SR Ca2+-loading is made. A second possibility is that 
all th ree  control g roups described  in figure 7.3 have p e rs is te n t 
phosphorylation  of the SR Ca2+ pum p which is present in all control 
trabeculae at the time of SR Ca2+ uptake assessment. This could result from 
high circulating levels of catecholamines in all animals prior to death as a 
result of the stress associated with handling. This might produce saturation 
of all in tra-cellu lar phosphorylation sites such that fu rther doses of 
isoprenaline would have no effect. One way to test this hypothesis w ould be 
to treat the preparations with protein phosphatase after the skinning 
procedure which w ould dephosphorylate any phosphorylated  sites on 
phospholam ban (Kranias, 1985). P-blockers, given to control animals for a 
period of time prior to sacrifice might also be expected to reduce stimulation 
by endogenous circulating catecholamines, reduce levels of intra-cellular 
cAMP and so produce a reduction in SR Ca2+-loading compared w ith animals 
not given p-blocker.
Adrenergic stim ulation - effects on the m yofilaments
There was no difference in maximum force production in Triton-skinned 
fibres from Iso-OP and controls. This result is similar to other published 
reports of a maintained response to Ca2+ in cardiac myocytes despite evidence 
of P-receptor dow n regulation (Jones et al, 1990, Bohm et al, 1988). At the 
level of the myofilaments there is no mechanism by which maximum  force 
production  may be increased via adrenergic stim ulation (Solaro, 1993). 
H ow ever, m yofib rilla r responsiveness to C a2+ can be a ltered  by 
catecholamines in a num ber of ways. Phosphorylation of the amino-terminal
region of troponin-I at Ser 20 increases following stim ulation of the heart 
w ith  catecholam ines (Solaro, Moir & Perry, 1976). This results in an 
alteration in the Ca2+ binding properties of troponin-C and inhibits the ability 
of Ca2+-troponin-C  to release the th in  filam ent from  the troponin- 
tropom yosin complex. The net result is a reduction in the responsiveness of 
the myofibrillar proteins to Ca2+ and a rightw ard shift in the Ca2+-tension 
relationship (Herzig, Kohler, Pfitzer, Ruegg & Wolffle, 1981). In my study, 
there was a slight rightward shift in the Ca2+-tension relationship in Iso-OP 
anim als suggestive of a reduction in myofilament responsiveness to Ca2+. 
This could indicate a greater level of phosphorylation of sites on troponin-I 
in the chronically infused animals. However, there was no significant 
difference in the values obtained for m yofilam ent Ca2+ responsiveness, 
rep resen ted  as pCaso, between the Sal-OP anim als given isoprenaline 
immediately prior to sacrifice and the other control groups used in this thesis 
(e.g. RV Sham-ligation: 5.58±0.07, P=NS, RV saline-injected ADR controls 
5 .55±0.103; P=N S). This suggests that there w as no significant 
phosphory la tion  of troponin-I p roduced by acute adm in istra tion  of 
isoprenaline. Alternatively, phosphorylation of troponin-I had occurred in 
all of the control groups and therefore no m easurable difference in 
myofilament Ca2+ responsiveness could be revealed between groups.
In conclusion, therefore, there was no apparent change in the Ca2+-loading 
ability of cardiac sarcoplasmic reticulum induced by chronic infusion of 
isoprenaline in rabbits. The phosphorylation state of the phospholam ban in 
these preparations was not known and although there was some slight 
evidence for a myofibrillar phosphorylation in the chronically-infused 
rabbits, suggested by a decrease in the myofibrillar Ca2+ responsiveness, we 
could not be sure of the level of phosphorylation within these preparations 
after the skinning procedure was completed. If the phosphorylated state did 
persist, then one w ould expect that the control anim als w ould be most
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sensitive to catecholamines (i.e. having no adreno-receptor dow n regulation) 
and  w ould  dem onstra te  evidence of in tra-ce llu lar p h o sp h o ry la tio n  
(enhanced SR Ca2+ uptake, reduced myofibrillar responsiveness to Ca2+) 
while the chronically treated animals (and the heart failure animals) w ould 
not show  evidence of intra-cellular phosphorylation. The possibility  of 
persisten t baseline phosphorylation of the SR Ca2+ pum p has not been 
exam ined as a possible explanation of the difference in SR Ca2+ uptake 
observed in many previous studies of failing and normal myocardium.
164
CHAPTER 8 
Sarcoplasmic Reticulum Ca2+-loading 
in Ventricular Trabeculae from 
Patients with Heart Failure
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INTRODUCTION
There are a num ber of mechanisms responsible for contractile abnormalities 
in heart failure including myocardial cell-slippage (Weber & Brilla, 1991), 
abnorm al m yocardial architecture, peri-cellu lar fibrosis, (3 -recep to r 
dow n-regu la tion  (Bristow, 1993) and abnorm alities of m yocyte Ca2 + 
regulation. Previous studies examining Ca2+ transients in failing hum an 
cardiac muscle fibres suggested that the rate of uptake of Ca2+ by the SR was 
reduced (Gwathmey et al, 1987). This was supported by evidence from a 
num ber of studies using isolated SR vesicles which dem onstrated a reduced 
rate of uptake of radio-labelled 45Ca2+ in heart failure (Movsesian, Bristow & 
Krall, 1989). Further evidence for a reduced activity of the SR Ca2+-ATPase 
was obtained by demonstrating a reduced levels of m-RNA coding for this 
pro tein  in failing hum an m yocardium  (Brillantes et al, 1991). W hile this 
evidence is fairly convincing there are a num ber of lim itations to these 
studies.
The Ca2+ transients reported by Gwathmey et al (1989) suggest two phases to 
the Ca2+ transient in failing hum an myocardium. These are: (1). LI, which 
represents Ca2+ release from the SR (2) L2 - sarcolemmal Ca2+ influx via the 
voltage dependent Ca2+ channels. The authors propose that the am plitude of 
L2 is more pronounced in failing myocardium as a result of reduced re­
uptake of Ca2+ by the SR . There are a number of problems with this result . 
Firstly, the m ethod of loading aequorin into the cells requires high 
concentrations of EGTA which can damage a significant portion of the 
preparation. Preparations which demonstrated a greater than 30% fall in peak 
twitch during the aequorin loading procedure were discarded. This creates a 
rather biased selection procedure and additionally indicates that as m uch as 
30% of the preparation was damaged in the chemical loading procedure in 
preparations which were deem ed acceptable. Secondly, it is interesting to
166
note, that since the widespread use of more sensitive and ratiom etric Ca2+ 
indicators in recent years, there have been no further reports of this type of 
biphasic Ca2+ transient associated with heart failure. A num ber of studies 
have reported a slower rate of fall of the Ca2+ transient in heart failure tissue 
but the am plitude of the transients have often been similar in control and 
failing hearts (Perreault, Gonzalez, Litwin, Sun, Armstrong & M organ, 1993, 
Gwathmey & Morgan, 1985, Bing et al, 1991).
M easurem ents of Ca2+ uptake in isolated vesicles represents an interesting 
and rather simple way of assessing SR function. However, the vesicles are 
typically incubated over long periods w ith oxalate anions which act in a 
similar way to the endogenous protein, calsequestrin. That is, once Ca2+ is 
taken-up into the SR, calsequestrin binds to it and effectively reduces the 
f re e -[C a 2+] w ithin the SR lumen. The SR Ca2+ pum p is therefore not 
inh ib ited  by high intra-SR [Ca2+], the gradient for Ca2+ across the SR 
m em brane is m aintained and Ca2+ uptake continues. There is, however, a 
finite quantity of calsequestrin within the SR and once the buffering capacity 
is exceeded then free Ca2+ will increase and inhibit the Ca2+-pum p. Oxalate, 
on the other hand, can pass freely into the SR where it forms an insoluble 
p rec ip ita te  w ith  the pum ped  Ca2+ ions p rovid ing  an infinite Ca2 + 
accum ulating capacity. The SR Ca2+-pum p is therefore never inhibited by 
in tra-lum inal [Ca2+] and continues to work at very high rates. Therefore, 
although the rate of Ca2+ uptake can be measured, there is no outw ard leak of 
C a2+ as w ould occur physiologically. Furthermore, the uptake of Ca2+, in 
isolated vesicles, is expressed per unit of protein (of SR vesicles) and so 
changes in the level of protein as a consequence of heart failure will confuse 
the interpretation of the calculated result.
M easurem ent of the m-RNA for the SR Ca-ATPase provides inform ation on 
the turnover of this protein within the myocyte. It is assum ed that a lower 
level of m-RNA represents a reduced expression of the protein. While this
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m ay be a valid assum ption it may not be representative of how the SR 
functions within the cell. One study which attem pted to relate molecular 
biology w ith function dem onstrated that the levels of m-RNA for SR Ca- 
ATPase could be negatively correlated with m-RNA for atrial naturetic 
peptide (Arai, Alpert, McLennan et al, 1993).
There have been no previous studies which have specifically examined SR 
function in saponin-perm eabilised ventricular trabeculae in hum an heart 
failure. In this study, hum an RV trabeculae were obtained from patients 
undergoing cardiac transplantation. The right ventricle is more trabeculated 
than the left and provided free-running preparations of appropriate length 
and diam eter for the experimental set-up. Additionally, the left ventricle 
tended to contain large infarcted areas of m yocardium  w ith w idespread 
diffuse areas of fibrosis and so suitable preparations were extremely difficult 
to find with consistency.
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METHODS
All tissue was obtained with w ritten consent from patients undergoing 
elective orthotopic cardiac transplantation. These patients were assessed by 
coronary angiography and cardiac catheterisation 3±1.3 m onths before 
transplantation (range 1-5 months). M easurements of right and left sided 
cardiac pressures were done using a fluid filled system and were calculated 
from  a paper trace obtained from  an ink-jet pen recorder (Siemens 
M ingograph 7). Left ventricular ejection fraction was m easured by radio 
nuclide blood pool imaging.
Transplantation was routinely performed during the hours of 2300 and 0500 
and so all experim ents were done in the early hours of the m orning 
im m ediately after excision of the heart. The heart underw ent in-situ cold 
cardioplegic arrest and, after excision, was p lunged in cold cardioplegia 
solution (4-6°C, modified St Thomas' solution). The RV was opened along 
the length of the interventricular septum  from the tricuspid valve ring 
tow ards the apex. A number of free-running trabeculae were excised from the 
free wall of the RV and were placed in cold Ringer containing 2,3- 
butanedione monoxime (30mM). These were immediately transported to the 
laboratory and a suitable preparation, from those dissected, was chosen under 
the dissection m icroscope. This was m ounted  for isom etric tension 
m easurem ent and placed in relaxing solution (solution B) containing 
saponin (50jig/ml) for 30 minutes. The trabecula was stretched to a length 
w hich provided a sarcomere length of 2.1-2.2pm and the p reparation  
diam eter (major and minor) was m easured under light microscopy. The 
experim ental protocol described in chapter 3 (figure 3.1) w as followed. 
Caffeine contractures were evoked at a variety of [Ca2+] (150-400nM) and 
loading times (15-150s). At the end of the protocol assessing SR function, the 
trabecula was treated with Triton-XlOO to remove all cell membranes leaving
only the myofilaments intact Cmax was measured in all preparations and the 
Ca2+/force relation was assessed in 8.
H um an control tissue
Various sources were pursued, including fast-track post m ortem , to try  to 
obtain fresh hum an tissue which could act as a control. Several experiments 
were attem pted using this tissue but even when rem oved w ithin 1 hour of 
death there was obvious rigor and no experimental data were obtained. On 
one occasion, tissue was near to being obtained from a donor heart turned 
dow n for transplantation on the basis of single vessel coronary disease but 
the relatives finally refused permission for experimental use.
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RESULTS
Clinical details
Experimental data were successfully obtained on eighteen patients. Details 
relating to clinical diagnosis, drug therapy and severity of heart failure are 
described in table 6. The majority had an underlying diagnosis of ischaemic 
heart disease. However, eight patients were transplanted w ith a principle 
diagnosis of heart failure with New York Heart Association (NYHA) class IV 
symptoms, six were transplanted on the basis of left ventricular dysfunction 
but w ith an additional diagnosis of inoperable coronary artery disease and a 
further four patients had a diagnosis of idiopathic dilated cardiomyopathy 
(IDCM). Five had a history of previous coronary artery by-pass surgery. Five 
patients had a history of essential hypertension controlled on drug therapy 
and one had type Ila hyperlipidaemia.
All pa tien ts w ere taking Frusem ide, ACE inhib itors and  nine were 
anticoagulated with warfarin. Two patients were taking beta-blockers. One 
patien t was taking amiodarone therapy at the time of transplantation and 
one was taking the lipid-lowering agent, bezafibrate. Six were taking digoxin 
and three were taking Ca2+ antagonists.
Examining the haemodynamic data, it is clear that there is a range of left 
ventricular dysfunction ranging from severe to moderate. Unfortunately, not 
all data was obtained for some of the measures of LV function such as cardiac 
ou tpu t (CO), cardiac index (Cl), right atrial pressure (RA) and maximum 
oxygen consumption. The data are complete for the measures of pulm onary 
capillary wedge pressure (PCWP), mean pulm onary artery pressure (MPA) 
and left ventricular ejection fraction (LVEF). For the purpose of some aspects 
of data analysis the IHD patients were separated into two groups on the basis 
of ejection fraction and pulm onary capillary wedge pressure. Those with 
m ore m arked haem odynam ic evidence of heart failure (LVEF of <19%,
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PCWP>20mmHg) were defined as severe left ventricular dysfunction while 
those with less haemodynamic im pairm ent (LVEF>20%, PCWP<20mmHg). 
were defined as having moderately impaired LV function. The patients with 
IDCM also had evidence of severe left ventricu lar dysfunction  and, 
haem odynam ically, are equivalent to the IHD group w ith  severe LV 
im pairm ent (all 4 patients had LVEF<19%, PCWP>20mmHg).
172
Ta
bl
e 
6 
- P
at
ie
nt
 D
at
a
DR
U
G
S
Ca
pt
o, 
Fr
us
, 
D
ig
,W
ar
f
Fr
as
, D
ig
, C
ap
to
, A
m
io
,W
ar
f,H
yd
ra
l
Fr
us
,D
ig
, 
En
al
,W
ar
f, 
N
it
Ca
pt
o, 
Fr
as
, 
W
ar
f
C
ap
to
,D
ig
,F
ra
s, 
A
sp
Ca
pt
o, 
Fr
as
, 
W
ar
f, 
N
it
En
al
, 
D
ig
, 
Bu
r, 
As
p,
 B
ez
a
C
ap
to
,B
ur
ne
t,I
sm
o,
R
an
it,
W
ar
f
Bu
ri
ne
x,
En
al
,W
ar
f,G
TN
En
al
,D
ig
,F
ra
s, 
N
if
En
al
,F
ra
s,T
em
az
, 
N
ic
ar
d
Ca
pt
o, 
Fr
as
, 
Am
il 
A
sp
Ca
pt
o, 
Fr
as
, 
As
p,
 N
it
R
an
it,
D
ilt
, A
te
n,
 W 
ar
f,G
TN
C
ap
to
,F
ra
s,A
sp
,W
ar
f
En
al
,B
en
dr
o,
D
ig
,A
llo
p,
Fr
as
En
al
, 
M
et
op
, 
Fr
as
, 
A
sp
C
ap
to
,F
ra
s,A
sp
,W
ar
f
G
re
at t H
<N
t -H
VOo
r -H
in
<N
r -H
r-H
t H 9
5 (NO
H
cno
t-H 9
3 r H
t- H
ON
(N
r H
cn
H
^ H 7
4
8
9
8
2 HH
H
cn
1—H
cn
r H
r H
r H
r H
m m
111111
Z
'Z
.
r -H
in 6
.9
8
.6
9
.9
7
.2
1
0
.2
4
.3
L'L
9
.4
5
.6
2
.5
3
.6
2
.3 OO
MD 1
1.
1
9
.2
6
.3
IIB
r -H
CN r -H 2
.7 r H
CN
On
r H 2
.6 t—H
CN
CO 3.
6
2
.9
2
.4
3
.8
4
.3 r -H
CN 4
.3
3
.8 OO
to
>
►4
r H
VO
r H
in
H
r H
r-H OO
r -H
r-H OO r - OO 1
0
.5 r H
r H
OO H
CN 2
8
2
2
.5
2
2
2
0
3
0
PC
W
P
2
0
2
5
2
2
2
2
3
2
1
2
2
2
5
1
2
2
3
0
2
4
2
0
2
9
t—H
O
H CN OO VOr H in
M
PA 30 37 36 32 incn 30 33 28 incn incn 22 38 r HCN Ont - H 20 23 25 VOr H
S or H tHr -H <Nt—H VO r-Hr-H cnt -H in ON OO On r H •'i'
DI
AG
NO
SI
S
ID
C
M
ID
C
M
ID
C
M
ID
C
M
IH
D
,C
A
BG
,M
V
R
IH
D
,C
A
BG
IH
D
Q
H
I IH
D
,V
F
IH
D
o
PQ
<U
Q
B IH
D
PL,
£
>*s
Q
«HH IH
D
IH
D
O
PQ
<U
Q
ffi
t - H
Q
s IH
D,
 C
A
BG
Ag
e
5
4
4
0
3
9
2
0
4
3
4
9
4
5
4
4
5
8
5
7
4
6
3
9
4
2
5
4
5
3
4
7
5
5
4
2
173
Isolated trabeculae experiments 
SR function
Trabeculae used for experiments were typically elliptical in cross-section with 
m ean m ajor and m inor diam eters of 213.5±58.4|im and 85.9±25.5pm 
(mean±SD) respectively. Figure 8.1 illustrates the am plitude of caffeine 
contractures produced at various [Ca2+] at 120 second loading periods for 15 
patients studied. There was a wide range of SR loading abilities as assessed by 
caffeine contracture amplitude. The patients with ischaemic heart disease 
(IHD) were separated into two groups on the basis of left ventricular function 
as described above. There were six patients with reasonably well preserved 
ventricular function and eight with more severe heart failure. Patients with 
a diagnosis of IDCM (n=4) are also presented as a separate group.
Figure 8.2 illustrates the mean caffeine contractures produced after 30,60,90 
and 150 seconds loading periods at various [Ca2+]s for the 3 groups of patients. 
There was some separation in the SR loading abilities of the two IHD groups, 
with the moderate heart failure patients demonstrating a tendency for larger 
caffeine contractures, reflecting a greater SR loading ability. At 60 seconds 
load ing  period , the m oderate LV dysfunction  g roup  dem onstra ted  
significantly larger caffeine contractures at lower [Ca2+] and had  produced 
contractures at 200nM loading [Ca2+] while the more severe heart failure 
group had failed to produce contractures (0% vs 7.3±4.1% Cmax; P=0.011). 
Differences between the three groups was most m arked at 250nM loading 
[Ca2+] at 60 seconds and was most pronounced at 150 seconds loading period 
(severe HF group 32.8+9.0 vs moderate HF group 65.2±11.3% Cmax, P=0.016). 
H ow ever, at higher loading [Ca2+], at all loading periods, there was no 
significant difference in the amplitude of caffeine contractures between the 
two IHD groups and between those and the DCM patients. The moderate HF 
group dem onstrated a marked fall in caffeine contractures at [Ca2+] above
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250nM which was not an effect produced by averaging but is indeed present 
in a significant num ber of individual trabeculae (see figure 8.1). This pattern 
w as seen in preparations exhibiting spontaneous oscillations at higher 
[Ca2+]s.
Trabeculae from patients with IDCM dem onstrated significantly smaller 
m ean caffeine contractures than the moderate and more severe IHD groups 
at a range of [Ca2+]s up to 300nM but at higher [Ca2+] there was no significant 
difference between any of the three groups. The shape of the loading curves 
was also different in that the DCM group did not show a plateau phase until 
[Ca2+] was greater than 350nM at 150 seconds loading. This is consistent with 
the observation  that none of the DCM prepara tions dem onstra ted  
spontaneous oscillations at any of the conditions of [Ca2+] or time tested.
Using the range of SR loading abilities at 250nM [Ca2+] and 150 seconds 
loading it was possible to correlate clinical indices of heart failure and SR 
loading capacity. This loading condition of [Ca2+] and time was chosen 
because it showed maximum spread of data allowing a possible relationship 
betw een SR function and severity of heart failure to be established. A 
num ber of these relationships are illustrated in figure 8.3. There was a 
relationship between the ability of the SR to load Ca2+ and the severity of 
heart failure for a num ber of indices of LV dysfunction. The strongest 
relationship was with pulmonary capillary wedge pressure (PCWP, r = -0.68, 
P<0.01) but there was also a relation with mean pulm onary artery pressure 
(MPA, r = -0.56, P<0.04) and left ventricular ejection fraction (LVEF, r = 0.59, 
P<0.05).
Spontaneous oscillations
Spontaneous oscillatory behaviour was observed less often in trabeculae 
from failing hum an hearts than in those from failing rabbit hearts. The 
Ca2+*time product at which oscillations first appeared in the loading protocol
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tended to be greater i.e. longer loading periods and higher [Ca2+] ([Ca2+]«time 
product - 54.3±3.6 pMseconds), than in failing rabbit hearts (26.1+2.6 |iM 
seconds). The [Ca2+]*time product at which oscillations were first observed 
was slightly lower in the moderate heart failure group (48.2±3.8 vs 57.2±3.1 
pM seconds). N one of the four trabeculae from patien ts w ith IDCM 
dem onstra ted  spontaneous oscillations. The first appearance of these 
oscillations in the SR loading protocol was not correlated w ith severity of LV 
dysfunction (PCWP - r = 0.09, P=NS).
M yofilam ent force production and Ca2+ sensitivity
C a2+ sensitivity of the myofilaments was assessed in 8 preparations from 
patients with a range of clinical LV impairment. A typical experimental trace 
of a cumulative Ca2+ activation, used to assess the Ca2+/force relationship in 
a hum an trabecula, is shown in figure 8.4. Hill equation curves were plotted 
to the data for seven of the patients studied (figure 8.5). There was a range of 
values for pCaso (5.05-5.79) with a mean value of 5.45±0.19 for all 8 patients. 
The Hill coefficients for these patients ranged from 0.41-2.66 (mean 1.63±0.45). 
There w as no sign ifican t re la tionsh ip  betw een  the m yofilam ent 
responsiveness, to Ca2+ (pCaso) or the maximum Ca2+-activated force and the 
severity of heart failure (figure 8.6b).
Maximum force produced per unit cross-sectional area was not significantly 
different between the three heart failure groups. For the more severe heart 
failure group, the mean peak force production was slightly lower than the 
m oderate heart failure group (2.92±2.15 vs 5.05±2.60gwt/mm2; P=0.12). There 
was no significant difference between the IHD patients, as a single group, and 
the patients with IDCM (IHD 3.98+2.38 vs DCM 3.78+0.71gwt/mm2; P=0.3) 
There was no correlation between the severity of heart failure as assessed by a 
num ber of clinical param eters and the maximum force developed by the 
Triton skinned preparation (Figure 8.6a; mean PAP, r = -0.19, LVEF, r = 0.18).
176
Ca
ffe
in
e 
Co
nt
ra
ct
ur
e 
(%
C
m
ax
)
100
l 1----------- r
100 200 300 400
[Ca2+] (nM)
F igure 8.1 SR Ca2+-loading (120 seconds) in hum an  sapon in -trea ted  
ventricular trabeculae.
177
Ca
ffe
in
e 
C
on
tr
ac
tu
re
 
(%
C
m
ax
)
4 0 -,
30 seconds
30-
2 0 -
1 0 - -O
300 400100 200
Loading [Ca2+] (nM)
40-,
60 seconds
30-
20 -
10 -
400300200100
Loading [Ca2+] (nM)
03a
V£
o>SM
o
03I*
f io 
U
<L>
c
2
03
u
100
90 seconds
80-
60-
40-
2 0 -
100 200 300 400
2+,Loading [Ca ] (nM)
100 -.
150 seconds * * P<0.01(all 3 groups) 
* P<0.05
80- ★ *
60-
40-
2 0 -
100 200 300 400
2+,Loading [Ca ] (nM)
Figure 8.2 (and facing page) SR Ca2+-loading at 30-150 seconds in hum an 
trabeculae from patients with severe (open circle, n=8) and m oderate (closed 
circle, n=6) LV dysfunction, and dilated cardiomyopathy (closed square, n=4).
178
Ca
ffe
in
e 
Co
nt
ra
ct
ur
e 
(%
C
m
ax
)
Figure 8.3 Various correlations of severity  of heart failure w ith  SR 
Ca2+-loading ability (120s/250nM Ca2+).
100 n 100 i
80-80-
r = -0.68
I y=63.71-1.87x60.60-
40.40-
2 0 -20 -
-i U - -
40 o20 300 10 10 20 30 40
Ejection Fraction (%) PCWP (mmHg)
100 n
80-
x
BU 60 -  
£ r = -0.56
y=58.64-1.05x
40 -
co
U
g  20-
■ ■
40 50 60302 01 0
MPA (mmHg)
179
10 mg wt
30seconds
pCa
7.29 5.85 5.63 5.42 5.15 4.24 4.02
Figure 8.4 Experimental trace of a cumulative Ca2+-activation 
hum an ventricular trabecula from a patient with heart failure.
180
curve in a
Re
lat
iv
e 
fo
rc
e
1 .0
0
[C alcium ]
Figure 8.5 Ca2+ sensitivity curves of T riton-treated hum an ventricular 
trabeculae.
181
Figure 8.6a Correlation of maximum Ca2+-activated force (Cmax) of hum an 
trabeculae with severity of heart failure.
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DISCUSSION
The results from this study suggest, that with increasing severity of heart 
failure, the ability of the SR to load Ca2+ diminishes. SR Ca2+-lo ad in g , 
reflected as the amplitude of the caffeine-induced contracture, was reduced in 
a sub-group of patients with more severe LV dysfunction com pared with a 
group of patients with m oderate LV dysfunction. Patients w ith idiopathic 
dilated cardiomyopathy demonstrated SR Ca2+-loading capacity which was 
even lower than the IHD group with the most severe LV dysfunction. These 
IDCM patients did have severe LV impairment and the m arkedly reduced SR 
C a2+-loading ability may therefore indicate a more severe form  of heart 
failure rather than a separate and distinct group. Previous work examining 
m-RNA indicated possible differences in the expression of a num ber of SR 
pro teins betw een ischaem ic and id iopath ic  d ila ted  card iom yopathy  
(Brillantes et al, 1992).
Correlation of SR function with severity of heart failure
SR loading capacity correlated with a num ber of clinical indices of left 
ventricu lar function. The strongest relationship was w ith pulm onary  
capillary wedge pressure which is an indirect measure of diastolic function of 
the left ventricle. However, the m easures of SR function used  r ig h t  
ven tr icu lar  trabeculae, one m ust speculate that the same influences on 
relaxation in the LV were also active in the RV. This is unlikely to be the 
case, although, widespread RV and LV fibrosis in heart failure can produce 
diastolic dysfunction in both chambers. Ideally, it w ould have been more 
appropriate to obtain some measure of right ventricular diastolic function in 
order to attem pt to relate SR function to RV relaxation. Right atrial pressure 
was obtained in some patients but was often not recorded. The relationship 
observed here between PCWP and SR Ca2+-loading is therefore more likely to 
be due to an overall reflection of heart failure and left ven tricu lar
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performance. There was also a relationship w ith ejection fraction which is 
m ore a reflection of systolic function of the LV. Once again, there were some 
data available for RV ejection fraction but not in a sufficient num ber of 
patients to allow correlations. The relationship w ith mean pulm onary artery 
pressure probably also reflects the severity of left ventricular dysfunction 
although it m ay also reflect RV hypertrophy secondary to pressure and 
volum e overload.
Clinical and haemodynamic data
The patient data of left ventricular function were acquired in the clinical 
setting during assessm ent of the patients suitability for transplantation. 
Clearly, there is a considerable possibility of error and variation in these 
m easurem ents especially since treatm ent of heart failure can change the 
values obtained significantly. However, this can be interpreted as being of 
added value since they were obtained, in the clinical setting, in the routine 
clinical assessment of patients, w ith no bias tow ards the SR experiments 
finally performed. The measurements were made several m onths before the 
hearts were finally excised and the condition of some of the patients had 
deteriorated in the period immediately before the transplantation. This could 
certain ly  have altered the values for some of the m easures of LV 
dysfunction. No attem pt was made to correlate patient sym ptoms w ith SR 
function since most of the patients were in NYHA III-IV which is often a 
prim ary reason for inclusion on the transplant program.
Control human tissue
W ithout norm al hum an tissue for comparison it is not possible to make 
direct statem ents as to the nature of the changes in SR function in heart 
failure. However, there are reasons why comparison of SR function within 
the same group of patients is more valid than attem pting to use non-heart 
failure hum an controls. Normal hum an control tissue is now  very difficult
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to obtain and is often taken from patients that are brain-dead following 
cranial injury. Raised intra-cranial pressure is known to produce profound 
effects on cardiac performance, both at a clinical and cellular level (McLeod, 
Dwyer, Meyer, Richardson, Cruikshank & Bartlett, 1982). Additionally, brain- 
dead patients are often treated with large doses of inotropic drugs to maintain 
circulation in the terminal stages of their illness. Indeed potential donor- 
hearts are often rejected for transplantation on the basis that they are over- 
stimulated with inotropic drugs. It is these hearts which become available for 
experim ental analysis as "normal control tissue'. Some studies have used 
control tissue from post-mortem specimens (Hassenfauss et al, 1992). Unless 
these were obtained very rapidly the effect of warm-ischaemia is m arked, in 
our experience, and will have a profound effect on contractile performance at 
a cellular level.
Patient drug therapy at the time of removal of the heart m ay have additional 
effects on cellular function. The recipient heart tissue may have been exposed 
to diuretics, ACE inhibitors, Ca2+ antagonists, beta-blockers and  anti- 
arrhythm ic drugs. Amiodarone, for example, has been show n to have effects 
on SR Ca2+ uptake (Watson, Balke & Gold, 1993). Clearly, control tissue is 
not exposed to this pharmacological cocktail. Most of the patients in this 
s tu d y  w ere also given the im m unosupp ressan t d ru g , cyclosporin , 
intravenously before going to theatre for transplantation. Cyclosporin is 
know n to have effects on Ca2+ regulation w ithin cardiac myocytes and so 
m ight alter SR function (Banijamali, ter Keurs, Paul & ter Keurs, 1993). 
Therefore, the tissue used for this study was from patients on a comparable 
baseline long-term drug regimen, treated in the same w ay in the period 
immediately before the heart was excised and all tissue was rem oved rapidly 
from the heart during cold-ischaemia. For these reasons a comparison of SR 
function between patients with heart failure undergoing transplantation is a 
more valid and controlled study.
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Myofilament force production and Ca2+ sensitivity
M aximum force production by the myofilaments was not different between 
groups and did not correlate with severity of heart failure. This is similar to 
other reports that the myofilaments are intrinsically able to produce a similar 
quantity of force in heart failure. The Ca2+ sensitivity of myofilaments was 
not significantly different from that reported in other studies (Morano et al, 
1988, Schwinger et al, 1994) and was not correlated with severity of heart 
failure. This indicates that measured force would accurately reflect Ca2+ in a 
similar way in all patients, regardless of the severity of heart failure. This is 
an im portant finding for this study since we did not measure Ca2+ directly. 
This result indicates that the differences observed in SR loading were due to 
changes in the quantity of released Ca2+ and not due to changes in response 
of the myofilaments to similar quantities of Ca2+. This result also suggests 
that the co-operativity of the regulatory proteins is essentially unchanged 
even in severe heart failure. Changes in the regulatory proteins have been 
reported in hum an heart failure (Solaro et al, 1993). Changes in troponin-I 
have been dem onstrated but how these changes influence function is less 
clear. There is no evidence for a significant change in myosin types in 
hum an heart failure as occurs in heart failure seen in small mammals.
Spontaneous oscillations
Spontaneous oscillations were observed in hum an trabeculae but these 
tended to occur at higher loading [Ca2+] and longer loading times than had 
been observed in the rabbit model. There was no evidence of spontaneous SR 
C a2+ release in any of the patients with IDCM. These patients had the lowest 
SR loading capacity and therefore this would suggest that the appearance of 
oscillations is more likely in SR which loads to a greater extent. There is 
some evidence that the probability of oscillations is related to the absolute
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[Ca2+] within the SR (Tripathy and Meissner, 1994). This suggests that the 
final intra-SR [Ca2+] reached during the various loading conditions was lower 
in the IDCM trabeculae than in those trabeculae which dem onstrated 
spontaneous oscillations. This implies that there was not only a reduction in 
the total quantity of releasable Ca2+ but that the final luminal SR [Ca2+] was 
lower in those patients with IDCM and with more severe heart failure. This 
lower intra-SR [Ca2+] would result from a reduced SR Ca2+-pum p activity and 
not simply from a reduction in the volume of SR. However, a change in the 
intra-SR Ca2+ buffering capacity might bring about a similar experimental 
result. For example, an increased level of calsequestrin w ithin the SR of 
IDCM patients could reduce the probability of oscillations. However, studies 
of the calsequestrin gene have failed to dem onstrate significant changes in 
expression of this protein in heart failure (Takahashi, Allen, Lacro et al, 
1992). The conclusion from this m ust be that the rate of Ca2+ pum ping is 
reduced, and therefore, that there is indeed a qualitative change in SR 
function and not simply a change in the quantity of SR.
Further support for this argument is revealed by examining the SR loading 
patterns of the three heart failure groups (figures 8.2). All three curves reach 
the similar maximum point at 400nM loading [Ca2+] for each of the loading 
periods shown. This suggests that the total volume of SR is similar in each 
group but clearly the patients with more severe heart failure require higher 
loading  [Ca2+] to achieve this maximum. This also suggests that the SR 
volume is the similar but that the rate of Ca2+ uptake is different.
Skinned vs  Intact preparations
The sarcolemma of preparations used in this study was perm eabilised with 
saponin and therefore the contribution to developed force from Ca2+ influx 
via the voltage -gated Ca2+ channels could not be assessed. While a num ber 
of studies on 'sarcolemma-intact' cardiac muscle preparations have indicated 
a reduced rate of Ca2+ re-uptake, the amplitude of the Ca2+ transient has been
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reported as unchanged in human heart failure (Gwathmey et al, 1987, Vahl et 
al, 1994). The Ca2+ transient in such tissue is made up of Ca2+ entry via the 
sarcolem m al voltage dependent channels and Ca2+ release from the SR. 
Since the bulk of evidence suggests that the SR Ca2+ content is reduced in 
heart failure then for the transient to be of the same size there m ust be 
compensation by increased influx across the sarcolemma. This theory has not 
been supported by other evidence suggesting a reduction in the m-RNA 
coding for L-type Ca2+ channels in heart failure (Takahashi et al, 1992, 
Brillantes et al, 1992). This discrepancy remains rather difficult to explain. 
H ow ever, reduced  re-uptake of Ca2+ in the presence of increased 
sarcolemm al influx does provide conditions for cytosolic Ca2+ overload 
which is recognised as a possible mechanism for inducing spontaneous 
electrical activity by activation of the transient inw ard current. Thus, in 
addition to the effects on contractile function a reduced rate of re-uptake of 
Ca2+ will predispose the heart to arrhythmogenic conditions!
Consequences of reduced SR Ca2+-loading ability
Reduced SR Ca2+ uptake will contribute to diastolic dysfunction by reducing 
the rate of relaxation of the myocyte. The diminished rate of uptake will also 
tend to reduce the Ca2+ content of the SR and therefore reduce the quantity of 
C a2+ available for subsequent activation. During conditions of adrenergic 
drive the increased influx of Ca2+ across the sarcolemma may overwhelm the 
SR buffering capacity. This would produce Ca2+ overload and could generate 
arrhythm ogenic activity.
Conclusions
These results indicate that with increasing severity of heart failure the ability 
of the SR to load Ca2+ becomes diminished. The data support the hypothesis 
that total SR volume is not reduced but that the rate of Ca2+ uptake is 
diminished. SR function was reduced to the greatest extent in patients with
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dilated cardiomyopathy. Whether this represents a specific response to the 
cause of the cardiomyopathy or simply reflects more severe heart failure is 
not clear. Such a reduction in SR function w ould tend to predispose the 
myocyte to Ca2+ overload and delay relaxation.
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CHAPTER 9
Effects of cyclic Adenosine Monophosphate (cAMP) 
on Sarcoplasmic Reticulum Ca2+-loading 
in Ventricular Trabeculae from 
Rabbits and Humans with Heart Failure
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INTRODUCTION
Adrenergic stimulation of cardiac tissue produces an increase in the in tra­
cellu lar second m essenger, cyclic adenosine-m onophosphate  (cAMP). 
A denylate cyclase is activated by way of a stim ulatory G TP-dependent 
protein. ATP is converted to cAMP which activates protein kinase C and 
which, in turn, phosphorylates a num ber of intra-cellular sites including the 
C a 2+ channel on the sarcolemma, phospholam ban on the sarcoplasm ic 
reticulum and sites on the myofibrillar proteins. This results in an increased 
force of contraction and an increased rate of relaxation i.e. a positive 
inotropic and lusitropic effect. Therapeutically, this physiological mechanism 
is of considerable potential benefit for patients with heart failure. However, 
ad renorecep tor dow n regulation, resulting  from  chronic sym pathetic  
activation, limits its effect in improving cardiac performance.
cAMP m etabolism
cAMP is hydrolysed by the enzyme phosphodiesterase to the inactive 5'- 
AMP. Drugs which directly inhibit this enzyme, effectively, by-pass the 
adrenoreceptor increasing levels of cAMP by inhibiting its breakdow n. 
Phosphodiesterase inhibitors, such as m ilrinone and enoxim one, have 
proved successful in improving cardiac output and various haem odynam ic 
indices (Colucci, Wright & Braunwauld, 1986) but have been associated with 
increased m ortality w ith more long-term  use in the treatm ent of heart 
failure (Packer et al, 1991). The reasons for this increased m ortality are 
unclear but are thought to be related to an increased incidence of arrhythmias 
(Holmes et al, 1985) secondary to Ca2+ overload. The relative increase in 
levels of cAMP induced by PDE inhibitors is dependent on the level of 
background substrate available (Feldman et al, 1987) and on the background 
activity of the enzyme. The levels of PDE enzyme were found to be similar in 
iso la ted  SR vesicles from  failing and norm al hum an  m yocard ium
(M ovsesian, Smith, Krall, Bristow & M anganiello, 1991) although the 
m easurem ent in such m yocardial extracts should not be in terpreted  as 
representative of the cytosol in the intact cell. A ttem pting to assess the 
functional activity of PDE enzymes in intact tissue is extremely difficult since 
m any PDE inhibitors have direct effects on a num ber of cellular systems 
including the SR and myofilaments in addition to the effects produced 
indirectly via cAMP.
cAMP in heart failure
Pervious studies have dem onstrated that the reponse of isolated cardiac 
myocytes to cAMP is abnormal in heart failure (Harding et al, 1994). These 
authors also reported that a diminished response to cAMP was also present 
in a guinea-pig model of (3-receptor dow n-regulation. This suggests that 
adrenoreceptor changes in the sarcolemma have effects, downstream , on the 
mechanisms which control the reponse to cAMP. At what point downstream 
does this abnormality of response to cAMP exist? In isolated SR vesicles from 
rabbits w ith pressure overload hypertrophy Lamers and Stinis (Lamer & 
Stinis, 1979) demonstrated a reduced baseline SR Ca2+ uptake and this failed 
to reach control levels in the hypertrophied hearts after incubation with 
cAMP and protein kinase. However the relative increase was sim ilar in 
controls and hypertrophied animals suggesting that the sensitivity of the 
cAMP mechanism remained intact. This result, however, does indicate that 
the abnorm ality lies further downstream  than protein kinase C. Movsesian 
(1992) used a phospholamban stimulating antibody on isolated SR vesicles 
from failing hum an heart and could find no difference in the response of SR 
Ca2+ uptake. This result suggests, therefore, that the abnormality of response 
to cAMP lies between protein kinase C and phospholam ban. However, it 
should be noted that, in this study by Movsesian, the baseline levels of Ca2+ 
uptake by SR vesicles was not significantly different betw een failing and 
control myocardium.
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There are, therefore, conflicting reports on the response of failing 
m yocardium  to cAMP and the direct effects on Ca2+ uptake in 'in-situ SR' has 
not previously been directly evaluated in failing myocardial tissue.
Aim of this chapter
This chapter examines the direct effects of cyclic-adenosine m onophosphate 
on SR Ca2+-loading in saponin-treated ventricular trabeculae. The results 
obtained have general implications for SR Ca2+ regulation in heart failure 
bu t are also an interesting extension of the results obtained in chapter 3 
(Ligation 8 weeks). The hypothesis follows from chapter 7 in which the 
possible difference in the phosphorylation-state of phospholam ban was 
discussed. In 8 week LIG animals, the scope for further increase in SR Ca2+- 
loading might be reduced compared with SH animals. Therefore, cAMP may 
increase SR Ca2+-loading to a greater extent in the Sham -operated animals 
com pared with LIG animals. By comparing the cAMP response of SR Ca2+- 
loading in isoprenaline infused rabbits with the response in heart failure 
anim als this will also allow an assessment of the effects of adrenoreceptor 
down-regulation alone. These results are compared with the SR response of 
failing human, saponin-treated trabeculae to cAMP under identical loading 
conditions. The results of this part of the study are presented as a separate 
chapter because they represent a comparison of the two rabbit m odels and 
also of these models with the human failing trabeculae.
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METHODS
cAMP: effects on SR Ca2+-loading
The effect of cAMP on SR Ca2+-loading was studied in rabbit and hum an 
right ventricular trabeculae : coronary ligation rabbits(LIG) with heart failure 
and  sham -operated  controls (SH); rabbits chronically  in fused  w ith 
isoprenaline by mini-osmotic pum p (Iso-OP) and saline infused controls 
(Sal-OP); hum an hearts explanted at the time of cardiac transplantation. 
Haemodynamic assessment was undertaken in the way described in chapter 2 
for all rabbits studied. The patient details related to the hum an preparations 
are presented in table 6, chapter 8.
The trabeculae were prepared and m ounted as previously  described. 
Following treatm ent with saponin for 30 m inutes, the preparation  was 
placed in solution B with 200nM [Ca2+] to allow the SR to load Ca2+ for 120 
seconds. Caffeine (lOmM for 5 seconds) was used to effect release of Ca2+ from 
the SR and evoke a contracture. A train of four contractures was produced at 
baseline and at various [cAMP]s ranging from 10“^ to 10“5 M. The mean of 
the final three contractures at each [cAMP] was calculated.
Ca2+ m easurem ents
In two experiments, one using a trabecula from sham -operated animal and 
one using a ligated rabbit, Ca2+ was measured using the fluorescent indicator 
Fura-2 at the same time as measuring tension. The experimental set-up is 
described in chapter 2. The effect of cAMP on Ca2+-loading was observed 
using a similar protocol to that used in the experiments where tension was 
m easured alone.
cAMP: effects on the myofilaments
At the end of the SR protocol the preparation was treated w ith Triton to 
d isrupt all cell membranes. Cmax was assessed and the effect of 10-5 cAMP on
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myofibrillar responsiveness to Ca2+ was also assessed in a small num ber of 
rabbit preparations.
Experimental note: cAMP stock solution
The sodium  salt of cAMP was used, dissolved in solution B to make a stock 
which was frozen in 1ml aliquots and defrosted for use in each experiment. 
Q uantities of this solution were added to the bath to obtain the desired 
concentration. Vigorous agitation with an electric stirrer ensured a rapid  
diffusion of the cAMP throughout the bath chamber . However, some of the 
observed delay in response to cAMP may be related to diffusion throughout 
the bath and into the preparation. The problem of lipid solubility of different 
types of cAMP, experienced by workers using intact preparations (Harding et 
al, 1994), does not apply in skinned preparations since the holes in the 
sarcolemma allow free access to ions and small molecules including cAMP.
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RESULTS
Effects of cAMP on SR Ca2+-loading
A typical response of cAMP on the caffeine-evoked contracture is illustrated 
in a rabbit and a hum an preparation in figure 9.1 (upper and m iddle panel). 
The am plitude of the caffeine contracture increased significantly after a 
period of approximately 2 minutes in both species. This delay in response 
was a consistent finding in all preparations which responded w ith  the 
increase always occurring at least one cycle of loading and caffeine release 
after the addition of cAMP. There were a num ber of additional features of 
note. Firstly, the response to cAMP was all or nothing and did not follow a 
dose response relationship in any of the trabeculae studied. Secondly, this 
response was not observed in all preparations studied (figure 9.1, lower 
panel). A response to cAMP was defined as an increase in the CIC of >25% 
occurring at any of the [cAMP]s tested (figure 9.2). Using this definition, 90% 
(9 of 10) of the hum an trabeculae studied produced a response. However, 
only 20% (1 of 5) of the Sal-OP animals responded compared with 86% (6 of 7) 
of the Iso-OP animals but a similar number of preparations responded in the 
SH (5 of 8) and LIG groups (7 of 11). The third feature, which is not shown, 
was that after the initial increase in amplitude of the CIC with cAMP there 
was often a gradual fall in the size of the CIC over a period of 4-5 cycles of 
Ca2+-loading and release. The possible mechanisms for this third observation 
are discussed.
There are a num ber of ways in which the actual m agnitude of response to 
cAMP may be illustrated. The first is to express the m ean increase in the 
am plitude of the CIC as a percentage of the baseline level (figure 9.3). The 
second is to express the increase as a proportion of the m axim um  force 
produced by the trabecula (Cmax) (figure 9.4). Using the former, the hum an 
trabeculae dem onstrated a marked increase in the am plitude of the CIC of
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approxim ately x4.5 fold (364.5±102.8% increase above baseline). The LIG 
anim als dem onstrated a slightly greater increase than the SH controls 
(170.7±60.4 vs 126.9±31.9% increase; P=0.58) but both are significantly less than 
the hum an (P=0.02,P=0.03). The Iso-OP animals dem onstrated a significantly 
greater response than the Sal-OP animals (96.4±18.1 vs 33.4±7.6% increase, 
P=0.038). However, the SH group are not significantly different from the Iso- 
OP animals. When these responses are normalised to Cmax the m agnitude of 
the response to cAMP in terms of absolute force becomes more apparent. The 
hum an trabeculae produced a relatively large increase in SR Ca2+-load ing  
which was equivalent to a 0.2-fold increase (20.2±4.7%). LIG rabbits produced 
a similar increase in absolute force compared w ith the respective controls 
(LIG 8.3±2.86 vs SH 10.6±3.22 % Cmax; P=0.55) while the isoprenaline treated 
animals produced a greater increase in force compared with controls (15.1±5.4 
vs 2.2±1.1 % Cmax, P=0.02). Although the Iso-OP animals appear to produce a 
greater increase in SR loading than the LIG or SH animals the difference did 
not reach statistical significance (P=0.48, P=0.30).
The baseline caffeine contractures, before application of cAMP, were not 
significantly different between groups (LIG 8.1±4.0, SH 12.4±6.0, H um an 
11.5±4.6, Iso-OP 14.5±3.4, Sal-OP 19.9±4.2 % Cmax). The scope for further 
increase in the caffeine contracture, with respect to Cmax, w as therefore 
roughly similar between groups (approximately 80-90% Cmax).
Trabeculae which dem onstrated no significant response to cAMP, by the 
definition used above (<25% relative increase in CIC), tended to have larger 
caffeine contractures at baseline than the responders (27.4±7.4 vs 13.3±4.4; 
P=0.04) but this was clearly not close enough to Cmax to limit the scope for 
increase. The relative increase in am plitude of the CIC in the 'non­
responders' group was significantly lower than any of the responding groups 
(10.3±3.9 %) and represented only a very small proportion of Cmax (2.3±1.8 %).
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Figure 9.1 Experimental trace of the response of hum an and rabbit saponin- 
treated trabeculae to cAMP. The SR is loaded in 200nM [Ca2+] for 120 seconds, 
the subsequent challenge with caffeine induces a Ca2+ release and a 
contracture results. The increase in am plitude of the caffeine contracture is 
due to enhanced SR Ca2+-loading as a result of phosphory la tion  of 
phospholam ban. The lower trace is from a SH rabbit which failed to 
dem onstrate a significant response to cAMP.
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Figure 9.2 Proportion of trabeculae from hum an (n=10) and rabbit models 
(LIG n = ll ,  SH n=8, Sal-OP n=5, Iso-OP n =7) dem onstrating a response to 
cAMP (>25% increase in baseline caffeine contracture).
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Figure 9.3 Effect of cAMP on the am plitude of the caffeine contracture 
relative to baseline caffeine contracture (numbers are as in figure 9.2).
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Figure 9.4 Effect of cAMP on the am plitude of the caffeine contracture 
relative to Cmax (numbers are as in figure 9.2).
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Ca2+ measurements
The LIG rabbit in which SR Ca2+-loading was m easured  using  Fura-2 
dem onstrated a modest increase in the am plitude of the Ca2+ transient 
(figure 9.5, panel A) following application of 10"6 cAMP (24.1±2.6% increase 
in peak [Ca2+]) associated w ith a small increase in the tension transient 
(8.8±3.6%). The SH trabeculae failed to demonstrate an increase in either the 
Ca2+ or tension transient in response to cAMP.
In addition to the increase in the amplitude of the Ca2+ transient, there was a 
slight increase in the rate of fall of the Ca2+ transient in the LIG rabbit studied 
with Fura-2 (figure 9.5, panel B). This increased rate of decline corresponded 
with the increased peak light transient observed in this rabbit. In addition the 
overshoot in the Ca2+ trace norm ally observed imm ediately after the Ca2+ 
transient was more marked after cAMP was applied suggesting that the rate 
of Ca2+ uptake was significantly increased. The SH rabbit Trabecula failed to 
show an increase in the peak Ca2+ transient and dem onstrated no change in 
the rate of decline of the Ca2+ transient
cAMP : effect on myofilaments
The time to peak-twitch (TPT) of the CIC was not significantly different 
betw een the rabbit groups at baseline (LIG 1.8±0.8s, SH 1.9±1.0s, Iso-OP 
1.7±0.9s, Sal-OP 2.1±0.7s; P=NS). H ow ever, the hum an  trabeculae  
dem onstrated significantly longer TPT than all of the rabbit groups (3.2±1.6s; 
P=0.048). Following treatment with cAMP there was no significant change in 
TPT in any of the rabbit groups and no significant change in the hum an 
trabeculae (3.8±3.1s). The direct effects of cAMP was tested on a num ber of 
Triton-treated preparations. There was no effect produced on myofilam ent 
force production, at sub-maximal activations (result not shown), in any of 
the rabbit models tested.
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Figure 9.5 Sim ultaneous Ca2+ and tension m easurem ents in a saponin- 
treated ventricular Trabecula from a rabbit with heart failure (LIG). The 
arrow  heads represent the brief application of caffeine. Panel A demonstrates 
the response of caffeine-induced Ca2+ transient (upper trace) and tension 
(lower trace) to cAMP (10"6M, thick bar). There is a 15.-20% increase in the 
am plitude of the Ca2+ transient over a period of 2-3 cycles of loading and 
release. There is only a small increase in the am plitude of the caffeine 
induced contracture. Panel B demonstrates the Ca2+ transient before cAMP 
(closed circle) and after the addition of cAMP (open circle) to the bathing 
solution. The traces are normalised and super-imposed in the lower part of 
panel B to dem onstrate the more rapid  decline in the Ca2+ transien t 
following application of cAMP.
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DISCUSSION
The response to cAMP in saponin-treated trabeculae tended to occur as an all- 
or-nothing increase in the am plitude of the caffeine contracture rather than 
as a dose-response relationship. In addition, the effect of cAMP was only very 
slowly reversible and so once an effect was observed it was not possible to 
re tu rn  to a true baseline state. For practical reasons the concentration of 
cAMP was increased by a factor of five each time but it is possible that this 
w as not tuned finely enough to reveal a dose-response relationship. The 
apparent step-like response to cAMP may have been due to a very steep dose- 
response relationship between cAMP and phospholam ban phosphorylation. 
Reviewing the literature, few workers observing the effect of cAMP on SR 
C a 2+ uptake have reported their results in the form of a dose-response 
relationship. Indeed, previous work in this laboratory, using rat ventricular 
trabeculae, also dem onstrated a similar step-like response to cAMP (DS 
Steele, PhD thesis, 1990). It is possible that a threshold concentration is 
req u ired  to activate p ro te in  kinase w hich, once activa ted , causes 
phosphorylation of all sites on the SR such that further increases in [cAMP] 
are ineffective.
A response to cAMP was not observed in all trabeculae (figure 9.1, lower 
panel). I have represented this as the proportion of trabeculae responding by 
a >25% increase in amplitude of the baseline caffeine contracture (Figure 9.2). 
A lthough this seems an arbitrary cut-off, it reduces the effect of averaging for 
a num ber of caffeine contractures and does, in fact, reflect the actual increase, 
or lack of increase, in caffeine contractures observed during the experiment. 
It is assum ed that those trabeculae failing to show a response in the tension 
transient failed to increase the amount of Ca2+ loaded by the SR. This may 
not be the case since an increase in the Ca2+ transient in a rabbit trabecula 
w ith  only a very small increase in the size of the caffeine contracture was
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observed. This finding might be explained by a simultaneous increase in SR 
C a 2+-loading  and a reduction  in m yofilam ent Ca2+ responsiveness. 
Therefore, an alternative way of interpreting an absent response to cAMP is 
tha t the m ore dom inant effect was a reduction in m yofilam ent Ca2 + 
sensitivity  w ith a sm aller increase in Ca-uptake while those which did 
respond  produced a more m arked increase in SR Ca2+ uptake and little 
change in Ca-sensitivity. However, in another experiment where Ca2+ and 
tension were m easured simultaneously, cAMP had no effect on tension or 
C a2+ even at high concentrations (result not shown) indicating a complete 
failure to respond. One can only conclude, therefore, that since Ca2+ was not 
m easured  directly in the m ajority of the experim ents, some of those 
trabeculae, bu t not all, which apparently  failed to respond  m ay have 
p roduced an increase in SR Ca2+ uptake which could not be detected by 
m easuring tension alone.
The relative increase in the caffeine contracture produced by cAMP was 
greatest in the failing hum an trabeculae studied (figure 9.3). However, there 
is no hum an control tissue w ith which to compare this result. Therefore, 
although it represents an interesting comparison with the rabbits, it would 
n o t be ap p ro p ria te  to m ake defin itive sta tem ents concerning  the 
responsiveness of failing hum an myocardium to cAMP. The LIG animals 
dem onstrated a slightly greater response to cAMP than the SH but this failed 
to reach statistical significance. The Iso-OP animals did show a significantly 
greater response to cAMP than the respective controls although the response 
w as no greater than in the LIG or SH animals. W hen this increase is 
expressed in terms of proportion of Cmax then the hum an and Iso-OP rabbits 
dem onstrate the greatest increase in force production w ith the LIG animals 
only slightly greater than the SH controls. This finding suggests that the size 
of response to cAMP might reflect the degree of P-adrenergic receptor down- 
regulation - the hum an hearts followed by the Iso-OP rabbits then LIG rabbits.
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The responsiveness to cAMP might, therefore, be a reflection of the severity 
of heart failure and the degree of resulting p-adrenergic receptor dow n- 
regulation. One possible reason why the Sal-OP rabbits are less responsive 
than the SH group could be that they were given boluses of isoprenaline 
imm ediately before sacrifice. This may have caused phosphorylation of all 
intracellular sites and, because the process is slowly reversible, this state 
persisted such that no further effect could be produced in-vitro. The LIG and 
Iso-OP animals however, because of p-receptor-down regulation, had  sites 
available for phosphorylation which resulted in increased SR Ca2+-up take  
and an increase in amplitude of the caffeine contracture. 
cAMP in heart failure
These data suggest that the response of SR Ca2+-loading to cAMP is, at least, 
m aintained in heart failure which is similar to other reports in isolated SR 
vesicles (Movsesian, 1992, Lamars, 1977). This m aintained  response is 
som ewhat different from other reports in isolated failing myocytes (Harding 
et al, 1994). Clearly, the nature of the preparations in these studies are 
d ifferent and this may explain the differences observed in functional 
response to cAMP. The results from this study and the studies on isolated SR 
vesicles take no account of changes in sarcolemmal Ca2+ flux in response to 
cAMP. Therefore, these apparently conflicting reports can be in terpreted  
together to suggest that if the response to cAMP is dim inished in intact 
failing myocytes then the SR might not be the limiting factor.
The mechanism responsible for the diminished response to cAMP, observed 
by H arding et al, m ight not due to diminished Ca2+ uptake by the SR and 
could be the result of reduced influx of Ca2+ via voltage dependent Ca2+ 
channels. Such reduced influx might delay the process of Ca2+-induced Ca2+ 
release and reduce the Ca2+ available for myofilament activation com pared 
w ith control tissue. There is evidence supporting a reduction in the num ber 
of d ihydropyrid ine-sensitive  Ca2+ channels in heart failure (Takahashi,
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Allen, Lacro et al, 1992) and this has often been proposed as a mechanism for 
contractile dysfunction in the failing heart. The hypothesis suggested is, 
therefore, that cAMP is able to increase SR Ca2+ uptake in the failing heart 
bu t the sarcolemma is unable to increase the influx of Ca2+ to support a 
significant increase in contractile function. There is, how ever, evidence 
which indicates that the response to isoprenaline in (non-failing) isolated 
myocytes is mainly mediated via an increase in Ca2+ uptake by the SR (Sham, 
Jones & M orad, 1991). This was dem onstrated by using phospholam ban 
stim ulating antibody to stimulate SR Ca2+ uptake resulting in an increase in 
contraction amplitude with the subsequent addition of isoprenaline failing to 
increase contraction further. The authors interpret this finding as a marked 
SR-dependence of inotropic response to isoprenaline. Since we found the SR 
to have a normal or enhanced response to cAMP in heart failure then it 
seems unlikely, therefore, that a simple explanation of reduced Ca2+ influx 
via voltage-gated channels could be responsible for the depressed response in 
the intact single myocyte reported by Harding et al. (1994)
Time-course of response to cAMP
Previous studies have made no reference to a time-delay in the response of 
SR Ca2+-loading to cAMP. In this study, the increase in SR Ca2+ uptake often 
occurred within 2-4 minutes of adding the drug to the solution. Admittedly, 
some of this delay was related to diffusion from the solution into the 
p reparation  bu t some of the delay could have involved activation of 
en d o g en o u s p ro te in  k inase  and su b seq u en t p h o sp h o ry la tio n  of 
phospholam ban. It is possible that in 'sarcolemma-intact' preparations the 
increase in Ca2+ influx via the sarcolemmal Ca2+ channel, m ediated by an 
increase in intra-cellular cAMP, occurs at a slower rate than the increase in 
SR Ca2+ uptake. This would result in a faster rate of relaxation at a time when 
there had been no increase in absolute force production. Such an uncoupling 
of Ca2+ regulation has not been previously reported although H arding et al
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(1994) commented only on maximum amplitude of contraction, not on rate 
of relaxation and also did not comment on the time delay in the response to 
cAMP. However, if the long-term toxicity of drugs which increase cAMP is 
related to Ca2+ overload, as has been suggested, then perhaps a slower process 
of increased [Ca2+]i occurs via the sarcolemmal Ca2+ channel over a period of 
days, or even weeks, which eventually overcomes the SRs' ability for Ca2+ re­
uptake resulting in Ca2+ overload and generation of arrhythmias. 
cAMP and the myofilaments
The apparent fall-off in the tension transient with cAMP which follows the 
initial increase could have been due to a number of factors. Firstly, a straight­
forw ard decrease in sensitivity of the myofibrils for Ca2+ may occur, thus, 
despite an increased Ca2+-loading by the SR, the tension reponse to this 
increased  quan tity  of releasable Ca2+ was d im in ished . The direct 
m easurem ents of Ca2+ provide some evidence to support this suggestion 
since we observed that despite an increase in Ca2+-loading of the SR the 
caffeine contracture failed to increase significantly which m ust represent a 
decrease in myofilam ent Ca2+ sensitivity. The second suggestion is that 
oscillatory Ca2+ release from the SR increases as a result of cAMP (see figure 
6.2, increased oscillations following cAMP). This w ould tend to deplete the 
SR pool of Ca2+ and reduce the size of the caffeine contracture. These 
oscillations m ight not be observed on the tension trace because of a 
simultaneous reduction in myofilament Ca2+ sensitivity induced by cAMP. 
There was no effect of cAMP on the Triton skinned fibre. This is not 
surprising  since enzymes, including protein kinase C, are lost from the 
cytosol as a result of this treatm ent. However, these preparations had already 
been treated with cAMP and therefore myofilaments may already have been 
phosphorylated. Addition of further cAMP w ould therefore have had no 
effect on Ca2+ sensitivity. There was some indication that the myofilaments 
did show a decrease in Ca2+ responsiveness (figure 7.4).. These preparations
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had all been treated w ith cAMP in the saponin treated state and so this shift 
in response to Ca2+ may have been related to persistent phosphorylation of 
troponin-I.
Conclusions
The ability  to m anipulate  in tracellu lar levels of cAMP represen ts a 
potentially im portant mechanism for the treatm ent of heart failure. Early 
stud ies of PDE inhibitors were encouraging w ith reports of significant 
im provem ents in both haemodynamic indices and patien t symptoms. This 
study suggests that the response of the SR to cAMP is m aintained in heart 
failure and is possibly even enhanced. Therefore if the increased m ortality 
associated with long-term use of PDE inhibitors is related to Ca2+ overload, 
then the mechanism which brings this about m ust be related to increased 
influx of Ca2+ across the sarcolemma or a secondary reduction in the SR 
uptake of Ca2+ with chronic exposure to the drug. Alternatively, the initial 
im provem ents in heart failure p roduced by PDE inhib itors could be 
associated w ith a reduction in sym pathetic stim ulation  which in turn  
replenishes the p-receptor population. Thereafter, combined PDE inhibition 
and a return of p-receptor sensitivity might then cause a m arked increase in 
the level of intracellular cAMP which would result in Ca2+ overload.
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CHAPTER 10 
General discussion
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GENERAL DISCUSSION
A num ber of previous studies have examined SR function in animal models 
of heart failure and virtually all have suggested reduced cardiac SR Ca2+- 
loading ability although there have been a few where enhanced SR function 
was observed such as in mild pressure overload hypertrophy (Limas et al, 
1980) and after training (Greenen, W hite & Lapman, 1987). The results 
presented in this thesis from the rabbit models are therefore at odds with the 
weight of evidence in the literature. Before discussing each chapter in turn, 
therefore, it would be appropriate to discuss the validity of the technique 
used for assessment of SR Ca2+ content.
The caffeine-contracture as an indicator of SR Ca2+-content
Tension was used as a 'bio-indicator' of SR Ca2+ content. That is, it was 
assum ed that when the SR contained more Ca2+ for release this resulted in a 
larger contracture following application of caffeine. The question which 
arises is whether the caffeine-induced contracture was accurately reflecting 
SR Ca2+ content?
Firstly, we dem onstrated that the Ca2+/force relation was not significantly 
d ifferent betw een LIG and SH trabeculae, assessed in T riton-treated 
preparations, under steady state conditions. To exclude the possibility that 
caffeine was having a differential effect on LIG and SH myofilaments during 
caffeine-induced  contractures the effects of lOmM caffeine on the 
m yofilam ents was exam ined. This dem onstrated that the shift in Ca2 + 
sensitivity produced by caffeine was similar in LIG and SH rabbits (figure 4.9). 
These experiments indicate that the enhanced SR Ca2+-loading observed in 
LIG trabeculae was not the result of increased responsiveness of the 
myofilaments to Ca2+.
Secondly, the release of Ca2+ by caffeine was examined in LIG and SH rabbit 
trabeculae. These experim ents show ed that lOmM caffeine released all
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'caffeine-releasable' Ca2+ from the SR and this effect had saturated in both
ligation and control rabbits at the concentration used in the SR experiments
i.e. lOmM (figure 6.1). Thus, one may conclude that caffeine was having a
similar effect on Ca2+ release in the two groups. However, it is theoretically
possible that in control rabbits, maximal concentrations of caffeine (even
50mM) released proportionally less of the total SR Ca2+ content compared
with LIG rabbits. This would result in an apparent increase in SR loading in
LIG trabeculae. The SR in control trabeculae m ight load Ca2+ to the same
extent and at the same rate as LIG trabeculae but might only release e.g. 50%,
of that loaded w hen challenged with caffeine compared w ith e.g. 100% in the
case of LIG preparations. Previous work has indicated that caffeine might not
Smith, McAinsh & Steele, 1994 
release all Ca2+ from the SR (Fabiato, 1985, .). However,
the saponin-treated preparations used in this study were 'p lunged ' into
caffeine causing a rapid increase in the [caffeine] w ithin the preparation.
Under these conditions, the release of Ca2+ by caffeine may, itself, generate
Ca2+ release by the mechanism of Ca2+-induced Ca2+ release (Fabiato, 1985)
and, therefore, it is likely that all Ca2+ was released from the SR in these
preparations.
In separate experiments, Ca2+ and tension were m easured simultaneously in 
saponin-treated trabeculae from a ligation and a sham -operated rabbit, using 
the Ca2+ indicator Fura-2. These experiments indicated that the SR Ca2+- 
loading curve, represented by the tension transient, follow ed a similar 
pattern  to that of the Ca2+ transient in both the LIG and SH rabbit (figure 
10.1). A lthough the numbers are small, this implies that the m easurements 
of tension alone, in the majority of experiments perform ed in this thesis, was 
indeed reflecting Ca2+ release from the SR under the various conditions, of 
[Ca2+] and loading-time, applied.
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Figure 10.1 Comparison of the tension and Ca2+ transients to assess SR 
C a2+-loading in a ligation and sham trabecula (loading [Ca2+] 200nM). The 
am plitude of the sham Ca2+ signal (open circle) and tension signal (closed 
circle) show a parallel response to increasing loading periods. A similar 
pattern  is seen in the ligation Ca2+ (open square) and tension signal (closed 
square). These values for LIG and Sham rabbits are norm alised to their own 
maxima and comparison between the am plitude of signals is not possible 
(hence why the LIG appear lower than SH).
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Figure 10.2 Representative Ca2+ (upper noisy trace) and tension transients 
from a Sham (Panel A) and ligation (Panel B) trabecula. The trabeculae used 
for these experiments were of similar size (~200jim diam eter). The Ca2 + 
transient from the sham is of a similar amplitude to the ligation but has a 
slow er rate of decay. The tension transient is, however, more brief in the 
sham . The Ca2+ and tension transients are super-im posed in panel C 
dem onstrating the more rapid decay phase in the LIG trabecula.
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A further interesting observation in these experiments was that the rate of 
fall of the Ca2+ transient was more rapid in the LIG Trabecula (figure 10.2) 
suggesting that there was a faster rate of Ca2+ re-uptake by the SR. This falling 
phase of the Ca2+ transient is dependent on diffusion characteristics of the 
individual preparation but can be affected by the rate of Ca2+ uptake by the SR 
(as dem onstrated by the effects of cAMP, figure 9.5). This provides further 
evidence to support the finding of enhanced SR Ca2+ uptake in LIG rabbit 
hearts.
Taken together, this evidence suggests that the caffeine contracture was a 
valid indicator of SR Ca2+ content in saponin-treated trabeculae in this study.
A driam ycin-induced cardiomyopathy
There w as evidence that the SR Ca2+-loading ability was greater in those 
anim als w ith evidence of significant m yocardial toxicity secondary to 
adriam ycin  adm inistration. Previous studies have suggested  that the 
long-term effects of adriamycin may be the result of block of the Ca2+ release 
channel of the SR thus rendering it less leaky (Dodd et al, 1993) while others 
had suggested increased leak from the SR (Pessah et al, 1990). The results 
from the present study suggest either that the SR Ca2+ pum p is more active 
or Ca2+-leak is reduced after chronic adriamycin treatment. Since adriamycin 
is know n to inhibit membrane pum ps (Boucek et al, 1987) then it is more 
likely that the enhanced Ca2+-loading resulted from a reduction in Ca2+-leak.
This finding may be considered further by examining the relative uptake and 
leak of Ca2+ from the SR under steady state conditions.
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The rate of uptake of Ca2+ by the SR can be described by the following 
equation:
The first part of the equation (on the right) represents the rate of Ca2+ uptake 
by the SR Ca2+ pum p and is dependent on the Ca2+ concentration outside the 
SR ([Ca2+]0), the second represents the efflux from the SR by active transport 
(dependent on SR internal Ca2+ concentration ([Ca2+]i» and the third portion 
represents the passive flux of Ca2+ across the SR m em brane, as defined by 
Fick's first law, where D is a diffusion constant. It is clear from this simple 
equation that a reduction in efflux of Ca2+ from the SR (second part) would 
result in an increase in the rate of uptake. Similarly, a reduction in both the 
first and second parts might result in no net change in the m easured rate of 
uptake.
This principle of altering SR Ca2+-loading ability by changing the balance of 
uptake and release provides a more interesting interpretation of changes in 
SR function rather than simply proposing a change in the rate of the SR Ca2+- 
ATPase pump.
Coronary ligation model of heart failure
This proved to be an extremely reliable and reproducible m odel of left 
ventricular dysfunction in the rabbit. The spectrum  of heart failure which 
results is beneficial in that it allows correlation of measurements m ade in the 
whole animal with those made at a cellular level over a range which spans 
severely impaired to essentially normal left ventricular function (but with an 
infarct present). In this way, ligation animals provide a complete group since 
the most appropriate "control' is a rabbit with an infarct bu t no significant LV 
dysfunction.
(Hara & Kasai, 1977)
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8 weeks following ligation there was evidence of significant LV dysfunction 
which correlated with the ability of the SR to load Ca2+. In a group of animals 
w ith the m ost consistent evidence of the heart failure, there was a m arked 
increase in SR Ca2+-loading (in both RV and LV) com pared with a group 
w ith less severe heart failure which, in turn, also demonstrated a greater SR 
Ca-loading than controls. At 15 weeks, the ability of the SR to load Ca2+ had 
returned to baseline levels, in RV trabeculae, with no significant difference 
from control hearts despite evidence of a similar degree of left ventricular 
dysfunction to that found in 8 week ligations. This suggests that there may be 
changes in SR Ca-loading which are not related to deterioration of left 
ventricular function bu t which occur with increasing duration of heart 
failure. Similar changes were reported by Afzal et al (1992) in a rat infarct 
m odel where SR Ca2+-uptake increased at 8 weeks then fell below control 
values 15 weeks after infarction. This period of increased uptake, early in the 
developm ent of heart failure, could represent a period of compensation 
which is followed by a gradual fall in SR Ca2+-uptake. In my study, at 15 
weeks, it is possible that SR Ca2+-uptake had not yet fallen below control 
values bu t if allowed to continue, beyond this time, a further fall m ight be 
observed.
H um an SR function in  heart failure
The hum an preparations studied represented a spectrum  of clinical disease 
from  very severe to m oderate LV dysfunction. The average duration of 
disease was approximately 3 years although the range was much larger (0.8-7 
years). In these patients there was a clear trend for SR Ca2+-loading ability to 
be negatively correlated with severity of heart failure (or pu t alternatively 
-positively correlated w ith LV function). Indeed, some of the patients with 
m oderate LV function dem onstrated caffeine contractures close to Cmax 
w hich represents a greater SR Ca2+ content than has previously been 
estim ated in the hum an (Bers, 1991). This could be interpreted as enhanced
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SR Ca2+-loading during moderate LV im pairm ent in the hum an similar to 
that observed in the 8 week ligation rabbits. The hum an trabecular numbers 
are small bu t the results in chapter 8 support the idea that the SR may 
respond to hypertrophy in a biphasic way - a period of enhanced function 
followed by a fall below control values as heart failure becomes more severe.
Adreno-receptor down-regulation
There was no evidence to suggest that chronic infusion of isoprenaline 
p roduced  a significant change in SR function in the rabbit. However, 
although there was some evidence for down-regulation, there was clearly a 
higher resting heart rate and cardiac output in the isoprenaline treated rabbits 
consisten t w ith  a reta ined  response to chronically  h igh  circulating 
catecholamines. Chronic phosphorylation of phospholam ban (for 7 days) 
p roduced  no m easurable change in SR Ca2+-loading. It is possible that 
phosphorylation, present in the heart before the animal was killed, did not 
persist beyond saponin-treatm ent as a result of the action of endogenous 
phosphatase enzymes. This did, however, raise the question as to whether 
the baseline state of phosphorylation of SR-phospholamban could influence 
the C a2+-loading  ability  as m easured  in the sapon in -trea ted  fibre. 
Saline-infused rabbits (control m ini-osm otic pum ps), given boluses of 
isoprenaline w ithin 15 m inutes of being killed, failed to dem onstrate an 
increased rate of SR Ca2+-loading compared with other control animals not 
given isoprenaline imm ediately before death (figure 7.3). There are three 
possible reasons for this finding: (i) dephosphorylation by endogenous 
phosphatases occurs rapidly before skinning or (ii) dephosphorylation occurs 
d u rin g  sapon in  trea tm en t or (iii) all the con tro ls w ere equally  
phosphorylated  as a result of high endogenous levels of catecholamines 
immediately prior to excision of the heart.
V ariation in the level of SR-phosphorylation is im portan t since it may 
account, at least in part, for the reduced SR Ca2+-loading observed in severe
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hum an heart failure where levels of phospholamban have been reportedly 
reduced (Arai, Alpert, MacLennan, Barton & Periasam y, 1993). There is 
certainly a need to repeat these experiments both in the rabbit and in the 
hum an under conditions where intracellular phosphorylation is minimised. 
This could be done in the rabbit by administering (3-blockers intra-venously 
im m ediately before excision of the heart, placing (3-blocker in the Ringer 
solution used for dissection or by bathing the saponin-treated trabecula in a 
so lu tion  containing a pro tein  phosphatase enzym e before assessing 
Ca2+-loading.
Response to cAMP
The hypothesis being tested in this chapter was that the SR Ca2+-pum p was 
more phosphorylated in LIG rabbits and would respond less to cAMP than 
controls. Ligation and sham rabbits demonstrated a similar response to cAMP 
with the LIG rabbits showing a tendency for a slightly greater response. The 
isoprenaline treated rabbits also dem onstrated an increased response to 
cAMP compared with controls. The greatest increase in SR Ca2+-loading in 
response to cAMP was observed in hum an preparations. These results 
indicate that the preparations in which a reduced level of phospholamban 
was expected demonstrated the greatest sensitivity to cAMP. The reason for 
this ra ther paradoxical result is unclear bu t there are a num ber of 
possibilities. Firstly, the levels of phosphodiesterase enzyme may be reduced 
in those failing hearts therefore reducing the breakdow n of exogenously 
applied cAMP. Secondly, the levels of protein kinase may be different and 
thirdly the activity of phosphatase enzymes may also be different. The ideal 
experiment (which is planned) would be to, firstly, treat the preparation with 
phosphatase enzyme then apply phospholamban stim ulating antibody and 
observe the increase in SR Ca2+-loading. This rem oves the problem  of 
interm ediary metabolism of cAMP and places the SR from failing and non­
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failing  tissue in a sim ilar baseline state before p h o sp h o ry la tin g  
phospholam ban by exogenous means.
Changes in SR function during the progression of heart failure
The combined results of this study of SR Ca2+ regulation in rabbits and 
hum ans with heart failure suggest that there may be a biphasic response of 
the SR to progressive left ventricular dysfunction. Early after a myocardial 
infarction there is a period of com pensation w here SR Ca2+-uptake is 
enhanced. As heart failure becomes more severe or prolonged there is a 
reduction in Ca-loading ability which eventually reduces below control 
levels.
There are a num ber of ways in which these changes m ight occur but one 
hypothetical scheme is described in figure 10.3. This scheme takes account of 
the findings of this thesis with enhanced uptake at 8 weeks, normal (or not 
different from controls at 15 weeks) and diminished Ca2+-loading in humans 
w ith a longer history of heart failure. Since the rate of Ca2+ uptake by the SR 
is the result of the net Ca2+ loaded m inus the net Ca2+ leaked then, by 
implication, the relative proportion of Ca2+ pum ps and Ca2+ release channels 
w ill determ ine the quantity of Ca2+ loaded by the SR during any given 
loading period (i.e. Net Ca2+-loaded = Ca2+-uptake - Ca2+-leaked). Since very 
few studies have indicated that the rate of the SR Ca2+ pum p is increased in 
heart failure this model assumes that there is, initially, no change and then a 
gradual fall in the rate of Ca2+ uptake (open circle). For the total or net Ca2+ 
loaded to be increased there would require to be a more rapid  fall in the 
num ber of Ca2+ release channels (open squares). This combination of changes 
w ould result in an initial rise in net SR Ca2+-loading (closed circles), a fall 
back to baseline values and then a reduction as both Ca2+-pum p and leak 
rates reduced further. The curve representing the net Ca2+ loaded is simply 
the arithmetic sum of the other two curves.
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Figure 10.3 Hypothetical scheme for changes in SR Ca2+-loading, w ith time, 
during the development of heart failure.
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This biphasic change in SR Ca2+-loading w ould tend to predispose the 
myocyte to Ca2+ overload in the early and late stages of heart failure but by 
different mechanisms. In the early stages of heart failure while net SR Ca2+- 
loading was increased his w ould tend to over-fill the SR resulting in 
spontaneous Ca2+ release as dem onstrated in the ligation rabbits. These 
spon taneous releases of Ca2+ could generate triggered  activity and 
arrhythmias. In the later stages of heart failure reduced net SR Ca2+-loading 
m ight predispose the myocyte to cytosolic Ca2+ overload which could also 
generate arrhythmogenic activity. The overall picture is one of disturbed Ca2+ 
regulation w ithin the cell which could act to alter contractile function and 
predispose to arrhythmogenesis.
There are several qualifications to this model which deserve consideration. 
The relative contributions of SR Ca2+-uptake and leak described in the 
equation (page 228) apply to steady state conditions and the majority of 
m odels of Ca2+ efflux and influx have been based on such steady state 
conditions in isolated SR vesicles (Feher & Briggs, 1983). There is no 
evidence to indicate that this condition applies in the physiological setting 
where time periods involved are short, processes occur more rapidly and 
where the SR may never reach a state of equilibrium during the cardiac cycle. 
However, although this is true, the hypothesis is valid in that it goes some 
way to explain the experimental findings of this thesis since at longer loading 
periods (100-150s), in saponin-treated trabeculae, these conditions of steady 
state are relevant. The second im portant qualification has already been 
discussed in some detail. It is assum ed that the phosphorylation state of 
phospholam ban is similar in failing and non-failing m yocardium  to allow 
claims that the relative pum p and leak rates are intrinsically altered in failing 
m yocardium. As was revealed in the experiments using cAMP this may be a 
false assum ption and requires further investigation.
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